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ABSTRACT
DeVilbiss, Frank T. PhD, Purdue University, May 2016. Is Metabolism Goal-Directed?
Investigating the Validity of Modeling Biological Systems with Cybernetic Control via
Omic Data. Major Professor: Doraiswami Ramkrishna.
Cybernetic models are uniquely juxtaposed to other metabolic modeling frameworks in that they describe the time-dependent regulation of cellular reactions in
terms of dynamic “metabolic goals.” This approach contrasts starkly with purely
mechanistic descriptions of metabolic regulation which seek to explain metabolic processes in high resolution - a clearly daunting undertaking. Over a span of three
decades, cybernetic models have been used to predict metabolic phenomena ranging
from resource consumption in mixed-substrate environments to intracellular reaction
fluxes of intricate metabolic networks. While the cybernetic approach has been validated in its utility for the prediction of metabolic phenomena, its central feature, the
goal-directed control strategy, has yet to be scrutinized through comparison with omic
data. Ultimately, the aim of this work is to address the question “Is metabolism-goal
directed? through the analysis of biological data. To do so, this work investigates the
idea that metabolism is goal-directed from three distinct angles.
The first is to make a comparison of cybernetic models to other metabolic modeling frameworks. These mathematical formulations for intracellular chemical reaction
networks range from purely mechanistic, kinetic models to linear programming approximations. Instead of comparing these frameworks directly on the basis of accuracy
alone, a novel approach to systems biological model selection is developed. This approach compares models using information theoretic arguments. From this point of
view, the model that compresses biological data best captures the most regularity
in the data generated by a process. This framework is used to compare the flux

xvi
predictions of cybernetic, constraint-based and kinetic models in several case studies.
Cybernetic models, in the test cases examined, provide the most compact description of metabolic fluxes. This method of analysis can be extended to any systems
biological model selection problem for the purposes of optimization and control.
To further examine cybernetic control mechanisms, the second portion of this
dissertation focuses on confronting cybernetic variable predictions with data that
is representative of enzyme regulation. More specifically, the dynamic behavior of
cybernetic variables, ui , which are representative of enzyme synthesis control are
matched with gene expression data that represents the control of enzyme synthesis
in cells. This comparison is made for the model system of cybernetic modeling,
diauxic growth, and for prostaglandin (PG) metabolism in mammalian cells. Via
analysis of these systems, a correlation between the dynamic behavior of cybernetic
control variables and the true mechanisms that guide cellular regulation is discovered.
Additionally, this result demonstrates potential use of cybernetic variables for the
prediction of relative changes in gene expression levels.
The last approach taken to test the veracity of cybernetic control is to develop a
technique to mine objective functions from biological data. In this approach, returns
on investment (ROIs) for various pathways are first established through simultaneous
analysis of metabolite and gene expression data for a given metabolic system. Following this, the ROIs are used to determine a metabolic systems observed “goal signal.”
Gene expression data is then mined to select genes that show expression changes that
are similar to the goal signal’s behavior. This gene list is then analyzed to determine
enriched biological pathways. In the final step, these pathways are then surveyed
in the literature to establish feasible metabolic goals for the system of interest. This
method is applied to analyze diauxic growth and prostaglandin systems and generates
objective functions that are relevant to known properties of these metabolic networks
from the literature. An enhanced understanding of metabolic goals in mammalian
systems generated by this work reveals the potential utility of cybernetic modeling in
new directions related to translational research.
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Overall, this investigation yields support of the notion of dynamic metabolic goals
in cells through comparison of metabolic modeling approaches and through the analysis of omic data. From these results, a lucid argument is made for the use of goaldirected modeling approaches and a deeper understanding of the optimal nature of
metabolic regulation is gained.
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1. INTRODUCTION
Cybernetic models have been used, for a period that now spans over three decades, to
predict a variety of metabolic phenomena. From their initial starting point in describing diauxic growth in a highly lumped fashion, they have been modified and advanced
to provide descriptions of complex metabolic behavior including intracellular reaction
fluxes and support efforts in metabolic engineering.
1.1 “Are cybernetic control variables a good approximation of cellular regulation?”
The distinguishing feature of cybernetic models of metabolism is the inclusion of
control variables that represent the modulation of cellular chemical reactions towards
goals. While cybernetic models have had much success in predicting a variety of
metabolic phenomena, this control policy merits further scrutiny and validation. This
dissertation seeks to test the veracity of cybernetic control as a means of describing
the bulk of regulatory actions undertaken by cells. To examine cybernetic control
further, several approaches will be taken.
The first is to make a comparison of cybernetic models to other metabolic modeling frameworks. The mathematical formulations of these descriptions of intracellular
chemical reactions range from purely mechanistic, kinetic models to linear programming ones. Instead of comparing these frameworks directly on the basis of accuracy
alone, a novel approach to systems biological modeling is developed. This approach
compares models using information theoretic arguments. Through the lens of this approach, the model that compresses biological data best, captures the most regularity
in the data that the process generates. In establishing the fact that cybernetic models
provide the most compact description of metabolic dynamics relative to other models,
the control goals that make them unique are validated in their pragmatism. They
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provide accurate predictions that require less effort for parameterization and model
specification. This method of analysis can be extended to any systems biological
model selection problem for the purposes of optimization and control.
To further verify cybernetic control, the second portion of this dissertation focuses
on the comparison of cybernetic variables with data that is representative of enzyme
regulation. More specifically, the dynamic behavior of cybernetic variables, ui , which
are representative of enzyme synthesis control are matched with gene expression data
that represents the control of enzyme synthesis in cells. This comparison is made for
the model system of cybernetic modeling, diauxic growth, and for prostaglandin (PG)
metabolism in mammalian cells. From this analysis, it becomes clear that there is
a strong correlation in the dynamic behavior of cybernetic control variables and the
true mechanisms that guide cellular regulation. This makes a strong argument for the
validity of cybernetic control mechanisms. Additionally, this analysis demonstrates
how cybernetic variables could be used to make predictions about the relative changes
in gene expression data for a given application.
The last approach taken to test the veracity of cybernetic control is to make an
attempt at mining objective functions from biological data. If one can determine
feasible metabolic goals through unbiased analysis of cellular observations, a strong
argument for goal-directed metabolism is made. In this approach, returns on investment (ROIs) for various pathways are first established through simultaneous analysis
of metabolite and gene expression data for a given metabolic system. Following this,
the ROIs are used to establish a metabolic systems observed “goal signal.” Gene
expression data is then mined to determine genes that show expression changes that
are similar to the goal signal’s behavior. This gene list is then analyzed to determine
enriched biological pathways. These pathways are then surveyed in the literature to
establish feasible metabolic goals for the system of interest. This method is applied to
diauxic growth and prostaglandin systems and is used to generate verifiable objective
functions.
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Overall this dissertation demonstrates the veracity of cybernetic control through
comparison of metabolic models and also through the analysis of omic data. In
accomplishing this task, a lucid argument is made for the use of goal-directed modeling
approaches. Moreover, a deeper understanding of the optimal nature of metabolic
regulation results.
1.2 Organization of Dissertation
The organization of this dissertation is as follows. In chapter 2, extensive coverage
of literature relevant to metabolic modeling is made. This should serve to provide
context to the cybernetic approach and the research questions at hand. In chapter 3,
an information theoretic model selection framework is developed for systems biological
applications. This helps to show that cybernetic models provide a more succinct
description of metabolic dynamics than other approaches. Chapters 4 and 5 cover the
validity of the matching cybernetic variable via its comparison with time-dependent
changes in gene expression data. Chapter 6 establishes a case for mining omic data
for objective functions and for improved parameterization approaches for cybernetic
models through a discourse on some shortcomings in the framework with making
postulates about objective functions. Following this, Chapter 7 introduces a method
to mine omic data for metabolic goals. Chapter 8 provides for an improved method
of parameterizing cybernetic models that is computationally efficient. Chapter 9
summarizes the findings of this work and Chapter 10 covers some recommendations
for future work.
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2. BACKGROUND AND LITERATURE REVIEW
Many formulations have been developed to model and characterize metabolic processes. Among these, the cybernetic framework stands out in its ability to describe the
evolution of metabolism using the concept that the cell has some preprogrammed artificial intelligence coordinating the complex mechanisms that drive metabolic changes.
This behavior comes about through the iterative refinement of organisms via an evolutionary process which converges upon this seemingly optimal behavior. From the
Darwinian viewpoint, organisms that are more refined towards achieving goals related
to their survival are better equipped to pass on their genes to the next generation.
Behaviors that demonstrate optimality, in other words, those which conform to perfected survival strategies, will be the most competitive and outlasting. The following
review of relevant research seeks to provide the reader with an understanding of prior
work to date in the field of cybernetic modeling and to give context to the cybernetic
framework by discussing other metabolic model formulations.
2.1 Cybernetic Modeling
Cybernetic modeling of metabolism, at its core, embodies a framework of ordinary
differential equations that describe the time-dependent evolution of metabolite and
enzyme concentrations. In cells, these changes in concentrations, both inside and
outside of the cell, are governed by the directed actions of a host of complex biological machinery. The main feature of cybernetic models is the inclusion of control
variables that interpret the sum of these regulatory processes as actions that seek a
goal related to the cell’s survival. Without knowing the full detail of all mechanisms
related to biological control, these variables endow the cybernetic approach with the
ability to describe changes in metabolites in a host of biological systems with accu-
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racy. Monod’s seminal work upon the diauxie provides a cornerstone for the study of
biological regulation and inspired the first cybernetic models [1]. Monod subjected
Bacillus coli cells to environments with multiple carbon substrates upon which the
cells could grow. From this, the changes in substrate and cell concentrations were
tracked over time and it became apparent that the cells preferred some substrates
over others and would not simultaneously consume carbon sources simply according
to the relative concentrations of substrates available. Describing the diauxie was the
first system described by the cybernetic approach as it embodies a foundational study
of regulatory phenomena in biology.
2.1.1 Lumped Cybernetic Models
Cybernetic modeling started almost 30 years ago with the goal of modeling microbial growth on multiple substrates using the control variable ui to describe resource
allocation for enzyme generation for each substrate’s digestion [2]. This simple model
was then expanded upon in Kompala’s work which included the variable vi as an
approximation of the modification of enzyme activity for the digestion of different
substrates [3]. Following this, constitutive enzyme synthesis was incorporated into
the framework [4]. In other work by the same authors, provisions were added to describe maintenance, non-growth associated processes, within the cell [5]. This model
was able to explain the behavior of cell cultures at low growth rates on single and
multiple substrates. However, it was incapable of predicting transients in continuous
culture. To remedy this, Baloo and Ramkrishna included specifications for cellular
resources that become limited during the lag period in step-up experiments, namely
transcriptional resources for enzyme production [6, 7]. Also included were control
variables that described competition among growth and maintenance processes on
single and multiple substrates.
Pushing the framework forward, using dynamic analysis, Narang observed that
Kompala’s model was unable to describe the simultaneous uptake of substrates and
organic acids given their structural rigidity [8]. This was in part due to the assump-
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tion that growth rate on a mixture is never greater than the maximum growth rate
of individual substrates. Moreover, the structure of Kompala’s model regarded the
formation of biomass from substrate as a single step. Reworking this framework to
include generic M1 and M2 biomass precursors, Ramakrishna et al. were able to
describe simultaneous uptake patterns in mixtures of substrates [9]. Until Ramakrishna’s model, the cybernetic approach had been highly lumped. The inclusion of
biomass precursors marks a departure in cybernetic approach from simple substrate
pathways towards applications in metabolic engineering and systems biology because
it describes the formation of biomass in multiple steps.
2.1.2 Structured Cybernetic Models
The subsequent class of cybernetic models decomposed the aforementioned lumped
pathways into functional units that reference individual parts of the metabolic networks. The first effort in this direction sought to apply cybernetic principles related
to resource competition among generic features present in metabolic networks including linear, branched and cyclic pathways [10]. In principle, these features could
be modeled with local objective functions and then integrated together to develop
models for larger networks.
Expanding the scope of this work with the explicit desire to apply the cybernetic
approach to metabolic engineering applications, Varner and Ramkrishna postulate
that individual enzymes are controlled by the product of both local and global objective functions where the local objectives determine resource allocation within pathways while global objectives determine regulation between different pathways [11,12].
These local and global control policies complement one another towards the cell’s
ultimate goal of survival. Using these ideas, a framework for predicting the behaviors
of genetically modified microorganisms is proposed using metabolic control analysis to analyze the sensitivities of enzymes. This framework was used to describe
modification of amino acid synthesis within Cornyebacerium lactoferum using overexpression [13]. In a later work, a model was developed to describe gene knockouts
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in Escherichia coli which provided an accurate prediction of almost all flux ratios
in central carbon metabolism’s split points. Following this, Namjoshi et al. showed
how these structured cybernetic models can be used to predict steady-state multiplicity for hybridoma cells in chemostat reactors using a highly simplified reaction
network [14, 15].
Within Young et al.’s work, a refined the notion of global control variables was
introduced to depict the regulation of various modules of metabolism in the central
carbon metabolism of E. coli [16]. Essentially, the global control variables coordinate the control of metabolism to maximize the rate of formation of various growth
precursors which results in the dynamic maximization of growth. This model is then
able to predict the behavior of wild-type and acetate knockout strains of bacteria.
The key element of this work is how it divides the metabolic network into related
components which are similarly controlled.
Also of note, Young et al. analyzed the cybernetic framework underneath the
microscope of optimal control theory and compared a variety of control policies in
order to demonstrate their relative merits related to growth in mixed substrate cultures [17]. Of these policies, the enzyme weighted matching and proportional laws
proved the best fit to data demonstrating the validity of cybernetic models.
2.1.3 Pathway Cybernetic Modeling
While structured cybernetic models could be used to model problems relevant to
metabolic engineering, their formulation was cumbersome in that the metabolic network analysis underpinning their formulation, first prescribed by Straight et al. [10],
relied upon the modeler’s intuition when dividing the network into various modules.
This subjective approach cannot easily be extended to an arbitrarily defined network
which is a significant limitation. To more systematically incorporate reaction networks into cybernetic regulation, a new class of cybernetic models were developed
using elementary flux modes (EFMs) by Young et al. [16]. EFMs describe the fundamental, non-decomposible pathways through a metabolic network from beginning
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point to end point [18]. Given that the generation of EFMs entails an unbiased and
comprehensive breakdown of the network into its basic functional units, modeling networks on the basis of EFMs provides a more consistent and generalizable approach. In
the first cybernetic model using EFMs, Young et al. decomposed a simplified network
of 12 reactions into 8 EFMs and described the regulation of these pathways in order
to achieve the objective of maximizing biomass [16]. Note that in order to apply this
method, one must use a lumped biomass reaction which represents the conversion of
precursors, ATP and NADH into a unit of biomass.
Expanding upon this framework, Kim et. al described a similar model termed
Hybrid Cybernetic Model (HCM) in which the maximization of substrate uptake was
the objective function [19]. The main difference between HCM and Young’s model is
that the former makes use of a quasi-steady state hypothesis about the concentration
of metabolic intermediates which relieves the HCM framework of its need for kinetic
parameters related to intermediate reactions. To implement the objective function
of substrate uptake maximization, in terms of the cybernetic variable, the coefficient
for substrate uptake in each EFM was used to weight the return on investment. This
approach yielded a slightly better fit to the data as compared to Young’s model for
the simplified 12 reaction network. Also, the expression of each EFM in terms of the
cybernetic variable profile was also different in Kim’s model. The HCM framework
was then applied to a more complicated metabolic network for E. coli strain GJT001
which included 23 different reactions. This more complicated network incorporates
the pentose phosphate pathway (PPP) and oxaloacetate formation as an intermediate
in the production of succinate. The lumped biomass reaction contains 14 biosynthetic
reactants compared to the 3 reactants in the simpler network. This more detailed
model helps to demonstrate HCM’s potential to be applied to more complex reaction
networks.
HCM has also been used to identify a multiplicity of steady states in a chemostat
reactor for the GJT001 strain growing on mixtures of glucose and pyruvate [20]. The
model was composed of EFMs that described the sole uptake of glucose, pyruvate

10
as well as mixed modes for the combined uptake of both substrates. Depending
on which direction the steady state was established from (i.e. from low dilution
rate to high or the opposite), different combinations of EFMs would be activated.
Mathematically, this is the result of the nonlinear nature of the equations describing
the biological phenomena. This steady state multiplicity was later validated via
experimental observation in [21].
One of the main drawbacks of HCM is the number of parameters required to
describe the unregulated kinetics of each pathway. As the number of reactions in
the network increases the number of EFMs undergoes a combinatorial explosion.
In order to address this, Song and Ramkrishna proposed Yield Analysis (YA) to
pick out the EFMs that defined extreme edges circumscribing the convex hull in
yield space [22]. Using YA, one could drastically reduce the parameterization of
HCM by only considering these edges as many EFMs can be represented as a convex
combination of the selected subset of EFMs and still retain an ability to model the
majority of the possible metabolic phenotypes using all EFMs.
Further expanding upon this idea that the pathway-based cybernetic model can
be parametrically simplified, Song and Ramkrishna introduced a Lumped Hybrid
Cybernetic Model (LHCM) in which EFMs for specific substrates are weighted and
summed into a single flux mode based upon each EFM’s ability to generate ATP
for maintenance and biomass for growth [23]. Using this lumping scheme, the total
set of EFMs is first divided into substrate specific groups. Within these groups, a
structural return on investment (s-ROI) is calculated based off of the yield of biomass
and ATP in each EFM. The EFMs within the substrate group are then combined
with a weighted sum based off of each EFM’s s-ROI. This drastically reduces the
parameterization of this type of model however there is a tradeoff in that the modes
within each substrate group are not subject to dynamic control only the lumped
EFMs have cybernetic variables regulating their changes in expression and activity
over time. Another issue with the original formulation of Song and Ramkrishna was
the fact that the lumping process severely reduces the amount of possible metabolic
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states that can be modeled. To address this, Song and Ramkrishna added tuning
parameters in the lumping process that are designed to fit the lumped elementary
modes to yield data [24].
L-HCM has been used in a variety of applications relevant to metabolic engineering. It has been used to model the behavior of different strains of E. coli with the same
general metabolic network. It has also been used to model the behavior of mutant
E. coli strains using limited wild-type data demonstrating its relevance to metabolic
engineering [25]. L-HCM has also been used to calculate the metabolic fluxes of reactions related to the complex growth phases of Shewanella oneidensis (MR-1) on
lactate [26]. When compared to flux predictions generated by Flux Balance Analysis
(FBA), the L-HCM model demonstrated better predictive ability. These practical
applications of the L-HCM framework help to display the validity of lumping as a
tool to simplify the parameterization of pathway based cybernetic models.
2.2 Other Metabolic Modeling Tools
There are a wide variety of other modeling tools available to one who would like
to describe various aspects of metabolism. Kinetic models, describing the rates of
different metabolic reactions as a function of metabolite and enzyme concentrations,
are often used to describe the dynamics of metabolism. Other approaches that mainly
consider stoichiometric information, termed constraint-based models (CBM) like flux
balance analysis (FBA) offer one an ability to quickly ascertain general features related to metabolic fluxes through a given network. Depending on the system, certain
models are more appropriate than others. The discussion that follows intends to outline the general features of analytical tools for metabolic engineering that intersect in
functionality with the cybernetic framework.
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2.2.1 Kinetic Models
Kinetic models are formulated using a system of first order ODEs that track the
changes in concentration of various chemical species. The rates of chemical reactions are determined by appropriately formulated rate expressions that dictate the
speed at which chemical species are transformed from one type to another. Typically, rate expressions are formulated in a manner that captures the behavior of
enzymes. Approximations of enzymatic behavior can range from simple linear kinetics or Michaelis-Menten kinetics to complex forms like Monod-Changeux-Wyman
kinetics [27]. While linear kinetic models may be considered to be an oversimplification of enzymatic reactions, they lend themselves to convenient analytical techniques
that determine criteria such as stability around steady states [28]. Nonlinear kinetic
descriptions of enzymes, such as Michaelis-Menten kinetics, also approach linear behavior when the substrate concentration is significantly lower than the reaction’s
Michaelis-Menten constant.
As time moves forward, progressive degrees of complexity are being incorporated
into kinetic models of biological phenomena. Provisions for regulation mechanisms in
metabolism like allosteric interactions, transcriptional regulation and signaling serve
to shed light on the feedback structures within metabolic processes [29, 30]. While
there is an increasing breadth of omic data available to aid in the development of kinetic models, the determination of kinetic parameters is still a pressing problem [31].
Limitations in the amount and resolution of data make nonlinear regression difficult.
Also challenging is the fact that modeling intuition is needed when determining which
interactions are necessary in a model and which ones can be lumped together. Ensemble modeling approaches can help the modeler determine which interactions are
necessary to include but require significant computational input to implement [32].
Also adding to the difficulty of kinetic modeling is the fact that, in vivo, many parameters related to biological phenomena change from what is measured in vitro.
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2.2.2 Constraint-Based Models
CBMs on the other hand, offer quick solutions to determine metabolic fluxes with
minimal parameterization. Using the stoichiometric matrix describing metabolic reactions, CBMs can be used to analyze theoretical yields of various pathways and
determine metabolic overflows. FBA is formulated as a linear programming problem designed to find the metabolic pathway that optimizes some objective function.
These objective functions can take the form of maximization of biomass yield in
single cellular organisms [33] or minimization of reactive oxygen species (ROS) in
hybridoma cells [34]. To determine the behavior of a modified network, a relevant
constraint-based approach is minimization of metabolic adjustment (MOMA) which
uses quadratic programming to solve an objective function that seeks a flux distribution that minimizes the norm between an original flux distribution and a perturbed
one [35]. This approach is useful for predicting the phenotypes of various knockout strains. Another useful feature of MOMA is that it does not require the input
of substrate uptake rates to make predictions. Similar to MOMA, regulatory on/off
minimization predicts alternate flux distributions for gene knockouts. Instead of minimizing the total change in all fluxes, ROOM identifies a solution of the lowest number
of individual fluxes changed using MILP in which a vector of Boolean variables classifies whether the vector of fluxes has been changed from its original formulation and
is summed [36].
Investigating the validity of different objective functions to be used in the FBA
approach, specifically maximization of growth rate, Schuetz et al. generated a Paretooptimal surface to model the tradeoffs between a set of objective functions [37]. Comparing CBM predictions determined by different combinations of the objective functions of growth maximization, ATP maximization and minimizing the sum of fluxes
with actual data from nine different organisms, it is shown that metabolic data is
close to the Pareto-optimal surface determine by combinations of objective functions.
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CBMs are also readily applied to large, genome-scale networks for quick analysis of
metabolic states.
The main weakness of CBMs is the exclusion of the dynamics and regulation inherent to biological systems [38]. Attempting to add time-dependent considerations
into this framework, dynamic Flux Balance Analysis (dFBA) adds either a static or
dynamic optimization approach into calculating the flux distribution [39]. However,
constraining these predictions is the fact that the objective functions are calculated
towards the maximization of yield given a network structure and do not make use of
actual kinetic information regarding the network. Another weakness, as compared to
kinetic models, is that CBMs do not accomodate intracellular metabolic concentrations.
2.2.3 Biochemical Systems Theory
Biochemical systems theory (BST) is a simple modeling approach that is able to
capture the full dynamics of complicated systems [40]. The change in each metabolite
is modeled using easily analyzed power-law expressions that describe the rates of formation and degradation of different species in the system. All changes in metabolites
ẋi are described with expressions of the form:

ẋi = αi

Y
j

g

xj ij − βi

Y

h

xj ij

j

The parameters αi and βi are constants of formation and degradation and are
constrained at values above zero. The exponents gij and hij in the model describe
xj ’s participation in the formation or degradation of species xi . Even signaling effects
like inhibition or activation of enzymes can be modeled for species xj by specifying
an appropriate gij or hij . Using BST, one can model the response of the system
to perturbations, steady states, and complex oscillatory phenomena. While easily
generated, a major drawback of BST is that it is unclear if the model can be used
over a wide range of physiological conditions, especially those far from what was

15
used to parameterize the model. Moreover, the physical meaning of the exponents is
unclear. BST has been used for a variety of applications including the modeling of
the growth of E. coli on glucose [41].
2.2.4 Metabolic Control Analysis
Toward the metabolic engineering of different biochemical pathways within cells,
there exists a strong desire to effectively manipulate elements of the pathways for
certain applications. While one may wish to manipulate a biochemical pathway to
increase or decrease its throughput, manipulation of the rate-limiting step is not
necessarily the best way to do this. Unforeseen control interactions or pathway dependencies can prevent one from truly achieving this goal. Metabolic control analysis
(MCA) is designed to systematically and qualitatively gauge the amount of control
each enzyme and effector has on the overall flux of a pathway [42, 43]. MCA is useful
in that it can help one determine the most appropriate modification for a pathway,
however the predictions it provides are limited to conditions from which the control
coefficients are calculated. These control coefficients can also be generated from a
kinetic model describing the dynamics of a pathway.
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3. MODEL SELECTION PROBLEM: RELATIVE COMPRESSION OF
SYSTEMS BIOLOGICAL DATA BY CYBERNETIC MODELS
Chapter Summary
The field of systems biology thrives upon the use of models to organize biological knowledge and make predictions of complex processes that are hard to measure.
When attempting to generate model descriptions for metabolic systems, one arrives
at a crossroads. A variety of mathematical explanations are available for metabolic
data with varying degrees of resolution from simple to complex. Biological modelers often rely upon subjective arguments to choose one framework over another.
While there is no universal rule to determine the absolute utility of a model, certain
metrics founded on information theoretical principles, demonstrate promise in providing a coherent, rational, and objective basis for addressing this model selection
problem in systems biology. A model seeks to capture the regularity in biological
data. Models that best capture regularity in data without excessive complexity are
the most useful for applications in optimization and control. To demonstrate the
efficacy of such an approach, several metabolic model selection scenarios are investigated. This work develops the argument that information theoretic model selection
metrics should be extended to non-nested model comparison applications in systems
biology. It also makes a novel comparison of kinetic, constraint-based and cybernetic
models of metabolism based not only on model accuracy, but also model complexity.
The results show the strengths of Lumped Hybrid Cybernetic Model (L-HCM) and
Flux Balance Analysis (FBA) for applications in steady state flux prediction. Also,
the Hybrid Cybernetic Model’s (HCM) merit in the modeling of dynamic changes in
fluxes is also established.
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3.1 Introduction
When given an arbitrary set of data, one can generate a host of different mathematical descriptions for it. Metabolic systems are no exception and embody an
important branch of systems biological study. In order to predict the effects of perturbations to metabolic networks such as deleting genes or inhibiting enzymes, it is
useful to first use a model to understand, without additional experimentation, the
effects of such modifications. To model the changes in metabolic systems, one can
select kinetic, constraint-based or cybernetic formulations. Each of these metabolic
models are unique in formulation and are widely used for similar goals.
In very general terms, the utility of a model is derived from its ability to describe
regularity in data. Regularity, or coherence in a set of data, means that the data is
generated as the result of some intelligible process [44]. For metabolic flux data, each
type of model is able to capture the coherence of metabolic processes to a certain
degree. These models also have varying degrees of complexity which are used to
explain the behavior of data. To establish which model is best for the purposes of
optimization and control, it is proposed that models are selected on the basis of how
well they are able to capture the regularity of data without being excessively complex.
In this work, a number of widely used mathematical approximations of metabolic
systems are compared according to the ability of each to capture regularity in data.
While there is much discourse on the merits of each modeling framework [45–49], no
systematic method has been implemented to quantitatively and simultaneously measure the relative accuracies and complexities of metabolic models. This work, applies
information theoretic metrics, well-known in other fields, to address this problem.
Treating each model as an entity that compresses data for communication through
a channel, one can quantitatively evaluate how well a model balances accuracy and
complexity. Models that accurately reproduce data with low complexity require less
information to communicate and embody a more compressed description of a pro-

19
cess’s data. This method of evaluation is especially useful in situations where model
formulations are vastly different (i.e. non-nested).
The establishment of the model that best minimizes penalties for both error and
parameterization is deemed to be the best model for an application related to the
optimization and control of biological systems. Restated, there is a point in diminishing returns for model complexity. Additional parameters may enhance accuracy,
but each additional parameter has an intrinsic cost associated with it.
A set of 4 distinct models of metabolic fluxes are judged in their ability to describe
metabolic reaction rates at a given steady state. Following this, dynamic metabolic
models are compared in their ability to predict changing metabolic fluxes. These
dynamic models of metabolic fluxes have never been compared in this objective fashion. Neither have such a wide range of steady state descriptions of metabolic fluxes
been compared. The application of these metrics in these scenarios helps to establish
a new way of thinking about metabolic model selection. Moreover, a quantitative
framework for comparing non-nested biological models is necessary to introduce to
the field of systems biology.
3.2 Methods
3.2.1 Theory
To develop the model selection framework, it is first useful to review some basic tenets of information theory for those who might be unfamiliar. In the field of
communication, signals that are being passed through a channel are analyzed and
compressed depending on how much regularity is present in a given message. Compression is a useful tool in that shorter messages lead to faster communication. For
example, consider the two messages below:
a. 011010111010010001011
b. 000010000000000000000
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Sequence (a) is generated from some arbitrary process where either 0 or 1 share
equal probabilities of occurence. Sequence (b) on the other hand is generated from a
process where the probability of 1 is 1/20. To communicate either sequence, one could
send each 1 or 0 value individually or one could compress the information down into
a shorter sequence. Given the fact that either ones or zeros are equally probable in
(a), it is virtually incompressible. Sequence (b), on the other hand, can be shortened
in a number of ways.
For example, sequence (b) can be simply described by specifying the position of
the single one rather than the whole sequence assuming the decoder understands the
compression scheme. In case (b), one could rewrite the sequence as “5” specifying the
location of the single 1. For this 20 bit sequence, specifying the position of a single
one in any of 20 possible locations requires up to 5 bits (d(log2 (20)e) instead of 20 for
compressing any position in the sequence of 20 bits. This represents a compression
factor of 0.25 compared to communicating the entirety of the original sequence. Other,
more efficient coding schemes are possible and the fundamental limit of compression
of these data sequences is quantified using Shannon’s entropy [50]
H(x) =

X

pi log(pi ),

(3.1)

i

in which pi represents the probability of a 0 or 1 occurring in the sequence. The
motivation for compression is increasing the overall rate of communication. The more
compressed a message is the less time is spent communicating it. In terms of entropy,
the highest entropy sequence will consist of bits generated by the method of (a). In
the same way that a message can be compressed by a proper coding scheme, we can
say that biological data can be compressed by a model. It is here where the minimum
description length princple (MDL) becomes useful in that one can reinterpret the
model selection problem as one of data compression [44]. The aim is to shrink the
data D into some D0 from which D can be perfectly reconstructed after compression.
For some model M , there is a length of the data L(D0 ) that is determined as
L(D0 ) = L(D|M ) + L(M ),

(3.2)
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where L(D|M ) expresses the data in terms of the model and L(M ) is a description of
the model’s complexity [44, 51]. The term, L(D|M ), accounts for the extra information that needs to be transmitted in order to describe the model prediction’s distance
from the real data. For example, if the model prediction comes close to the data, less
information is needed to communicate the model error than if the prediction is far
from the data in the same way that smaller integers can be communicated by fewer
bits than larger ones (e.g. in the case of integers, the number 2 can be encoded into
binary as “10” at 2 bits vs. 20 as “10100” at 5 bits). The complexity term L(M )
defines the amount of information that must be communicated in order to describe
the model and is typically defined by the number of parameters in the model. Together, the model and a specification of its error can be used to perfectly reconstruct
the data from D0 to D.
To represent L(D0 ) for some model, one can apply metrics like Akaike’s Information Criteron (AIC) [52] or Schwarz’s Bayesian Information Criterion (BIC) [53].
These information theoretic metrics take the form of either

AIC = n log(σ̂ 2 ) + 2k,

(3.3)

BIC = n log(σ̂ 2 ) + k log(n).

(3.4)

or

In the above, σ̂ 2 is the error of the model, k is the number of parameters within the
model and n is the number of data points that the model approximates. Note that
these metrics are valid asymptotically and correction factors are applied in the case
of limited data. These correction factors increase the penalty on extra parameters
when there are fewer data points.
AIC is formulated using Kullback-Liebler divergence and seeks to select a candidate model that best describes reality. This is due to the fact that KL divergence
is a measure of the extra information needed to transmit some information using a
model distribution as compared to some real generating distribution [54]. BIC, built
from a Bayesian arguments, seeks to select a “true” model from a possible set of mod-
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els. More specifically, it applies a likelihood function to gauge the probability that a
model is true given some observed data. AIC penalizes parameters less severely than
BIC which means that BIC tends to favor simpler models than AIC. For derivations
of these metrics, one should consult [52, 53].
Both metrics above are made from different arguments, but they embody a similar
principle. A model that optimally describes the data will strike a balance between
accuracy and complexity.
To further explain these metrics in the context of a communication problem,
consider the transmission of the model in the place of the raw data through a communication channel. In order to communicate the model itself, the parameters need
to be transmitted with a certain accuracy. Encoding parameters to a precision of
√
√
δm = 1/ n is the most reasonable way to do this as 1/ n represents the magnitude
of estimation error on the parameters themselves [55]. To transmit a model’s k pa√
rameters to this precision through the channel, one will need to use −k log2 1/ n bits
which makes up the latter portion of BIC.
The error of the model will also require communication which is approximated by
the mean squared error for the data set. Mean squared error represents the average
magnitude of error in the description of each data point. For a particular data point,
magnitude of error is relevant because, as stated previously, larger numbers require
more bits to communicate. When considering these model metrics in the context of
data transfer, they are formally referred to as two-stage description length or twostage MDL. Note that two-stage MDL has the same form as BIC.
To further illustrate the use of these information criteria, let us consider some
arbitrary data set as shown in figure 1. There are a range of polynomial models that
one could use to fit the n data points from an overly simple linear model of order 1 in
(a) to an over-fitting Lagrange polynomial of order n − 1 in (c). While the Lagrange
polynomial captures the data with no error, the third order polynomial has a better
qualitative fit to the data.
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Figure 3.1.: Example of model selection problem with polynomials. (a) is the fit of
a linear polynomial for the data. (b) is the fit of the third order polynomial. (c)
is the fit of a Lagrange polynomial of order n − 1. (d) shows the behavior of MSE
in red while AIC and BIC are shown in blue and green respectively for each order
of polynomial. Note that both metrics are minimized for the 3rd order polynomial
model.
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When using a model for the purposes of optimization and control, one desires a
model that will be accurate without being overly complex. By applying AIC and
BIC to the analysis of biological models, one can gain a relative sense of a model’s
balance between accuracy and complexity relative to other descriptions of the data.
An important advantage offered by these metrics is that they can be used to compare
non-nested models. In other words, these information criteria are valid for comparing models of vastly different formulations such as constraint-based and differential
equation models.
The model selection approach highlighted contrasts with other methods of model
selection that focus merely on accuracy. Approaches such as cross-validation are
useful for comparing models but do not offer any insight into the relative complexity of
different models. Other methods that seek to prevent overfitting such as regularization
are not necessarily useful for the applications discussed here.
3.2.2 Metabolic Models
To demonstrate the value of these information criteria for biological modeling applications, a set of models will be developed to describe the same set of biological
data. This set of models includes kinetic, constraint-based and cybernetic models.
These models can all be used to predict metabolic fluxes, or the rates of different intracellular chemical reactions, in cultures of cells growing on different carbon sources.
These models are all developed using experimental data representing quantities such
as the dynamic changes in concentration of carbon sources, and the growth rates of
cells to arrive at these predictions. Each model has varying complexity and predicts
metabolic fluxes with different amounts of error. It is the goal of this work to show
how well each model balances between these.
To understand the general features of each modeling framework, the structure of
all three classes of models will be highlighted. To start, one must consider the nature
of metabolic systems. They are composed of connected chemical reactions that form
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networks. This network is articulated in a stoichiometric matrix S of m metabolites
by n reactions. To model the changes in extracellular species, one can use
 
s
 
 
x = p
 
c

(3.5)

where s, and p are vectors of ns substrates, np products respectively, and c is the concentration of cells often referred to as biomass. Combining the extracellular variable
x with a vector for the cell density normalized intracellular components m yields an
expression that describes the time rate of changes of extracellular and intracellular
variables





1 dx
 c dt 
dm
dt

= Sr.

(3.6)

Above, r represents the rates of metabolic reactions or fluxes. In the kinetic model,
this differential expression is solved using expressions for r that approximate the fluxes
of the chemical reactions as a function of x and m. These flux expressions typically
use Michaelis-Menten kinetics such as
ri =

Vimax mi
,
Ki + mi

(3.7)

where Vimax and Ki are the maximum reaction rate and saturation constants respectively. These parameters rely on experimental data and can change significantly for
different reactions. Given that metabolic networks can be composed of thousands
of reactions, kinetic models can be quite complex. Also, the kinetics used can also
include enzyme influences and reaction inhibition. Kinetic models are typically very
high resolution pictures of cellular processes.
Constraint-based models such as Flux Balance Analysis (FBA) embody a much
simpler approach to predicting metabolic fluxes [33]. FBA makes two major assumptions to do so. One is that intracellular metabolites are at some pseudo-steady state
or
dm
=0
dt

(3.8)
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The other is that the cells organize their metabolic fluxes to optimize some objective
function. This objective function typically takes the form of maximizing the yield of
biomass. This objective function will be used in all of the proceeding scenarios. FBA
is written as an optimization problem as
max

J = cT r

subject to Sr = 0

(3.9)

a<r<b
and can be solved using LP. Above, the product cT r represents the combination
of fluxes that are maximized. Fluxes are constrained to be in the null space of S
and must satisfy a specified set of upper and lower bounds refered to as b and a.
These lower and upper bounds are determined by experimental evidence as well as
thermodynamic constraints on the reactions (i.e. some reactions only work in the
forward direction). The experimental evidence is typically used to constrain the
uptake rates of substrates consumption and product formation in the model. Other
intracellular constraints can be used, but these quantities can be difficult to measure.
To model the dynamic changes of fluxes in this work, the static optimization approach
will be used from dFBA where a model will be used to approximate the changes in
constraints over time [39, 56].
Cybernetic models use dynamic objective functions that optimize the system to
achieve goals at each time through the inclusion of control variables that regulate
enzyme synthesis and activity. Instead of exhaustively describing the kinetics of each
reaction as the kinetic model does, hybrid cybernetic models (HCMs) decompose the
reaction network into a set of pathways or macroscopic reactions termed elementary
modes (EMs) [19] that are expressed at varying levels over time. To do so, the
pseudo-steady state assumption must be made like in FBA. The flux vector can be
decomposed into a set of rates through the EMs as
r = ZT rM

(3.10)
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where Z represents the network’s nZ EMs and rM represents the regulated uptake
rate of each EM. Given the use of the pseudo-steady state hypothesis, the changes in
extracellular concentrations are tracked in the following way
1 dx
= Sx ZT rM
c dt

(3.11)

As stated previously, in kinetic models, the reaction rates of each chemical transformation are tracked. In HCM, the regulated rate expressions for rM take similar
Michaelis-Menten forms, however, they include regulation, vi and enzyme ei terms
rM,i

kin,max
rM,i
si
= ei vi
KM,i + si

(3.12)

kin,max
Above, parameters rM,i
and KM,i are similar to the parameters from the kinetic

model with one main distinction. They describe the rate of uptake into an EM or set
of reactions instead of the rate of a single reaction. In HCM, the change of enzymes
which regulates rM is
kE,i si
dei
− (µ + β)ei
= α + ui 0
dt
Ki + si

(3.13)

In HCM, enzymes are generated by a constitutive formation and induced formation
which make up the first two terms above. The last is an expression for the depletion
of enzymes due to growth dilution and degradation. Cybernetic control variables ui
and vi guide the induced synthesis of enzymes and the allosteric regulation of enzyme
activity respectively. Induced enzyme formation is expressed as some function of
each pathway’s return on investment (ROI), pi . ROIs typically are defined as each
pathway’s rate of substrate uptake or growth rate. To calculate the control of enzyme
formation, ROIs are compared for each pathway in
pi
ui = P ,
j pj

(3.14)

where the denominator represents the sum of ROIs for all pathways. This means that
the fraction of a finite resource pool devoted to the production of enzymes for one
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pathway is proportional to the ROI for that pathway. Similarly, the activity of the
different metabolic pathways is controlled by the vi variable which takes the form
vi =

pi
.
maxj pj

(3.15)

The pathway with the highest ROI will be fully expressed. All other pathways with
lower ROIs will be down-regulated proportionally.
For a given metabolic network, the number of elementary modes can be quite
high. Therefore, yield analysis is used to reduce the elementary modes in HCM down
to a minimal set that spans a given yield space [22]. This makes the generation of an
HCM model for the subsequent results facile and reduces the number of parameters
for the model’s specification.
Another version of cybernetic models that will be analyzed is the lumped hybrid
cybernetic model or L-HCM. The formulation of this model is quite similar to HCM
with one main distinction. Instead of enumerating uptake rate constants for all pathways, the EMs are lumped together into families based on their structural returns on
investment. These family modes are then expressed as a function of some dynamic
metabolic objective function. The procedure for lumping EMs is somewhat complex
and is best explained in [24].
Both HCM and L-HCM employ objective functions to dynamically maximize the
rate of carbon uptake in the models used in the subsequent scenarios.
3.2.3 Comparison Method
To compare the ability of each model with one another, both AIC and BIC are
computed for the set of models to gauge which one minimizes their values. Consitency among the modeling frameworks for minimizing both criteria are considered.
The metabolic model that best minimizes these information criteria for different scenarios is identified as the best model for the purposes of optimization and control
applications. In other modeling scenarios, such as those in which models are developed for the purposes of biological discovery, AIC and BIC should not be used for
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model selection as quantifying the tradeoff between accuracy and simplicity is not
necessarily relevant.
3.3 Results
3.3.1 Modeling Dynamic Fluxes of the Aerobic Growth of E. coli
To compare how well various biological models compress metabolic fluxes, four
different models describing the aerobic growth of E. coli were compared. In this
growth scenario, E. coli first consumes extracellular glucose while generating acetate
as a byproduct. Once the glucose has been exhausted, the culture then shifts its
metabolic state to consume the acetate product. The models chosen to describe
various aspects of this system are (1) a detailed kinetic model, (2) dynamic Flux
Balance Analysis, (3) HCM, and (4) L-HCM.
The reaction network used in this model selection exercise was taken from Kotte
et al. [29] whose metabolic network is summarized in Figure 2 which was also used as
the kinetic model for this comparison. The network includes a variety of metabolic
pathways including glycolysis, gluconeogenesis, and the TCA cycle. Note that some
metabolic reactions are truncated with others in order to simplify the network. For
example the network’s reaction for G6P’s conversion to FBP lumps together two
reactions and ignores the intermediate product of F6P.
The kinetic model [29] is taken as the basis for this exercise as this model type is
generally the most labor intensive to develop in terms of parameters and structure.
Then, dFBA, HCM and L-HCM formulations were developed for the kinetic model’s
growth scenarios. The structured biomass equation used to develop these models was
extrapolated from a prior E. coli model [57] and takes the form of
3.7478 AcCoA + 5.1971 alKG + 1.32915 G6P
+18.271 NADPH + 1.787 OxA + 0.5191 PEP
(3.16)
+1.496 PG3 + 2.8328 Pyr + 59.89551887 ATP
→ 1 Biomass + 3.547 NADH
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Figure 3.2.: Schematic of the simplified network used to construct the various models.
Reaction names used in subsequent plots are listed next to their respective arrows.
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3.3.1.1 Steady State Flux Predictions
Each of the models tested generates a description of this network’s metabolic
fluxes for both dynamic scenarios and steady state scenarios. Each one of these model
descriptions of fluxes can then be verified using steady state flux data for growth on
glucose and acetate from [58]. Figure 3 shows the correlation plots describing the
accuracy of each model’s steady state flux description with the appropriate Pearson’s
product-moment correlation coefficient. Note that FBA is used to calculate the steady
state fluxes instead of dFBA and that the kinetic model was parameterized, in part
upon the flux data.
Figure 3 clearly shows the kinetic model’s superior ability to describe the rates
of metabolic reactions. Nonetheless, it is evident that all models provide reasonable descriptions of metabolic fluxes. The Pearson metric is listed in table I for each
condition. The model with the most parameters, being the kinetic model with 193 experimental constants, produced the most accurate approximation of the experimental
flux values for both growth on glucose and acetate. The next most accurate experimental flux description is produced by L-HCM. Despite ranking third and fourth,
HCM and FBA also provide good approximations of the experimental fluxes of growth
on glucose. Both HCM and dFBA, however show low accuracy in generating steady
state approximations of the acetate fluxes.
Model comparison metrics were calculated for both the glucose and acetate conditions to gauge how well each model performed. Parameters for the models were
tabulated. L-HCM was the second most parameterized model with 14 parameters.
These parameters include the kinetic parameters as well as those used to lump the
elementary modes together. HCM had 12 parameters. FBA had only 3 parameters
which were the uptake and excretion rates of substrates and products in this system.
Note that the objective functions in these different models were not parameters, but
structures for the various models which did not imply additional penalty for model
complexity.
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Figure 3.3.: Correlation plots for each model’s description of steady state flux data
for E. coli growing on glucose. Horizontal axis shows the flux values predicted by
each model and the vertical axis corresponds to the experimental values for steady
state fluxes taken using carbon-13 labeling experiments.
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Table 3.1.: Correlations, parameterization and information criterion for the model
set for the steady state fluxes.
Kinetic

FBA

HCM

L-HCM

193

3

12

11

ρGlucose

0.9972

0.8172

0.8269

0.8548

AICGlucose

113.38

1.1445 4.0746

3.6997

BICGlucose

193.78

2.3943 9.0739

8.2823

ρAcetate

0.9980

0.3290

0.3307

0.7858

AICAcetate

186.63

14.411

18.635

0.3933

BICAcetate

267.03

15.661

23.634

4.9760

Parameter No.

The FBA model for the glucose steady state fluxes showed the best minimization of both information criterion. FBA, which demonstrated poor performance in
predicting the fluxes for the steady state growth on acetate and was outperformed
by L-HCM for both AIC and BIC. Despite the kinetic model’s very high correlation
with experimental flux data for both conditions, it was severely penalized by its large
number of parameters.
3.3.1.2 Dynamic Flux Predictions
Metabolic fluxes are difficult to measure experimentally and require carefully controlled experiments. Because of this, time-series experimental fluxes are unavailable
for this system. To compare the dFBA, HCM and L-HCM models on their ability to
model dynamic fluxes, the kinetic model’s prediction of dynamic fluxes will be treated
as an experimental approximation of the true dynamic metabolic fluxes for this system. The use of this artificial data is justified in part by the fact that the model was
parameterized upon a wide variety of data for multiple levels of cellular processes.
It incorporates a great span of regulatory phenomena including transcription factors,
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transcription-factor metabolite interactions, gene expression, enzyme production, kinase reactions, phosphatase reactions and protein degradation. Given the high degree
of complexity of the kinetic model, it will be reasonable to assume that it provides a
close to true approximation of the real dynamic fluxes for the E. coli system that is
being modeled.
Figure 4 shows the comparison of the information theoretic metrics with the artificial data. Generally speaking, HCM and L-HCM overpredict the flux rates through
the glyoxylate pathway. They also overpredict the flux of malate to pyruvate during growth on both glucose and acetate. On the other hand, dFBA underpredicts
the fluxes through glycolysis and the TCA cycle while L-HCM and HCM provide
good qualitative descriptions of the simulated data. L-HCM overpredicts the futile
cycling from G6P to FBP during the consumption of glucose while HCM and dFBA
underpredict this. HCM best predicts the flux through pyruvate dehydrogenase while
dFBA is lower and L-HCM is higher.
As in the steady-state flux model comparison, model selection metrics were calculated for the set of models. The complexities of the HCM and L-HCM models did
not change. However, to incorporate the dynamics of the system, 5 additional parameters were added to generate the dFBA description of the data. The artifical data
was generated at 15 min intervals for a 10 hour period of growth. The model that
best minimizes the information criterion for the dynamic flux data is HCM which is
shown in Table II. This is followed by L-HCM. dFBA places last for both information
criterion.
3.3.2 Another Case Study: FBA vs. L-HCM in S. oneidensis Flux Prediction
Case Study: A Comparison of L-HCM and FBA For another illustration of IC
and their ability to distinguish models, these concepts can be used to compare FBA
and L-HCM for flux predictions of Shewanella oneidensis [26]. Starting from the flux
data [59] as a means for testing the accuracy of model predictions, AIC and BIC
values were calculated for each respective model. Note that the range of predictions
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Figure 3.4.: Dynamic flux profiles for all three models. The flux titles correspond to
the reaction names given in Figure 2. The purple circles represent the values for the
artificial flux data. The red line represents flux predictions made by dFBA. the black
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Table 3.2.: Information criterion for dynamic flux descriptions for the artificial data.

Parameter No.

FBA

HCM

L-HCM

7

12

11

AIC

3580.8 -1607.4

2926.5

BIC

3612.7 -1552.7

2976.6
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is due to variability in interpretation as to how a parameter is defined. That is to say,
for instance, in the case of L-HCM, only (3-6) parameters are trained upon data. The
remaining (10 or so) parameters are generally insensitive ones. Refer to figure 3.5 in
order to see how AIC and BIC values compare for the various model classes. From
this table, the conclusion that L-HCM delivers, in relative terms to FBA, accuracy
at a low cost of model complexity is drawn.
3.4 Discussion
The results provided by the model selection framework presented in this work
varied by application. In the comparison of the different models’ abilities to predict
steady state flux data, there was a mixed outcome. While FBA was highly capable of
describing the steady state fluxes for the growth on glucose, it was less able to provide
an accurate description of the fluxes for the growth on acetate. L-HCM, conversely,
placed third in its minimization of the information criterion for glucose. However, it
best minimized them for the acetate fluxes. L-HCM also provided the best steady
state flux description for the glucose fluxes, after the kinetic model, but its complexity
penalized it into the third place. This additional complexity, allowed it to capture
the acetate steady state fluxes best. Because of the information criterion’s ability to
penalize models for their level of complexity, FBA has a clear advantage when it is
able to provide an accurate estimate.
The ability of L-HCM to capture steady state fluxes has also been demonstrated
in prior work [26]. The strength of L-HCM is that it combines multiple elementary
modes into a smaller subset of lumped elemantary modes. The lumping procedure
takes into account experimental data related to the yield of products and biomass
for various substrates. The strength of this lumping procedure is clearly seen in the
steady state flux results.
When treating these models as data compressing entities, it is noteworthy how
much FBA, HCM and L-HCM reduce the values of the information criteria relative
to the complex, kinetic description of the steady state fluxes. All three models reduce
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Comparison of Information Criterion Values for Different Models
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Information Criterion

Figure 3.5.: Information criterion for comparison of FBA (green) and L-HCM (blue)
flux predictions. Data point normalized AIC and BIC values are on vertical axis and
grouped on horizontal axis. Lower IC scores imply more compact description of data.
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the information criterion values by 2 orders of magnitude representing a significantly
reduced description length for the data. It is intuitive that the complex kinetic
description of the system would provide the most excessively complex description of
the equilibriated flux state for this system. The information criterion are able to take
this intuitive statement and establish it in quantitative sense. Moreover, they show
the degree to which the kinetic model over-explains steady state data.
The scenarios tested above showed that HCM provides the best description of the
artificial dynamic flux data despite the fact that it did not perform well in estimating
the steady state fluxes. This is most likely due to the fact that HCM employs a combination of elementary modes over time to describe the changes in fluxes. In steady
state scenarios, HCM will only express one of these numerous elementary modes that
embodies some extreme edge of the yield space as determined using yield analysis.
This comes from the cybernetic policy which will selectively produce only one pathway’s bulk enzyme pathway once a steady state is reached because there is only one
pathway that will have a maximum unregulated rate for the substrate concentration
present at a steady state. Notwithstanding HCM’s difficulty in the capture of steady
states for both of the substrate conditions modeled here, the inclusion of multiple
elementary modes for a single substrate becomes an advantage for HCM as it can
describe the span of an organism’s metabolic yield space.
In contrast to HCM, the L-HCM model shows a markedly less accurate prediction
of the dynamic fluxes for this system. Contrasting accurate steady state predictions,
it is less capable of reproducing the artificial data for dynamic fluxes in this scenario.
This might in part be due to L-HCM overpredicting the overall flux through different
pathways which stems from how it lumps together the different modes. Also, it
reduces the complexity of the model into merely two elementary modes which may
not be sufficient in spanning the total space of allowable fluxes. This could mean
that despite its dynamic objective function, it is limited to a more limited space
in its description of dynamically altering flux profiles. Regardless, both HCM and
L-HCM outperform dFBA in the compression of dynamic flux data. This makes
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the argument that rate-based objective functions are more descriptive of the data
compared to yield-based ones.
On the whole, dFBA provides the least accurate prediction of dynamic metabolic
fluxes. This could stem from the inadequacy of a yield-based objective function in
describing the dynamic shifts in metabolic states. dFBA consistently underpredicted
the values of fluxes which may be due to the biomass maximization objective function.
This is due to the formulation of the LP problem where maintenance and other
functions related to metabolism are ignored and therefore the total sum of fluxes
may be contracted from a realistic state. In other words, the goal of the FBA model
is to convert the most substrate into biomass with a given set of constraints and
will ignore phenomena such as futile cycling. Other objective functions such as total
flux minimization could provide better results but were not tested in this work. It
has been shown that the accuracy of objective functions vary by scenario [48]. This
would also help to explain the biomass maximization objective functions differences in
accuracy when describing the steady state scenarios. Also not tested were additional
constraints on flux values for the metabolic system.
The artificial data for the fluxes was a reasonable substitution given the lack of
actual dynamic data for this model system. It is possible that dynamic flux data
may be different from what is indicated by the kinetic model. However, given the
fact that the kinetic model incorporates a great number of regulatory phenomena and
captures steady state fluxes with near-perfect accuracy, it is likely the best possible
approximation of the dynamic fluxes.
The fact that the model selection criterion were minimized for each model for a
different application makes clear the fact that certain models are more relevant to
compress specific types of data. It is natural that FBA would be able to minimize
these information criterion for the steady state scenarios given its low complexity.
In the acetate steady state case, however, the fact that L-HCM outperforms FBA
brings to light the fact that FBA’s objective functions are not universally descriptive
nor applicable in all substrate consumption scenarios. HCM, with its incorporation
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of multiple elementary modes finds a balance between these two which captures the
dynamic states predicted by the kinetic model best.
Also, the varied results by scenario point out the fact that these information criteria are not biased towards one approach. Their ability to compare vastly different
formulations for the same metabolic system highlights their utility in systems biological applications. Information criterion treat each model as an alternate description
length for the data. A key assumption of these metrics is that the model structure itself is not communicated, only the parameters. This assumption allows these metrics
to compare non-nested models.
Finally, both AIC and BIC were minimized for the same model for all three model
selection scenarios. This consistency is a good indication of their utility in reaching
objective conclusions for model selection.
3.5 Conclusion
This work has shown, for the first time, how information criterion can be used for
the comparison of non-nested systems biological models. While these metrics have
been well-established for many applications, their use has not been brought to the
attention of metabolic modelers who could benefit from a deeper understanding of
how different models balance between accuracy and complexity. This work has shown
that L-HCM provides the most succinct description of steady state fluxes for E. coli
growing on acetate. It has also demonstrated that FBA optimizes the information
criterion for E. coli growing on glucose at steaty state. Finally, it has shown that
HCM minimizes these metrics for the description of artificial dynamic flux data.
These conclusions, however, are contingent upon the objectives of the modeling
effort. Application of models for the purposes of optimization and/or control requires
compromising model complexity in favor of rapid assessment of predictions. On the
other hand, a thorough understanding of the changes in metabolic performance due
to engineered perturbations can only come about by using detailed models without
serious compromise of complexity. Our analysis demonstrates quantitatively how dif-
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ferent modeling frameworks perform when the model objectives are defined. Thus
conclusions made for one objective will not necessarily carry over to other circumstances.
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4. INVESTIGATING THE RELATIONSHIP BETWEEN CYBERNETIC
VARIABLES AND TRANSCRIPTOMIC DATA: DIAUXIC GROWTH
Summary
Diauxic growth of E. coli is driven by a host of internal, complex regulatory actions. In this classic scenario of cellular control, E. coli prioritizes the utilization of
the substitutable substrates present in its external environment. Cybernetic models
of metabolism, whose development now spans three decades, were first formulated to
describe the growth behavior of cells in such multi-substrate environments. These
models utilize the hypothesis that the synthesis and activity of the enzymatic machinery is regulated to maximize a return on investment. While this assumption is
made on the basis of logical arguments rooted in evolutionary principles, little effort
has been spent to test the extent to which this reasoning mimics the regulation of
enzyme synthesis and activity in microorganisms. This work revisits the cybernetic
model describing diauxic growth and compares its predictions of enzyme synthesis
control with time series gene expression data in microarray and RT-PCR formats.
Three separate studies are made for two different strains of E. coli. The first study
is for the growth of E. coli BW25113 on a mixture of glucose and acetate whose
gene expression changes are monitored using microarray. The second study is for
the growth of E. coli MG1655 on glucose and acetate whose expression changes are
monitored using RT-PCR. The final study is for the growth of E. coli MG1655 on
glucose and lactose where gene expression changes are monitored using microarrays.
By demonstrating that the cybernetic variables for induced enzyme synthesis mimic
changes in transcriptional data, we show that the cybernetic models capture not only
the dynamic trends in the concentrations of extracellular substrates and products but
also accurately approximate the regulatory phenomena in microorganisms.
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4.1 Introduction
Cybernetic models, which describe the dynamic regulation of metabolism as a
goal-directed process, have been developed over the past three decades to describe
a host of complex microbial growth scenarios. The first scenario cybernetic models
sought to describe was that of diauxic growth of microorganisms [3]. These models
assume that microorganisms are optimal control systems that actively modulate their
metabolism through the cybernetic variables for enzyme synthesis, ui , and activity, vi .
These models further assume that microorganisms possess limited internal resources
that they use in an optimal manner to achieve their goals. Using matching and
proportional laws to describe enzyme synthesis and activity respectively, these first
cybernetic models were able to predict the distinct growth and lag phases of the
diauxie using parameters taken from growth data on individual substrates.
From this initial formulation, cybernetic models have been extended to describe
much more complex aspects of metabolism via incremental improvements over the
years. Cybernetic models have been useful in not only describing complex substrate
uptake patterns [9], but have also yielded successful predictions of intracellular fluxes
[26], gene-knockout behaviors [25], and multiplicity of steady states in chemostats
[21]. While cybernetic modeling’s ability to predict complex cellular phenomena
helps to realize the utility of this approach, no effort has taken place to verify the
extent to which the cybernetic control mechanisms mimic cellular regulation. More
specifically, the cybernetic variables for enzyme synthesis and activity, ui and vi , have
not been directly compared with cellular data that is representative of the regulatory
mechanisms in cells.
Experimental advances in the past decade have resulted in the collection of large
amounts of cellular data which provide insights into regulation in cells [60,61]. Various
techniques such as microarrays and RT-PCR are used to monitor the expression
of mRNA from a large number of genes in cells under a variety of experimental
conditions. These techniques have been used to characterize the gene expression
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changes that occur when E. coli switches from growing on one substrate to growing
on another.
To briefly explain the changes that occur, when E. coli switches from growing on
glucose to growing on acetate, a number of regulatory mechanisms are activated that
monitor the cell’s nutritional status and the propensity for internal acidification [62].
These mechanisms then coordinate a host of actions on the gene expression level
to induce the uptake of acetate predominantly through the ACS pathway where it
is converted to other growth precursors via increased flux through the TCA cycle
[63]. Glycolysis ceases and carbon is channeled in a completely reversed direction
via gluconeogenesis. Similarly, when E. coli switches from consuming glucose to
consuming lactose, a more limited number of events occur. As glucose is depleted,
cAMP levels are elevated and crp dependent factors promote the expression of the
lac operon which has already been derepressed by the presence of external lactose
[64]. The lac operon is then transcribed and translated into enzymes relevant to the
metabolism of lactose.
The present chapter focuses on comparing the predictions for cybernetic control
variable for enzyme synthesis ui with data that is representative enzyme synthesis
available in the form of mRNA measurements and measured using microarrays and
RT-PCR. It should be noted that these control variables are not a direct substitute
for gene expression and that the comparison made focuses on the relative changes and
not absolute level of mRNA. However, given the fact that these cybernetic control
variables describe the induction of enzyme synthesis, they should change in a temporal
fashion that is consistent with changes in mRNA levels.
Three separate studies wherein microorganisms grow on two substitutable substrate pairs are made. The first study is for the growth of E. coli BW25113 on a
mixture of glucose and acetate whose gene expression changes are monitored using
microarray. The second study is for the growth of E. coli MG1655 on glucose and
acetate whose expression changes are monitored using RT-PCR. The final study is for
the growth of E. coli MG1655 on glucose and lactose where gene expression changes
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Figure 4.1.: A simple schematic of the two competing metabolic pathways during
diauxic growth.

are monitored using microarrays. By demonstrating that the cybernetic variables for
induced enzyme synthesis mimic transcriptional data, we show that the cybernetic
models capture not only the dynamic trends in the concentrations of extracellular
substrates and products but also produce a control strategy that is consistent with
cellular data.
4.2 Materials and Methods
To describe the diauxic growth phenomena that occur in the two scenarios introduced, cybernetic models were developed. These models determine the cybernetic
control of each lumped pathways enzyme synthesis and are formulated using the
structure of prior cybernetic models [3, 4]. A schematic of this lumped type of model
is in figure 4.1.
Most simply, a cybernetic model of metabolism is a set of coupled, first-order
ODEs that describes the time-dependent rates of change in the concentrations of
cells, metabolites and enzymes. For each substrate, Si , there is a lumped enzyme set
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Ei that is employed to digest each substrate and a yield describing the total amount
of biomass, B, produced from each substrate according to the reaction:
E

i
B + Si −→
(1 + Yi )B + ...

(4.1)

In diauxic growth, once the cell consumes the entirety of the preferred substrate,
the production of lumped enzyme for the secondary substrate commences. In the
cybernetic formulation, the rate at which each substrate is converted into biomass is
governed by the concentration of the amount of pathway specific enzyme, ei , present
in the system. Also influencing this rate of reaction are the enzyme specific growth
rate µi , substrate concentration, si , and the total concentration of cells c. This rate
is formulated as

ri =

µi ei si c
,
Ki + si

(4.2)

where Ki is the substrate specific Michaelis-Menten constant. The formation of
biomass is determined by the summation of the activity controlled biomass formation
reactions and is written:
dc X
=
ri vi .
dt
i

(4.3)

Each substrate’s depletion is given by the negative substrate specific biomass
formation rate normalized by the substrate’s yield.
dsi
−1
=
ri vi
dt
Yi

(4.4)

Finally, the production of the lumped enzymes is as follows
dei
kE,i si
d ln c
= α + ui 0
+ β)ei .
−(
dt
Ki + si
dt

(4.5)

The above equation includes a number of terms for the phenomena related to changes
in enzyme concentration. The first is for the constitutive enzyme synthesis, α [4]. The
second is for induced enzyme synthesis which is controlled by the cybernetic variable,
ui . The rate of enzyme formation is established by a rate constant for induced enzyme
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synthesis kE,i , and is a function of the substrate level and a Michaelis-Menten constant
Ki0 . Lastly, the enzyme quantity is reduced both by dilution due to growth and from
enzymatic degradation β. Note that this enzyme control variable ui appearing above
will be the model variable that is compared to gene expression data.
4.2.1 Cybernetic Control Formulation
In the above model formulation, two control variables are presented. Control
variable ui specifies the regulation of enzyme synthesis for different pathways and vi
specifies activity adjustments of the lumped pathways. To efficiently allocate cellular
resources, single cells must make decisions regarding the regulation of competing
metabolic pathways. From this model’s perspective on diauxic growth, there are two
competing metabolic options for which the cell can invest resources in to grow. At any
given time, there is an unregulated growth rate for each substrate given by ri which
is a function of the amount of lumped enzyme present. This enzyme quantity, in
turn, changes as a function of the instantaneous rate through the ui control variable’s
effects. This control variable compares the different metabolic options and invests
resources proportionally to a metabolic pathway’s return on investment growth and
is written as the following matching law:
ri
ui = P
j

rj

(4.6)

In this simple cybernetic model, return on investment for a lumped metabolic
pathway is equal to its instantaneous rate of growth. This implies that cells prioritize
their limited capacity for enzyme synthesis for pathways that have a higher payoff.
This variable is normalized by the sum of returns on investment which represents the
total pool of resources available to convert sugars into biomass. The set of ui control
variables sum to 1. In this control variable, it is evident that there will be a higher
investment of resources into the lumped enzyme for a pathway if there is a higher the
return on investment or rate of growth.
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In addition to the efficient allocation of resources, pathways are also regulated by
mechanisms that adjust their activity. To model this, pathways that have lower rates
of growth than the maximal pathway are turned down via the proportional law which
is
ri
.
(4.7)
maxj rj
This is justified in part by the fact that some metabolic pathways may require
vi =

fluxes to route through different parts of the metabolic network in opposite directions.
For example, in the case of glycolytic and gluconeogenic substrates, glucose and
acetate, pathways for one or the other should be turned down in order to reduce
futile cycling. Therefore, the proportional cybernetic variables turn down pathways
that do not represent the highest return on investment and fully express the pathway
that does.
4.2.2 Estimation of Parameters
To develop two of the models in this work, sets of data including both batch
growth data and time series microarray data taken during the switching of substrates
were used. One data set is from [65] describing the growth of E. coli BW25113 on
a mixture of glucose and acetate. The other set from [66] elucidates the changes in
gene expression for E. coli MG1655 growing on a mixture of glucose and lactose.
For both of these data sets, a growth curve and initial substrate data are available.
Given that microarray data is inherently noisy, the findings for the glucose-acetate
growth scenario were verified with RT-PCR data. An additional model was developed
to describe the E. coli MG1655 strain using data from [67]. RT-PCR data was not
available in the literature to further validate the result from the glucose-lactose diauxic
growth scenario.
Models were first parameterized for the microarray data. From the growth curves
in the glucose-lactose condition, the parameters µmax
and Yi were estimated from the
i
knowledge of the initial substrate levels, biomass concentrations and slopes of the
growth curves. Michaelis-Menten parameters were at first taken from [3]. Michaelis-
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Table 4.1.: Parameter values for diauxic models of E. coli. Strains MG1655 and
BW25113 growing on multiple substrate sources.
Strain

MG1655

BW25113

Parameter (units) Glucose Lactose Glucose Acetate
Si,0 (g/L)

0.5

1.5

1.5

0.9

µmax
(h-1
i

0.642

0.618

0.442

0.426

Yi (gDW/g)

0.400

0.440

0.339

0.129

Ki /Ki0 (g/L)

0.005

0.50

0.0088

0.3317

1.67e-3

1.67e-3

1.67e-3

1.67e-3

kE,i

1e-3

1e-3

1e-3

1e-3

βi

0.05

0.05

0.05

0.05

αi

Menten constants, yields and growth rates for the glucose-acetate data were determined using available single substrate data. Once these initial values were collected
for both models, a genetic algorithm was used to refine the initial parameter values
using a normalized least squares error function for the model’s fit of the biomass data.
The parameter values are listed in table I. Note that the Michaelis-Menten parameters Ki and Ki0 take on the same value for both ri and the induced enzyme formation
terms for the same lumped metabolic pathway. For example, Ki and Ki0 have the same
value of 0.05 for the glucose growth pathway describing the glucose-lactose diauxie of
E. coli MG1655.
The RT-PCR model was built in a similar fashion. The main departure in its
formulation from the other models is the inclusion of an acetate production term. In
this scenario, glucose is the only substrate initially. While consuming glucose, acetate
is produced via overflow metabolism to adjust the intracellular redox ratio [68] which
is then consumed after glucose is exhausted. Note that acetate production is absent from the microarray models as the dynamic changes in substrates and products
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are not given in the datasets and modeling this phenomena would require extraneous assumptions. For more details on the parameterization and development of this
particular model, refer to the appendices.
4.2.3 Comparison of Dynamic Gene Expression Data and Model Variables
The general goal in the comparison between the ui control variables and dynamic
gene expression is the demonstration of qualitative similarity. These two entities
cannot be compared in an absolute sense because their magnitudes do not align.
The matching law variables are constrained between values of 0 and 1 while gene
expression levels vary over a greater range depending on how they are normalized.
Moreover, given the nature of microarray, it would not be useful to make absolute
comparisons as it is often referred to as a “semi-quantitative” method. Therefore, it is
pertinent to normalize both the control variables and gene expression in a fashion that
complements qualitative comparison. The method elected to do this is a standard
normalization procedure where the data is scaled by the standard deviation and centered around zero by subtracting a series mean [69]. For some series C = {c1 , c2 , ...cn }
of either gene data or model variables, the normalization is

c0i =

ci − µ(C)
,
σ(C)

(4.8)

of which µ(C) is the mean of the data series and σ(C) is the standard deviation of the
series. The mean of a data series µ(C) is not to be confused with the enzyme specific
growth rate for a given pathway, µi . This normalization method aligns the data in
such a way to make the comparison of the dynamic trends in the data more clear.
To quantify similarity between the model variables and experimental data, the use
of correlational statistics such as Pearson’s correlation coefficient is still appropriate
as this statistic is scale invariant. The microarray and RT-PCR data were already
provided as gene expression normalized sets in their original sources [65–67]. These
data sets were not processed in any additional way.
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4.3 Results
4.3.1 Model Capture of Biomass Formation
The models developed were able to accurately describe the growth of biomass. All
systems modeled capture the initial growth phase on glucose and the second growth
phase on either lactose or acetate. They also correctly represent the timing of the lag
phase as the batch culture transitions from the preferred substrate to the secondary
one. The predictions of these models is visualized in figure 4.2.
From these model descriptions of the data, it can be gauged how the values of
the control variables for each pathway change dynamically. As the glucose level
depletes, the ui variable for the glucose pathway decreases from one towards zero.
This transition is made during the lag phase of the diauxic growth. At the same
time, the ui variable for the lactose or acetate pathways increase from a value close to
zero towards one. It is at this critical point that the comparisons between the control
variable and gene expression will be made.
4.3.2 Study of Glucose-Acetate Diauxie
E. coli growing in a mixture of glucose and acetate can employ either glycolytic
and gluconeogenic pathways to synthesize biomass and grow. In this mixture, the
culture first consumes glucose and switches to acetate, a carbon source upon which
it has a lower growth rate. When the culture shifts from the digestion of glucose to
acetate, glycolysis is unneeded and gluconeogenic reactions must channel carbon to
synthesize essential biomass precursors. A host of other changes happen in the central
carbon metabolic pathways. Intuitively, acetate secretion goes down and uptake
increases. Fluxes through the glyoxylate pathway and TCA cycle increase [70]. Also,
the fluxes through the pentose phosphate pathway are significantly higher during
growth on glucose compared to acetate.
These changes in the various metabolic pathways are observable on the gene expression level. The cybernetic variable profiles have been compared accordingly with
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Figure 4.2.: Predictions of external metabolite concentration data for the three diauxic systems. (a) shows the biomass level for E. coli BW25113’s diauxic growth on
glucose and acetate. (b) exhibits E. coli MG1655’s growth on glucose and acetate
where RT-PCR data are available. The left axis shows biomass, c, in gDW. Substrate
concentrations, si , are in g/L and are tracked on the right axis with the time profile
of glucose in green and acetate in red. (c) shows diauxic growth of E. coli MG1655
on glucose and acetate.
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the dynamics of these various central carbon metabolic pathway gene expression profiles. Genes associated with pathways whose fluxes are upregulated have been compared with the acetate ui cybernetic variable and genes associated with pathways
whose fluxes go down have been compared with the glucose variable. Comparing the
changes in gene expression with the cybernetic variables for genes related to different
metabolic modules demonstrates that cybernetic variables predict the general trends
in gene expression for their appropriate pathways. Explicitly, the genes go from a
sustained high state to a sustained low state. Before making the comparison, it must
be noted that micro-array data is inherently noisy. Because of this, many genes from
these pathways were filtered out as their true behavior was hard to distinguish from
the scatter in the data. The less noisy genes are plotted for various pathways in figure
4.3. For a complete picture of the data for these pathways, refer to the appendices.
Starting with secretion of acetate via the reaction of acetate kinase (ackA), the
cybernetic variable for the glucose pathway was compared with dynamic transcriptional data. It is evident that both show a downward shift from a higher state to a
lower one. The gene expression levels for acetate uptake via acetyl-CoA synthetase,
acs, were also surveyed, however, an abundance of noise in the data made comparison
difficult. However, acs is compared with less noisy data using the RT-PCR data in
the next section.
Next, the cybernetic variables for glycolysis and gluconeogenesis were compared
with their respective model variables. Reactions for gluconeogenesis were first compared to the acetate control variable. Most transcriptomic data for the gluconeogenic
pathway were also noisy with the exception of yggF, fructose-1,6-bisphosphatase,
which is somewhat less noisy. This transcript profile matches the cybernetic variable’s increase. However, after reaching its highest value, the trend does not stay at
an elevated state and goes down to a value roughly between the initial low state and
the maximum level.
Transcripts of the glycolytic pathway show a decreasing trend as predicted by the
glucose pathway’s cybernetic matching law variable. For example, mRNA levels for
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Figure 4.3.: Gene expression profile comparison with cybernetic variables for subsets
of central carbon metabolism for strain MG1655’s growth on glucose and acetate.
Gene profiles are plotted in red with error bars and profiles are plotted in black. Subfigures with their respective pathways are labeled: (a) gluconeogenesis, (b) pentose
phosphate pathway, (c) acetate secretion (d) glyoxylate pathway, (e) glycolysis, and
(f) TCA cycle. Gene names are labeled on the verticle axis.
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pfkA go down along with the model control variable. Also showing this behavior is
pykF. Genes for the pyruvate dehydrogenase complex show varying behavior. aceE
transcription levels go down as the control variable does, but rebound after 2 hours
to a middle value. aceF shows significant fluctuations up and down and deviates
significantly from the behavior predicted by the glucose pathway’s cybernetic variable.
Finally, the TCA cycle and glyoxylate pathway were compared to the acetate
control variable’s behavior. Of the TCA cycle transcript data that did not have
significant noise, all the genes show trends close to the model prediction. sdhA
and fumC show increasing levels very similar to the selected control variable. gltA,
sucA, and sucB also show general increases in expression over time. However, these
expression level increases are delayed to varying degrees compared to the acetate
pathway’s variable. They are also characterized by an initial decrease in the first 1530 minutes of the data series. The glyoxylate pathway also shows a general increase
compared to its model prediction. Overall, the model’s prediction of control of enzyme
synthesis shows good conformance with what is seen at the level of gene expression.
4.3.3 Verification of Microarray Result Using RT-PCR Data from the Literature
To cross-validate the findings for the glucose-acetate diauxie previously modeled
above, a second model was developed to describe a similar scenario of acetate production during the consumption of glucose followed by acetate consumption after glucose
exhaustion. RT-PCR data was collected for the transcripts with the largest changes
in expression for comparing steady-state growth on glucose and growth on acetate.
For this analysis, this data has been partitioned into two sets. One set shows an increase in expression after glucose exhaustion corresponding to the acetate ui variable
and another represented by the glucose control variable shows a decreasing trend. A
depiction of this comparison is in figure 4.4.
In this system, the data for each transcript was not analyzed according to its
pathway but its general behavior overall. The genes corresponding to each control
variable are listed in table II. Looking at the Pearson correlation between the vector
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Figure 4.4.: Gene expression profile comparison with cybernetic variables for subsets
of central carbon metabolism for strain MG1655’s growth on glucose and acetate.
Gene profiles are plotted in red with error bars and profiles are plotted in black. Subfigures with their respective pathways are labeled: (a) gluconeogenesis, (b) pentose
phosphate pathway, (c) acetate secretion (d) glyoxylate pathway, (e) glycolysis, and
(f) TCA cycle.
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Table 4.2.: Grouping of genes with ui variables that show similar behavior for RTPCR data for glucose-acetate diauxie.
Acetate Group (Up) Glucose Group (Down)
acs

crp

pfkA

frd

cspA

ppc

glgS

cya

ptsG

ihfA

edd

pykF

pck

infA

sdhD

yfiA

lacZ

sucA

maeA

zwf

mdh

of model ui values at different time points and the vector representing each gene’s
normalized expression level, there is a strong correlation between the model prediction
of enzyme synthesis control and gene expression. Overall, these correlations are 0.9214
and 0.7814 for the glucose and acetate pathway with p-values of 4.351e-044 and 1.017e09 respectively.
After measuring the general correlation between the gene expression data and
the cybernetic variables, the grouping of genes into upregulated or downregulated
categories was further analyzed. Starting with uptake reactions, RT-PCR data for
acs for acetate uptake and ptsG for glucose uptake show appropriate grouping with
their matching law variable. The glucose variable is also grouped appropriately with
genes like pfkA, and pykF from glycolysis. As expected, zwf of the pentose phosphate
pathway also shows similarity to the glucose control variable. Genes strongly related
to the control of growth during glucose consumption, crp and cya also show a strong
similarity to the glucose control variable [71].
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As for the acetate control variable, pck representing the conversion of OAA to PEP
is also upregulated similar to what is expected when the cells retool their metabolism
for growth on acetate. This is a key entry point of carbon into gluconeogenesis. The
genes of fumarate reductase, frd, of the TCA cycle are also upregulated stepwise
along with the control variable for the acetate pathway. Other genes upregulated
with this control variable are glgS, ihfA and yfiA related to biofilm formation [72],
DNA regulation [73] and translation inhibition [74].
There were also some unexpected relationships between the glucose variable and
various components of the central carbon metabolic pathways. TCA cycle transcripts
for sucA and sdhD showed a downshift. Also indicating a downshift was maeA of
gluconeogenesis which convert members of the TCA cycle to gluconeogenic products.
This is further analyzed in the discussion.
4.3.4 Study of Glucose-Lactose Diauxie
To verify the relationships of the enzyme synthesis cybernetic variables to gene
expression in other diauxic growth systems, a glucose-lactose growth scenario for E.
coli MG1655 was also studied. After glucose has been exhausted, genes associated
with the digestion of lactose located of the lac operon are upregulated to facilitate
growth on the new substrate. From the comparison of cybernetic ui variables with the
expression data in figure 4.5, it is clear that the lactose cybernetic variables and the
regulation of genes related to the lactose pathway have a relationship. Both indicate
an increase from a low to high value.
Given that lactose is a disaccharide composed of glucose and galactose, there is
much overlap between the metabolic pathways for growth on lactose and growth on
glucose. The main element not involved in lactose metabolism, the PTS glucose
transporter complex consisting of ptsG and crr, was surveyed [75]. The behavior
of this gene shows some decrease as glucose is exhausted shortly before the glucose
control variable goes down. However, afterwards, it rebounds upward and shows much
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Figure 4.5.: Glucose-lactose matching law variables with gene expression profiles for
relevant genes. (a)-(c) in the top row show the expression profiles of lac operon genes
lacZ, lacY and lacA along with the lactose pathway’s ui variables. The bottom row
shows the profiles for genes relevant to glucose metabolism which are the phosphotransferase glucose transporter complex of (d) ptsG and (e), regulator crr.
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fluctuation up and down with decreases in expression being related to decreases in
growth rate indicated on the biomass curve.
4.4 Discussion
After making comparisons between the cybernetic variable for induced enzyme
synthesis, ui , and gene expression data for three separate growth scenarios, it is
evident that the two entities are related. Overall, the similarities between gene expression dynamics and the predicted control are qualitatively similar and occur on
the same time scales. Moreover, when looking at correlational statistics between
the least noisy data set, the RT-PCR scenario, and the cybernetic control values, a
strong statistical correlation is established. For the glucose variable showing a stepdown behavior, the Pearson correlation between the model and each gene related to
that pathway is 0.9214 with a p-value of 4.351e-044. For the acetate pathway, it is
0.7814 with a p-value of 1.017e-09. These significant correlations indicate that there
is a strong similarity between the dynamic behavior of the gene expression and the
model’s prediction of enzyme synthesis regulation.
It should be explicitly stated that the prediction of gene expression changes by the
model are not made using any information from the gene expression level. The only
input into each model’s development and parameterization comes from time series
data describing biomass and substrate levels. The prediction of gene expression is
only made from the assumption that enzymes for substrate pathways are regulated
in such a way to optimize the rate of formation of biomass. The fact that this
assumption endows the model with an ability to predict changes in gene expression
via the analysis of its enzyme synthesis control variable helps to validate the idea that
modeling E. coli cells from a goal-oriented perspective is useful.
Modeling E. coli growth using a cybernetic approach differs substantially from
other modeling methods. Instead of exhaustively enumerating the minutiae of metabolic
regulatory mechanisms as is done in a host of other, kinetically driven modeling
frameworks for this scenario [29, 76], cybernetic models instead model the sum of
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these regulatory actions as cohesive, integrated machinery that attains some optimal
behavior. By comparing the dynamics of E. coli ’s enzyme production machinery
with the cybernetic model’s prediction of enzyme synthesis regulation, the wealth
information related to gene expression regulation is compressed down into a succinct
description related to the organism’s goal. Unlike FBA which also makes assumptions regarding optimal yields [33], cybernetic models also retain considerations for
the dynamic nature of optimality. Cells cannot be entirely prescient and, instead,
react spontaneously to their changing environments.
The present work only has surveyed the ability of lumped cybernetic models to
predict changes in gene expression. More advanced cybernetic frameworks such as
the hybrid cybernetic model (HCM) [19] and the lumped hybrid cybernetic model
(L-HCM) [24] may be able to generate more detailed and accurate predictions of
gene expression in these scenarios. This stems from the fact that these models may
incorporate multiple pathways in the form of elementary modes to describe the consumption of a single substrate. The regulation of numerous metabolic pathways could
provide a higher resolution prediction of gene expression. The development of such
descriptions, however, would mandate more detailed information at the level of substrates and products.
Despite an overall success of the cybernetic models in predicting gene expression
changes, some discrepancies when comparing these different systems did arise. For
example, the glucose-acetate microarray data for BW25113 indicated increases in
expression for most all of the TCA cycle genes including frd, sucA, sdhA and mdh. In
the RT-PCR data for the MG1655, the transcripts for TCA cycle genes have varying
behaviors. frd shows an increase similar to the BW25113 strain data. However,
sucA, sdhD, and mdh show declining expression. For these inconsistencies, it should
be noted that the time periods over which the two data sets are taken varies. The
MG1655 data is taken over only one hour after glucose exhaustion. On the other hand,
the data analyzed in this scenario for the BW25113 strain goes for 3 hours longer than
the MG1655 data. Both data sets do indicate an initial decrease. The data taken
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over a longer time period demonstrate that these genes ultimately reach higher levels
of expression as indicated by fluxes taken at steady states for these growth scenarios.
The similarity of these gene expression profiles to the control variables is still notable.
Depending on the time-frame selected for this comparison, there may be a varying but
relatively small number of genes that change groupings among the different pathways.
Considering the expression data from a broader angle, a significant of agreement
remains between the control variables’ behavior and gene expression dynamics for a
majority of the genes surveyed.
The glucose-lactose system showed good agreement between the lactose pathway’s
cybernetic variable and the gene expression for genes dedicated to lactose metabolism.
However, the glucose variable did not show a strong relationship with gene expression
for genes related strictly to glucose metabolism. This is, in part, due to the fact that
glucose and lactose metabolic pathways have significant overlap. Particularly, the
entire pathway for glucose consumption is also used for lactose. Isolating particular
chemical reactions for glucose’s non-overlapping metabolic reactions is a difficult task.
The main component in the glucose pathway that is not in the lactose pathway is the
transporter ptsG. The expression of ptsG does not behave the same way the glucose
variable behaves. It is not only expressed when glucose is present in culture, but also
when lactose is being consumed. At first glance, the expression of this transporter
appears to be linked more closely with growth rate and not glucose presence. When
looking for explanatory information from the literature however, ptsG expression
is regulated by a number of intracellular factors including mlc, crp-cAMP and Fis
[77–79] and such conclusions require more consideration to develop. To model this
situation more accurately, a model that dedicates a larger portion of cellular resources
towards non-growth functions such as the production of ptsG could be used. Other
formulations of cybernetic models have considered the idea of fractional resource
investment into preadapted pathways based on other regulatory mechanisms which
may be another factor related to gene expression for the glucose pathway [80].
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While not all genes are exactly predicted by the trends in the ui cybernetic variables, it is apparent that many do have a strong relationship with the model’s projection of their dynamic behavior. This is especially true of genes related to the uptake of
various substrates including ptsG and acs in the glucose-acetate scenario and for the
lac operon of the glucose-lactose scenario. The foregoing work verifies this assumption
that cells dynamically regulate different metabolic pathways towards optimality. The
assumed, cybernetic mechanism of enzyme synthesis control correlates strongly with
how actual biological systems modulate enzyme synthesis. This indicates that cybernetic models have the potential to predict gene expression dynamics in other systems
using information at the metabolite level and an assumption of the organism’s goal
for metabolic regulation.
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5. INVESTIGATING THE RELATIONSHIP BETWEEN CYBERNETIC
VARIABLES AND TRANSCRIPTOMIC DATA: MAMMALIAN SYSTEMS
Summary
Prostaglandins (PGs) are lipid mediators that have been studied extensively due
to their role in the generation of inflammation. In this study, we investigate how
goal-directed models can be applied to this system to make predictions about (1) the
dynamics of the conversion of arachidonic acid into downstream PG products and (2)
the underlying changes in gene expression that regulate the fluxes of PG production.
The behavior of eicosanoids are modeled in four separate RAW 264.7 macrophage
cell treatments, a control, statin drug, KLA, and combined statin and KLA, using a
cybernetic objective of maximizing the rate of production of key inflammatory mediator TNF-alpha. The model is trained on metabolite data for three of the conditions
and used to predict the behavior of the fourth. The model makes predictions of induced enzyme synthesis regulation based off of the metabolic objective function and
metabolite data which are compared with gene expression data. This model, for the
first time, characterizes the dynamic regulation of PG synthesis and is subsequently
used for applications in predicting how various cyclooxygenase inhibitors affect PG
metabolism. This work embodies a novel departure from typical cybernetic modeling paradigms which typically focus on central carbon metabolism in bacterial cells.
Furthermore, a generalized method for the use of different objective functions is presented for applications in mammalian cells. Overall, this work provides a model with
an established ability to robustly predict perturbations to prostaglandin metabolism.
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5.1 Introduction
Cybernetic models embody a framework that describes metabolic regulation from
the perspective that chemical reactions inside the cell are controlled to achieve goals
related to an organism’s survival. For example, the regulation of metabolism can be
modeled using the goal that bacterial cells tune their modulation of enzyme activity
and synthesis to maximize the rate of substrate uptake [19] or the rate of growth
[3]. Metabolic goals such as these have been of great utility in predicting a number
of metabolic phenomena in bacterial systems including complex substrate uptake
patterns [3, 5, 9], metabolic fluxes [26] and the behavior of gene knockout strains [16].
The key advantage of cybernetic descriptions of cellular regulation is that they
truncate the multitude of molecular phenomena that control metabolic fluxes into an
intuitive regulatory principle that guides all of these individual actions. From the
cybernetic perspective, regulatory mechanisms at the molecular level are not isolated
events. They are small steps in a cooperative cascade of molecular incidents that are
coordinated to enhance a cell’s survival. Regulatory goals, such as maximizing growth
[3] or carbon uptake rate [23], provide a causality driven basis for the regulation of
individual chemical events. In the absence of high resolution, dynamic data for all
cellular events that modulate metabolism, cybernetic assumptions of regulation offer
a significant advantage in that they are simple and can robustly predict metabolic
phenomena given an appropriate objective function.
While cybernetic models have focused on bacterial systems in the past, we presently
adapt this framework to model the dynamic behavior of prostaglandin formation in
mammalian cell line, RAW 264.7 macrophages taken from Mus musculus. Prostaglandins
(PGs) are a well characterized set of inflammatory lipids derived from arachidonic acid
(AA) which have signaling roles. They are widely studied due to their influence in
a large number of cellular events including inflammation [81] and the prevention of
their formation is the intent of a large swath of cyclooxygenase (COX) inhibiting
drugs [82].
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Several kinetic descriptions of PG formation precede this work [83–86], but none
take into account the regulatory phenomena present in PG formation. To remedy this,
we develop a cybernetic description of PG formation which describes the regulation
of PG synthesis as a goal-directed process related to maximizing inflammation in
response to the presence of a stimulus indicative of infection.
In the development of a cybernetic model for PG formation, we seek to accomplish several outcomes. The first is to demonstrate that cybernetic models are a
robust description of metabolite formation and can be used to predict perturbations
to metabolism via various effectors including drugs. Having a more reliable description of PG formation is useful in that it can provide more predictive description of
the action of inhibitory drugs. Second, provide proof that cybernetic models can be
used to predict gene expression phenomena in complex mammalian systems which has
been shown previously in diauxic growth scenarios in chapter 4. Showing an ability to
predict gene expression allows for validation of the PG model’s objective function and
more generally, cybernetic models. Lastly, it is the goal of this work to offer proof of
concept that return on investment can be broadened to describe objective functions
in complex multi-cellular systems and have applications in predicting the response of
metabolic networks to drugs. Prior cybernetic formulations have used objective functions based off of arguments related to survival in competitive environments to model
the behavior of individual bacterial cells. In describing the behavior of cooperating
cells in multi-cellular environments, refinement of cybernetic objectives is needed.
In achieving the above, a new paradigm of cybernetic modelling is provided, one
that endows its users with the ability to make predictions in pharmaceutically relevant
systems. This opens up the potential for more robust modeling of the dynamics of
human metabolism using cybernetic models with a more refined interpretation of
objective functions. Also, the validation of cybernetic control variables using gene
expression data demonstrates the utility of this framework in providing mechanistic
explanations for the behavior of bioinformatic data.
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Figure 5.1.: Schematic of prostaglandin network modeled.

5.2 Materials and Methods
To describe the time-dependent formation of prostaglandins, a cybernetic model
is generated. This description approximates the conversion of AA into intermediate
product, prostaglandin H2 (PGH2 ) and its subsequent conversion into downstream
prostaglandin E2 (PGE2 ), prostaglandin F2a (PGF2a ), and prostaglandin D2 (PGD2 ).
To see the structure of the reaction network modeled, refer to the network schematic
in figure 5.1. The behavior of this network is modeled in four separate conditions, a
control, a treatment with compactin, Kdo2 -Lipid A (KLA), and a combined treatment
of compactin and KLA. Compactin is a type of statin that reduces cholesterol formation by blocking HMG-reductase CoA and also influences prostaglandin formation.
KLA, is an LPS analogue that signals the presence of infection to the macrophage
cells and stimulates the formation of prostaglandins by binding to a receptor on the
macrophage called Toll-Like Receptor 4 (TLR4) [87, 88]. The data for all of these
conditions was taken from [89].
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In this simple network of PG formation, the main focus is on how PGH2 is converted into downstream PGs because the regulation of this branch point involving the
synthesis of three separate products represents a central decision point in this small
metabolic system. In using cybernetic arguments to model PG formation, we are
assuming that these products are formed in varying amounts related to their ability
to help the cell achieve its metabolic objective. The production of PGs that have a
stronger relationship with the goal of the system will be upregulated while the pathways for those PGs which have a lesser relationship with the objective function will
be downregulated. Using goal-directed arguments such as these, gives the model generated here a more holistic perspective of cellular regulation as its regulation pertains
to the physiological function of the metabolic network itself. The network generates
metabolites in order to accomplish some ultimate function which is embedded into
the model using cybernetic regulation. To understand cybernetic regulation more
deeply, let us first focus on the model’s interpretation of metabolic fluxes.
5.2.1 Reaction Kinetics
The structure of the kinetics for this reaction network are simplified into two
segments. The first describes the conversion of AA into PGH2 using reaction kinetics
that do not involve cybernetic regulation. This is a reasonable simplification to make
in that there is a single pathway that leads from one reactant to one single product.
Despite its inability to be measured experimentally, PGH2 is preserved in this model
as it is a central intermediate for guiding the formation of PGs downstream and there
is a necessary delay between the consumption of AA and the formation of downstream
PG products. The kinetics of this reaction are modeled as three separate mechanisms
for PG formation including a basal rate of synthesis and stimulated generation due
to compactin, COM P and KLA, KLA.
rAA→P GH2

max
max
max
kH
AA kH
kH
AA
AA
2 ,base
2 ,comp
2 ,kla
=
+
[COM P ] +
[KLA]
KH2 + AA
KH2 + AA
KH2 + AA

(5.1)
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which simplifies to
rAA→P GH2

max
kH
,base AA
0
0
(1 + kH
[COM P ] + kH
[KLA])
= 2
2 ,comp
2 ,kla
KH2 + AA

(5.2)

This additive mechanism is a simplification of other possible kinetic formulations
that involve cofactors which increase activity. For further simplicity, these kinetics
involve the same Michaelis-Menten parameter for all three, additive mechanisms for
prostaglandin formation. Testing other kinetic formulations of this system did not
endow the model with an enhanced ability to fit or predict the changes in metabolic
data in a substantial way.
The other segment in this model employs cybernetic regulation as regulation between the different metabolic options is the central interest in this work. In cybernetic
models, there are two descriptions of the reaction kinetics. One is the raw, enzymedependent rate of reaction which will henceforth be termed the kinetic rate of reaction.
This kinetic rate includes an enzyme quantity ei which represents the relative amount
of enzyme devoted to the conversion of PGH2 to a PG product.
rPkin
GH

2 →P Gi

= ei

max
ki,base
P GH2
(1 + ki,comp [COM P ])
Ki + P GH2 + Kinh P GH22

(5.3)

This kinetic rate employs substrate inhibition constant Kinh in its formulation as
the metabolite data indicates that when compactin stimulation is present, there is
a decreased level of substrate but increased level product formation. Stimulation by
KLA for these downstream pathways was omitted because KLA stimulation upstream
provided a sufficient description of the metabolite data for the model. The second
reaction rate in this model is the activity regulated reaction rate which is modulated
by the cybernetic control variable vi
rPregGH2 →P Gi = vi ei

max
ki,base
P GH2
(1 + ki,comp [COM P ])
Ki + P GH2 + Kinh P GH22

(5.4)

More detailed information on the formulation of cybernetic control variables and
the regulation scheme used in this model can be found in the subsequent section on
cybernetic variables.
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5.2.2 Modeling Metabolite Changes
In this model, the changes in metabolites are modeled by several different mechanisms. The upstream production and downstream consumption of the AA substrate
in this network is not modeled due to the fact that the upstream generation of AA
comes from several pools of upstream resources and is not the focus of this work.
To describe the time dependent changes in AA, a simple time-dependent function is
fit to the AA data using cubic spline interpolation. The generation of downstream
metabolites PGH2 , PGE2 , PGF2a , and PGD2 from the consumption of AA are described using differential equations with generation and decay mechanisms. For all
PGs in the model, first order decay processes are used with decay constants γi . These
decay values represent the amount of the metabolite pool that are converted to other
metabolites which are not modeled due to lack of data for alternate reactions such as
thromboxane A and PGI2 . The changes in PGH2 are modeled as
3

X
dP GH2
= rAA→P GH2 −
rP GH2 →P Gi − γP GH2 P GH2
dt
i=1

(5.5)

Similarly, the changes in downstream PGs are modeled with
dP Gi
= rP GH2 →P Gi − γi P Gi
dt

(5.6)

Note that all metabolite concentrations described are normalized by the amount
of DNA taken from the culture and are in the units of pmol/ug DNA. Because of this,
the influence on cell concentration is ignored in the kinetics of this model this model.
In addition to the changes in metabolites, the relative changes in enzyme level, ei , for
each pathway are also modeled with first order ODEs.
dei
kE,i si
= αi + ui 0
− βi e i
dt
K i + si

(5.7)

Three phenomena, constitutive formation, induced formation and degradation, are
included in the description of changes in enzymes. The cybernetic variable ui represents the regulation of induced enzyme formation which will be given much attention
in later discussion.
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Lastly, to explain the changes in compactin and KLA, factors that stimulate the
formation of PGs, the treatments to the culture are modeled in a similar fashion
to [83] with a piecewise function. This piecewise function ramps up to a maximal
value of 1 at 0.5 hours and decreases exponentially afterwards.

 2t if x ≤ 0.5
KLA =
e−kd t if x > 0.5

(5.8)

The main departure of this piecewise function from previous work is that the
second term includes exponential decay instead of a linear function to describe the
desensitization of the cells to the stimulus which is modeled according to the dynamics
measured in [90].
5.2.3 Cybernetic Regulation for Novel Objective Functions
The distinguishing element of cybernetic models is their approximation of the cellular control of metabolic reactions through the modulation of enzyme quantity ei
and changes in activity for reaction enzymes. The fundamental assumption of cybernetic models is that cells control metabolism towards goals related to their survival
and propagation. Traditional cybernetic models with goals such as maximizing carbon uptake rate or the rate of growth are intuitively related to the natural fitness
of organisms. In the present work, we focus on the PG metabolic system which is
significantly smaller than central carbon metabolism. Despite differences in scale, the
concepts of cybernetic modeling remain applicable in that the efficient modulation of
subnetworks in the overall metabolic network is important to the overall survival and
function of an organism. PGs may not generate growth themselves, but the efficient
management of their production by the cell is an important component of the cell’s
function and its host organism’s overall survival.
PGs have an array of functions in multicellular organisms. After being generated
by the action of either COX-1 or COX-2 on AA, they are released into the cellular
medium and subsequently bind to PG specific G-protein-coupled receptors on the
cell surface [81, 91]. These receptors, such as EP1 through EP4 , FP, and DP1 and
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DP2 activate the formation of second messengers such as Ca2+ and cAMP. These
second messengers subsequently exert a number of varied effects on the cell. Generally
speaking, PGs are well-characterized for their roles in the formation and resolution
of inflammation. In this particular exercise, we will focus in on PGs’ role in the
generation of inflammation for the selection of the model’s objective function.
While there is no single entity that represents the totality of inflammation alone,
the cytokine tumor necrosis factor alpha (TNF-alpha) is well-known for its role in the
generation of systematic inflammation and is a product of the response to LPS [92].
Because of TNF-alpha’s well known role as a central mediator of inflammation [93],
it is our hypothesis that the metabolism of PGs is regulated to maximize inflammation which characterized by the amount of TNF-alpha generated by the system. To
quantify the relationship between each PG and TNF-alpha, a simple, linear model is
used that relates the time-dependent changes in TNF-alpha level with some weighted
combination of the time-dependent changes in PGs as
T N Ḟ α =

X

wi P Ġi

(5.9)

i

where wi is some weight that is fit using least-squares regression. What this objective
function means is that of the three pathways modeled, there is a varying amount of
inflammation that results from the generation of each P Gi . It is conceivable that other
mediators of inflammation may be more relevant as objective functions such as IL-6.
However, to justify our approach from the basis of biomolecular signaling pathways,
TNF-alpha is induced by NF-κB [94], a factor that is stimulated by Ca2+ [95], a factor
which is stimulated by various PG receptors [96].
In the cybernetic framework, the production of enzymes for pathways associated
with the objective function will be upregulated while enzymes for pathways that
are suboptimal in maximizing the objective function will be downregulated. This is
calculated using cybernetic variables which compare returns on investment (ROI) for
the various pathways
pi
ui = P
j

pj

(5.10)
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In this particular system, the ROI for each pathway is the assumed to be the amount
of TNF-alpha that each unregulated pathway can yield at each instant in time which
is
pi = wi rPkin
GH2 →P Gi

(5.11)

assuming no delay in between the formation of PGs and the downstream synthesis
TNF-alpha. This assumption of no delay is a remedy for the fact that there is little
quantitation of the actual delays between these two systems and the time scales
modeled are much larger than the relative magnitude of time over which this delay
would occur. The ui variable modulates the induced enzyme synthesis rate in equation
5.7. In essence, this cybernetic variable states that the fraction of the limited pool of
resources devoted to the synthesis of PG generating enzymes is proportional to the
ROI generated by making enzymes for that pathway.
The other form of regulation that is used in this model is for the regulation of
enzyme activity of different enzymes which typically occurs through allosteric mechanisms. This proportional variable is formulated as
vi =

pi
max (pj )

(5.12)

j

with the same returns on investment. To put the meaning of the proportional variable
into words, the pathway with the highest ROI is fully expressed while suboptimal
pathways have their activity proportionally downregulated as their full expression
consumes resources in a less-than-optimal fashion.
5.2.4 Model Parameterization
To first develop the model, the objective function needs to be established by
connecting the PGs in the model with TNF-alpha as in equation 5.9. To calculate
the linear weights, a linear least squares fitting was performed using numerically
approximated derivatives for TNF-alpha and PG data from the three of the four
conditions with a constraint that the linear weights must be positive. This constraint
is necessary in that cybernetic regulation mechanisms cannot reverse the flow of
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Table 5.1.: Parameter values for PG model
Parameter Name

Value

Parameter Name

Value

wP GE2

0.23

γP GE2

1.77

wP GF2a

0.20

γP GF2a

5.10

wP GD2

0.57

γP GD2

1.41

kP GE2

155

kP GH2 ,base

5.33

kP GF2a

121

kH2 ,LP S

208

kP GD2

165

kH2 ,comp

0.0037

KP GE2

2.14

kH2 ,base

1.7527

KP GF2a

1.62

Kinh

1.65

KP GD2

5.33

α

0.004

KH 2

1.74

β

0.05

γP GH2

34.9

kE

0.343

reactions or the induced enzyme term cannot become negative. To find the weights
calculated by the model, refer to table 5.1.
The model was parameterized using data from three of the four conditions, the
control, the compactin treatment and the KLA treatment. Data was available for
the metabolite concentrations of AA, PGE2 , PGF2a , and PGD2 over a 24 hour time
window. To fit the model to the data, a normalized least squares objective function
was used to ensure that the varying magnitude of each PG’s level did not skew the
parameters towards the sole fit of PGs with higher magnitudes. The time intervals
for the data were taken at 0, 0.5, 1, 2, 4, 8, 12, and 24 hours. To reduce the bias
of the fit towards the beginning of the series where there is a higher density of data

76
points, each time point’s data was normalized by the square root of its time value.
The overall objective function for fitting the data was

2
3 X
3 X
8 
X
√
yexp,ijk − y mod ,ijk
tk
yexp,max,ij
i=1 j=1 k=1

(5.13)

where i is the experimental condition, j is the downstream PG identifier and
k is a particular data point for the series. The ODEs in the model were solved
using the routine ode15s for stiff systems in MATLAB (2015, Natick, MA) and the
objective function was minimized using an optimization procedure that started with a
genetic algorithm seeded with random initial parameter values. The genetic algorithm
result was then refined using a constrained gradient search method (fmincon). After
running the optimization procedure for 2000 randomly generated starting points, the
final parameter values were selected as the ones that best minimized the objective
function. The parameter values can be referenced in table 5.1.
5.3 Quantifying Model Accuracy
Cybernetic variables describe the regulation of enzyme synthesis. An analogue to
the cybernetic variables is gene expression data which represent the concentrations
of mRNA which control the formation of enzymes. While ui variables and gene
expression are not directly substitutable, the changes in cybernetic variables should
ideally mimic the behavior of mRNA data. These quantities are hard to compare in
an absolute sense so the variables are scaled in the following manner consistent with
the scaling in chapter 4:
u0 i (t) =

u0 i (t) − µ(ui )
,
σ(ui )

(5.14)

where µ(ui ) represents the mean of the time-series’ values and σ(ui ) is the standard
deviation [69]. The gene expression variables are scaled in the same way. By scaling
both variables in this fashion, it is easy to compare the dynamic behaviors qualitatively and through scale-invariant metrics like Pearson’s product-moment correlation
coefficient. Demonstrating a strong correlation between changes in cybernetic vari-
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ables for enzyme formation and the changes in gene expression helps to validate the
goal-directed control mechanism in the model.
5.4 Results
5.4.1 Prediction of Metabolites
After fitting parameters to three of the four conditions (i.e. the control, compactin
treatment, and KLA treatment conditions), the model provided the following fits
which are shown in figure 5.2. The substrate curves for AA show a close representation
of the different conditions. Also, it is evident that the model correctly explains the
evolution of the metabolite concentrations for the different conditions involved in the
fit. The control and compactin treatment scenarios both show a relatively low rate
of prostaglandin formation. The KLA treatment shows a good agreement with all
prostaglandin products generated.
The kinetics of the model were cross-validated using the fourth condition, the
combined compactin and KLA treatment which is shown in the blue line in figure
5.2. While the fit of the cross-validation case is not perfectly accurate, it is evident
that the model predicts the qualitative behavior of the validation condition. The
substrate concentration, AA, goes down, but the levels of all products go up. The
predictions of the formation of PGD2 are especially accurate. Model predictions of
the behavior of PGE2 and PGF2a are under the observed data, however, there is,
nonetheless, an increase in formation of these products going from the KLA only
condition to the combined KLA and compaction treatment. Because of the model’s
ability to capture this unusual behavior without being directly informed of it, it is
reasonable to conclude that the model is predictive in describing the behavior of
prostaglandin metabolites.
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Figure 5.2.:

Time evolution of metabolite concentrations (pmol/ugDNA) for

prostaglandin system. Each condition is distinguished by color with the control case
in black, compactin treatment in red, KLA treatment in green and combined KLA
and compactin treatment in blue. Data points for the each of these conditions are in
the same color.
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Table 5.2.: Genes that catalyze different pathways in the model.
Entrez ID

Pathway

Gene Symbol

Name

64292

PGH2 → PGE2

Ptges

prostaglandin E synthase

96979

PGH2 → PGE2

Ptges2

prostaglandin E synthase 2

109857

PGH2 → PGF2a

Cbr3

carbonyl reductase 3

66469

PGH2 → PGF2a

Fam213b

family with sequence
similarity 213, member B

19215

PGH2 → PGD2

Ptgds

prostaglandin D2 synthase

5.4.2 Prediction of Gene Expression Changes
In order to validate the cybernetic control mechanism that drives the modulation
of reaction rates in the model, scaled gene expression data, representative of the control of enzyme synthesis, were compared to scaled versions of the cybernetic variables
that specify the control of enzyme synthesis. The qualitative trends among both the
gene expression data and the cybernetic variables should be similar. In other words,
if the gene expression for one of the pathway is increasing over a certain time period,
the cybernetic variable for enzyme synthesis control should also be increasing.
Before this comparison could be made, it was necessary to identify which genes
were related to the different pathways. These genes were isolated using the KEGG
database [97, 98]. The genes that produce enzymes that catalyze the pathways of
focus are highlighted in Table II. For two of the three pathways modeled there are
multiple genes that are associated with the catalysis of a pathways in the network.
This is addressed by comparing the behavior of the multiple genes with the individual
cybernetic variables for the given pathways.
It is evident in Figure 5.3 that the cybernetic profiles in red match the behavior
of the genes denoted by dashed and solid black lines. These comparisons are made
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Figure 5.3.: Behavior of the scaled cybernetic variables (red) compared to scaled
gene expression values (black solid and dashed lines) for PGE2 , PGF2a and PGD2
pathways in (top) KLA and (bottom) combined KLA and compactin treatments.
Genes for PGE2 are Ptges (solid) and Ptges2 (dashed). PGF2a genes are Cbr3 (solid)
and Fam213b (dashed). The PGD2 gene in black is Ptgds.
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for both the KLA and combined KLA and compactin treatments. They were not
made for the control or compactin treatments due the to the fact that the gene
expression data was very noisy. The cybernetic variable for the PGE2 producing
pathways shows a behavior where the gene expression values start at some level, go
down to a minimum value and then go up. This behavior is very similar to the
behavior of the prostaglandin E synthase 2 which also goes down to some minimum
around 8 hours and then increases in value. The genes and cybernetic variables for the
pathway that generates PGF2a also show similar behavior to each where the value
starts at a high value, decreases, and then goes up. The pathway for the PGD2
pathway has a cybernetic variable that shows the value starting at some low value,
increasing to a maximum around 4 hours and decreasing down. The gene expression
for prostaglandin D2 synthase also shows similar changes with the long term profile
showing a downward decrease.
Towards quantitative understanding of the similarity between the gene expression
profiles and the cybernetic variables, Pearson’s product-moment correlation coefficients were calculated for the two scenarios without noisy gene expression, the KLA
and KLA Compactin treatments. Each scaled gene expression series was compared
with its respective cybernetic variable. The KLA treatment case had a statistically
significant correlation coefficient (ρ=0.35 / p-value=5.2e-5). The combined KLA and
compactin treatment had an even more significant statistical correlation (ρ=0.43 /
p-value=5.3e-6). The significance of the correlation between the cybernetic variables
and data for gene expression, a mechanism that actually controls the rates of reactions, demonstrates the consistency of the regulatory description in the model with
the reality of metabolic control.
5.4.3 Predictions of Drug-Metabolism Interactions in PG Network
Given that the inhibition prostaglandin formation is the aim of a wide variety of
drugs called nonsteroidal anti-inflammatory drugs (NSAIDs), the present model is
capable of making predictions of how inhibiting the upstream conversion of AA to
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Figure 5.4.: Production of prostaglandins for KLA (top) and combined KLA and
compactin (bottom) treatments. Data points for untreated conditions are signified
by circles. The blue line represents the uninhibited network. The red dashed (- -)
lines represent the treatment with PGH2 inhibiting drugs.

PGH2 affects downstream PG concentrations. The behavior of PG formation can be
extrapolated through an understanding of how much cyclooxygenase is inhibited by
various NSAIDs which can come from many sources [99,100]. We can use these values
to characterize the effects of different drugs on the system.
Figure 5.4 shows the behavior of how 50% inhibition of cyclooxygenase affects the
formation of PGs relative to the uninhibited case in red. The model predicts that
there will be a significant decrease in the amount of PGD2 formed and increases in
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the amounts of PGE2 and PGF2a in both the KLA and KLA+compactin cases. The
behavior predicted is a function of the nonlinear kinetics used to model changes in
PG concentration. This result has yet to be experimentally verified.
5.5 Discussion
The foregoing model of PGs has been validated by two levels of biological data
that depict the synthesis of PGs. The kinetics that describe the rates of reaction are
able to predict the generation of PGs for conditions upon which the model has not
been trained. Furthermore, the control variables for enzyme synthesis show strong
correlation with gene expression data. Given the fact that this model shows consistency in the prediction of different biological phenomena, it is feasible that it should
provide for robust predictions of perturbations to the PG system of study.
The objective function in the model, maximizing the rate of TNF-alpha formation, is a central postulate of the model. It is feasible that other objective functions
could also be descriptive of the control of PG formation. While TNF-alpha is well
characterized as signaling molecule generated in the macrophage response to KLA
binding to TLR4, other inflammatory cytokines such as interleukins (ILs) like IL-1,
IL-6 and IL-12 could also be the goal of the system [101].
Control goals related to other functions of PGs besides inflammation could also
be of interest; however, given that the response of macrophages to KLA is an inflammatory one, the objective function of TNF-alpha has meaning in the context of the
system and conditions studied. To generate the cybernetic model, it is necessary to
first make an assumption of what the control goal is. This assumption can then be
tested on the basis of whether the model is capable of making predictions of data
beyond what the model is trained on. The fact that the model, with the TNF-alpha
objective function, is able to make predictions of the KLA and compactin treatment
as well as of gene expression trends helps to validate the control assumption central
to the model. This control goal gives deeper insight into the nature of prostaglandin
generation in response to infectious stimuli in that it describes an overarching prin-
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ciple of organization to metabolic regulation; the cells are tuning the generation of
various prostaglandins to maximize the rate of TNF-alpha formation.
The implementation of the TNF-alpha objective function as a linear combination
of PG product formation rates is made as means of convenience; the mechanism
connecting PGs to TNF-alpha production is not fully characterized in the format
of dynamic data. In the event that such data were available, a model connecting
the upstream formation of PGs with TNF-alpha could be generated using a hybrid
cybernetic model [19].
While the present work focuses on dynamics of a smaller metabolic network, the
success of the model in predicting various metabolites serves as a proof-of-concept
for cybernetic modeling to describe the segments of complex mammalian metabolic
behavior. This shows that cybernetic models could be developed to describe the
behavior of larger networks in mammalian cells as they have been generated for complex bacterial metabolic networks [26, 102]. Multicellular metabolism has already
been probed using static, yield-based objective functions [103–105], but the determination of dynamic objective functions would provide for a more complete picture of
the multi-cellular metabolic dynamics in more complex organisms.
5.6 Conclusions
This work, for the first time, developed the idea that cybernetic metabolic objectives can be used to describe the regulation of signaling systems mammalian
metabolism. It yielded a model describing PG synthesis that is capable of predicting
both metabolites and the relative changes in gene expression. This model was then
used to provide robust predictions of how drugs that inhibit PGH2 formation alter
the downstream generation of PGs which also marks the first time that cybernetic
models could be explicitly used for pursuits in translational research.
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6. MOTIVATING THE NEED FOR A METHOD TO ESTABLISH THE
UNIQUENESS OF OBJECTIVE FUNCTIONS
6.1 Introduction
In developing the model which describes the formation of Prostaglandins in the
prior chapter, the regulation of the metabolic reactions relied on a postulate that the
metabolic goal of the system was to maximize the rate of formation of TNF-alpha.
The model was subsequently validated using data for gene expression and metabolites.
Despite these levels of validation, TNF-alpha rate maximization, as the only feasible
objective function for the PG system, is inconclusive.
6.2 Testing of Arbitrary Objective Functions
When analyzing the uniqueness of weights for the objective of maximizing TNFalpha, there is an intriguing result.

To reiterate the approach to modeling the

eicosanoids, the basics of the implementation of the objective function will be covered.
The network for the model is quite simple as shown in figure 6.1 with the starting
lipid AA being converted into downstream product PGE2 , PGF2a , and PGD2 in a
simple two step reaction process that is linked with an objective function downstream
for the production of inflammatory cytokine TNF-alpha.
To connect the downstream products of this metabolic network with the objective
of TNF-alpha, a linear model is employed where the change in TNF-alpha is some
linear combination of the time-dependent changes in PGs:
T N Ḟ α =

X
i

wi P Ġi

(6.1)
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Figure 6.1.: Schematic of PG network with goal of TNF-alpha production.
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These weights then are used to bias the returns on investment in the cybernetic
control variable ui
pi
ui = P
j

pj

(6.2)

which is composed of the ROIs:
pi = wi rPkin
GH2 →P Gi .

(6.3)

where each pi represents the unregulated amount of TNF-alpha that can be generated
downstream through signaling processes by the full expression of each pathway. As
stated in Chapter 5, this assumes that the time delay in the signaling mechanisms
between prostaglandins and TNF-alpha is negligible for the time scales over which
the metabolites are modeled.
Depending on the objective function that is selected, the weights wi for each
prostaglandin’s production will be different. To test the uniqueness of the TNF-alpha
weights, 24 sets of weights were generated as arbitrary objective functions using Latin
hypercube sampling (LHS). Kinetic parameters were then fit to the data using each
weight set and the resulting gene expression trends were surveyed.
The results are in figure 6.2. The ui data is scaled so that it the whole set aligns
regardless of initial values of ui . The surprising result is that the average trends of
all the normalized weight sets that were tested show changes in ui variables that are
true to the gene expression pattern. One can see in figure 6.2 that the behavior of
all weight sets is more or less the same (especially for PGF2a and PGD2 ). This could
imply that judicious selection of the objective function is not necessary because the
cybernetic model can robustly model gene expression trends no matter what weights
are applied as an objective function.
6.3 Estimation of Cybernetic Parameters from Data: An Inverse Problem
The goal of this segment is to further reflect upon the nature and uniqueness of
objective functions in cybernetic approximations of metabolic changes. This deliberation is in response to the discovery that there is no unique set of return on investment
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Figure 6.2.:

Behavior of cybernetic matching variables for the production of

prostaglandin products PGE2 , PGF2a , and PGD2 for various objective function
weightings. Comparison of mean behavior of profiles compares favorably with gene
profiles in figure 5.3 (a).
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weightings that provide a singular description of the observed data for regulation.
The central issue is that the unregulated kinetics in the model, determined by the
fitting of parameters to data, tend to yield the same predictions of gene expression
trends despite variations in the unregulated kinetics themselves. In other words, the
inverse problem of estimating parameters from the data estimates the same trends in
regulation despite different control goals.
6.3.1 Background: Objective functions
Given an inferred objective, J , and some time-series representation of this objective, one can determine a relationship between the product or intermediate metabolites of the network, mi , using linear least-squares fitting on the time-dependent
changes in J and mi .
J˙ =

X

wi ṁi

(6.4)

i

These weights, the manifestation of the hypothesized relationship between the
objective and the metabolic system of interest can then be used to infer the regulation
mechanisms that govern this system through their participation in each pathway’s
calculated return on investment, pi where
pi = wi rikin

(6.5)

This expression for return on investment then goes inside the cybernetic variables
ui and vi :
pi
ui = P
j

vi =

pj

pi
max (pj )
j

(6.6)
(6.7)
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6.3.2 Unregulated vs. Regulated Kinetics
For the sake of analyzing the relationships between regulated and unregulated
kinetics in simple terms, let us first assume that the kinetics themselves are a simple
linear form with only one substrate, s, being consumed
rikin = ki s

(6.8)

Note that other factors such as saturation and enzyme concentration are presently
ignored. To establish how fitting affects parameters in the model, it is necessary to
further probe the regulated kinetics.
rireg = vi rikin

(6.9)

The regulated kinetics ultimately determine changes in metabolite concentrations
and need to be established accurately via optimization for the model to accurately
fit the system’s data. Expanding rireg :
rireg =

pi
wi k 2
wi ki s
wi rikin
rikin = max max ki s = max imax s
rikin = max kin,max
max pj
wj kj s
wj kj
w j rj

(6.10)

and truncating all of the parameters into a single parameter, θi , the regulated rate
becomes
rireg = θi s.

(6.11)

Taking this perspective of the combinations of weights and kinetic parameters, the
parameter set k = {k1 , ..., kn } will be fit accordingly so that the combined parameter
set θ, will provide regulated kinetics that are faithful to the data given any arbitrary
selection of the weight set w = {w1 , ..., wn }. For systems with Michaelis-Menten
kinetics, a similar result comes about assuming that the Michaelis-Menten constants,
K are all the same for each pathway

ks

rireg

i
wi K+s
pi
wi rikin
ki s
=
rikin = max kin,max
rikin =
max s ki
k
j
max pj
K +s
wj rj
wjmax K+s

wi ki2 s
θi s
= max max
=
. (6.12)
wj kj (K + s)
K +s
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From the above, it is clear that the weighting factors in the ui and vi expressions
are balanced out by the choice of parameters k. This helps to explain the phenomena
in the preceding section where multiple objective functions provided feasible gene
expression predictions.
6.4 Cross-Validation Study of Regulatory Weights
In the last two sections, it has been made clear that the choice of weights, those
representative of each pathway’s ROI, for the cybernetic model do not significantly
influence the ability of the model to qualitatively represent gene expression. These
were approximated by the control variable for induced enzyme production, ui .
To further probe the question “How do we validate the weights and the objective
question they represent?”, a 3-dimensional weight space was sampled for each of the
three pathways that represents an arbitrary set of potential objective functions. These
weights were then used to fit parameters for the unregulated kinetics in a model that
describes the formation of prostaglandins (PGs). Given that the weights appear in
both the numerators and denominators of both cybernetic expressions in the models,
their values were constrained between 0 and 1. This constraint, will not change
the result of this analysis as the weightings between different pathways can be fully
represented in this interval. To visualize the weight set used in this analysis, the 3d
scatterplot in figure 6.3 shows the spatial distribution of weights used in the different
models.
The blue dots represent each weight set analyzed and its corresponding weight
value, w = (wP GE2 , wP GF2a , wP GD2 , ), for each PG pathway. What should primarily
be observed in the 3-dimensional diagram is that the values of the randomly sampled
weight values evenly cover the space that we are trying to analyze. Parameters
were fit using a time-course set of PG data for four total conditions. These were: a
control; a compactin treatment, a statin drug that perturbs PG formation in addition
to inhibiting cholesterol formation through HMG-CoA Reductase; a KLA treatment
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Figure 6.3.: Scatter plot of weights tested representative of arbitrary objective functions. Randomly sampled weights are plotted with each axis representing weight value
for one of three pathways.
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which stimulates PG formation as an indicator of present infection; and a combined
compactin and KLA treatment.
To allow for cross-validation of the model, only 3 of 4 data sets were used for the
four conditions under which the data were taken. The combined compactin and KLA
treatment were left out to analyze the robustness of each model’s set of unregulated
kinetics. To fit all 16 parameters in the model to the data for the 24 trials, a numerical
optimization method was applied that employs a genetic algorithm, starting with a
randomly seeded initial population, followed by a gradient search. The function that
was minimized was the sum of squared errors of the model for the different conditions.
25 random starting points were surveyed in the parameter space for all 24 sets
of weights. This survey of the parameter space was by no means computationally
trivial. With an average time of 15 minutes per parameter set, total sampling of all
600 parameter sets took roughly one week on a desktop computer (Intel Core i7-2600).
A histogram showing the minimization values of the SSE for the best parameter set
for each wi is in figure 6.4.
To provide a more complete sense of what these SSE values mean, after running
this minimization scenario for the original weights for TNF-alpha for a total of 2000
initial parameter values, the minimum SSE is just under a value of 5. A visualization
of the fit of a model with a mean value of these SSEs above, observe the fit of a model
with an SSE value of 8.14 in figure 6.5.
As is evident in figure 6.5, most all weight sets provide an adequate fit of the
metabolite data modeled. This provides some insurance that the fitted parameters
in the foregoing analysis are valid.
Moving on to the cross-validation of the different potential weightings using the
KLA+compactin data, let us first visualize the fit of this treatment for the whole set
of models in figure 6.6.
As is seen in figure 6.6, some of the weighted fits leave much to be desired for the
cross validation set. Others, provide results that are similar to the KLA treatment.
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Figure 6.4.: Histogram of SSE scores for parameters determined using arbitrary objective functions.

Figure 6.5.: Visualization of model fit with SSE score of 8.14.
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Figure 6.6.: Visualization of fit of all models. The control scenario is in black, compactin treatment in red, KLA treatment in green and the CV set (KLA+compactin)
is in blue.
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Figure 6.7.: Visualization of fit of original TNF-alpha objective function model.

Figure 6.8.: Fit of the best cross-validation weightings from the randomly sampled
objective functions.

The original TNF-alpha objective function provides the fit of the cross validation data
set in figure 6.7.
Comparing the fit of the TNF-alpha objective function in figure 6.7 with the best
cross-validation fit from the random sampling of weights in figure 6.8, it appears
that the TNF-alpha weights provides better qualitative results in that the KLA +
Compactin case is above the KLA.
6.4.1 A Note on KLA + Compactin Treatment
Before jumping to the conclusion that neither model is descriptive of the KLA +
compactin scenario, an import point should be clarified. The results of KLA + com-
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pactin treatment (henceforth referred to as the combined treatment) are somewhat
counterintuitive. Relative to the KLA treatment, the combined treatment reduces
the level of this system’s input lipid, arachidonic acid or AA. Despite this decrease
in the concentration of the input, the concentrations of products of the metabolic
network increase. This effect of compactin treatment, in addition to KLA, is hard to
gauge when looking at the compactin data alone; the compactin and control scenarios
yield similar magnitudes of output prostaglandins. Therefore, it would be difficult for
any model to accurately capture the exact result of the combined treatment which
was, itself, a notable find experimentally [89]. In spite of the fact that the TNF-alpha
weights do not perfectly model the cross-validation set, the fact that they are able to
predict this sophisticated increase in PG level to any degree is an endorsement of the
model’s unregulated kinetics and objective function.
6.4.2 Deeper Analysis of Objective Weights
Even though the TNF-alpha model weights do seem to provide a more accurate
description of the cross-validation set, it is hard to say with certainty that this is
absolutely true. Unfortunately, more experimental data for this system is unavailable
to verify the unregulated kinetics of the various weights studied. Even though the
kinetics themselves cannot be further validated in this absence of experimental data,
further analysis of the weights can still be performed. Many relevant questions to
the weights still remain such as: If we look at the spatial distribution of weights and
their ability to fit the cross-validation data set, do any discernible trends arise? And,
furthermore, do the values of weights correlate with the ability of a model to fit data?
The spatial analysis of weights mentioned above was performed in the following
way. The weights were plotted 3-dimensionally as in figure 6.3 above. Below in
figure 6.9, the points representing the locations of the weights are sized according
each weight set’s SSE for the cross-validation set. This means that larger points have
larger SSEs than smaller points. Also, the color is representative of the SSE value
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Figure 6.9.: Spatial representation of cross-validation SSEs for randomly sampled
objective function weights in 3-dimensions.

with purple representing more accurate cross-validation predictions than blue, green
and yellow.
In figure 6.9, it appears that there is no obvious relationship between different
regions in the weight space and the values of the cross-validation SSE. The small
purple dots are evenly distributed throughout the space and the larger dots are mixed
evenly with the larger dots. To further analyze this, observe the depiction in figure
6.10 of the correlational matrix for a set of values containing the weights for PGE2 ,
PGF2a , and PGD2 in the first three columns and the SSE values for the CV set in
the forth. In figure 6.10, the panels of interest are in a red box.
Pearson’s correlation coefficients for the various scenarios are noted in the upper
left corner of each scatter plot. It is clear from this analysis that the values of the
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Figure 6.10.: Visualization of correlation matrix for various weightings with crossvalidation SSE values. Plots in red box show correlation between various weight
values and cross-validation SSE.
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weights do not have any significant relationship with the ability of the model to
predict the objective function. Both of these methods of scrutinizing the weights of
the various models paint a similar picture. While the TNF-alpha function allows for
the best fit of the cross-validation data, there is no discernible relationship between
the values of the weights and their ability to predict the cross-validation case.
This implies either one of two things, that there is some singular point in the weight
space that provides the best result. In this case, the singular point could possibly be
the TNF-alpha weights. The other, is that there is no apparent relationship between
the choice of objective function - in the form of weights - and the ability of the model
to fit the data.
6.5 Discussion
6.5.1 Drawbacks Associated with Parameter Estimation
This analysis suffers from one significant drawback which is the nature of nonlinear
parameter estimation. Because the parameters for this system are unknown, it is hard
to conclusively say that the results of nonlinear parameter estimation have reached
a global minima in the error function. Even for this relatively simple system with
five metabolites and 3 modeled enzyme quantities there are a total of 16 parameters.
Trying to find a minimum in this parameter space is difficult and can only be found
numerically. Ideally, the search for parameters would involve some kind of smooth
surface with an absence of local minima. To illustrate this, consider the surface of
SSE values (z-axis) in Figure 6.11 for the model for two parameters (the x and y axes)
in the model and no variation of the other parameters.
The minimum of this low-dimensional surface can be found using numerical methods. However, the complexity of this search is much higher in that while searching
for a minimum value of the SSE function for these two parameters, the minimization
algorithm also has to optimize the values an additional 14 parameters. To better illustrate the minimization of SSE for these two parameter values, consider the surface
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Figure 6.11.: Visualization of surface of error function used for parameter estimation
for two kinetic parameters in the model without variation in other parameter values.
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Figure 6.12.: Visualization of surface of error function used for parameter estimation
for two kinetic parameters in the model with 5% variation in other parameter values.

(figure 6.12) in the case where the values for all other parameters change arbitrarily
within an interval 5% of some informed guess at the correct value for the parameter.
The surface representative of this search space is extremely rough pockmarked by a
multitude of local minima.
Provided that the true parameters for each set of weights cannot be found, one
faces a dilemma. Even if we sample the parameter space more completely, we will
never be certain that the parameter values are a truthful representation of the underlying unregulated kinetics. At the same time, with this incompleteness in the parameters, it is difficult to say that these regulatory weights are important in providing
the model with an ability to fit the kinetics. The analysis of matching law control
variables indicates that the weights are not important when it comes to predicting
the general behavior of mRNA creation. However, the weights towards TNF-alpha
do show a slightly better fit on the cross-validation data. This could be an argument
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for the initially selected objective function. The main snag in this reasoning is the
apparent lack of correlation between weight values and the ability of a model to fit
the combined treatment scenario. As mentioned before, there could be a singular
point in the weight space that allows for the best cross-validation of the model, but
one could never determine that without a high confidence in the parameters used in
the analysis.
6.5.2 Final Thoughts
While many weights are able to fit the gene expression data, there was no discernible trend among weights to predict the cross-validation case. This issue is central
to the formulation of cybernetic models in that one has to develop a cybernetic model
upon a central postulate which is the objective function. In the case of cybernetic
modeling of bacterial cells, dynamic objective functions like growth rate maximization or substrate uptake rate maximization make sense from an evolutionary point of
view. When shifting focus to the modeling of dynamic regulation in complex mammalian systems, postulation of an objective function is not straightforward. In the
prior case-study of PG metabolism that spans this chapter and the last, it is evident
that many objective functions will work. Because of this, there is a demonstrable
need for a refined approach at establishing objective functions.
On one hand, it is feasible that one merely makes a clear statement that the
objective function is a postulate central to the model developed. Specifically, there is
no need to go further than explicitly stating that the objective function is a central
assumption of the model. On the other hand, it would be better to analyze biological
data in a structured fashion to make conclusions about what the objective function
is based off of statistical analysis and information gathered from curated biological
databases. A novel method to do this is proposed in the next chapter.
To make this analysis more complete, a better method to estimate parameters
that avoids complex nonlinear optimization is then proposed in the chapter 8.
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7. LEARNING CYBERNETIC OBJECTIVES THROUGH OBJECTIVE
ANALYSIS OF OMIC DATA
Summary
Cybernetic models describe metabolic changes by means of simplifying intricate
cellular regulation mechanisms with the notion of dynamic metabolic goals. In prior
work, these goals have taken the form of inductive assumptions about the nature of
metabolism and are explicitly stated as objectives like “maximize the rate of growth”
or “maximize the rate of carbon uptake.” These inductive metabolic goals have
yielded numerous predictions of metabolic phenomena, but a procedure to determine
the most descriptive metabolic goal for a given system has yet to be proposed. To
address this, a method to deductively resolve metabolic objectives from a combination of metabolomics and transcriptomics is developed. This analysis considers both
metabolic changes and the regulation of enzymes that influences those metabolic
changes. It provides an objective function that takes the form of optimal weightings
that represent the returns on investment for metabolic pathways that are competing
for resources. To give biological context to these returns on investment, a method
to mine gene expression data and explain the objective function using pathway enrichment analysis is presented. This approach is used to analyze three systems: two
diauxic growth scenarios and prostaglandin metabolism in a mammalian cell line.
Pathway enrichment analysis of the genes mined using this procedure provides objective functions that show agreement with already established experimental knowledge
related to the behavior of these systems in their respective conditions. The ability to
determine objective functions deductively from the data provides for robust cybernetic descriptions of systems where the objective function is difficult to determine.
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7.1 Introduction
For any metabolic process, there are a number of objective functions that are adequately descriptive. The common approach for modeling bacterial systems through
the use of objective functions is to assume that the cultured cells are regulating their
metabolic processes towards the maximization of growth yield [33] or rate [3]. A
popular objective function that has provided for the cybernetic prediction of unique
metabolic phenomena is the maximization of carbon uptake rate [20].
Overall, the utility of objective functions in cybernetic models is the compression
of many individual regulatory mechanisms of biological control into an overarching
principle of regulation. In single-celled organisms, objective functions that properly
represent regulation of metabolism towards states that maximize a biological entity’s
ability to propagate its genes are adequately representative of teleonomic principles
[106]. Cultures of bacteria, typically modeled on the scale of numerous generations,
must compete fiercely to ensure the survival of their genes and cybernetic objectives
like the maximization of growth rate or resource consumption have intuitive validity.
Prior work has relied on the inductive assumption of an objective which is validated through the examination of a model’s ability to predict different metabolic
phenomena [9, 21, 25, 26]. While successful, this approach ignores a multitude of
potentially descriptive statements of a particular system’s metabolic goal. This is
especially relevant in systems where the objective function is not as clearly defined
as it is in single-cellular organisms. For example, cells in multicellular organisms cooperate and may have different objective functions that depend on the nature of the
cell of interest. It is possible that hepatocytes have different objective functions than
adipocytes. The objectives of these two cells may even be complimentary in some
way. For these systems, inductive assumption of an objective function is possible.
However, the ability to deductively assert an objective function for a system has a
greater logical strength than a modeler’s prima facie assertions of what an objective function ought to be given what is understood about the cells. In light of this,
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the present work attempts to address the objective function identification problem
by employing methods to analyze dynamic cellular data. Other attempts have been
made at deductively asserting an objective function’s value for constraint-based models [48, 107, 108]. These attempts are characterized by a common limitation; they do
not make use of regulatory information and focus on models that employ yield-based
as opposed to rate-based optimization. The present work, on the other hand, seeks
to identify objective functions through the mining of data that is representative of
dynamic cellular regulation.
The similarity between the cybernetic variable ui , representative of the control of
induced enzyme synthesis, and gene expression has been demonstrated in chapters 4
and 5. Using this notion, an objective function can be deduced through the simultaneous analysis of time series metabolite and gene expression data. The similarity
between these two sets can be used to ascertain a deeper understanding of regulation
and generate what is termed a “goal signal.” The goal signal is then analyzed further
in the context of gene expression profiles, pathway knowledge and already established
biostatistical methodologies. At a high level, the method proposed mines the entirety
of time-series gene expression data to determine a set of similar genes that are representative of the objective function’s goal signal. The ability to extract objective
functions from biological data provides for a robust description of metabolic regulation. Furthermore, it endows the modeler with greater confidence in the robustness
of these predictions for systems as it can explicitly identify metabolic goals where the
objective function is not easily induced. Lastly, insight into the metabolic goals of
metabolic systems allows for a more holistic understanding of how the states of cells
evolve over time. The applications of this approach are as many as there are systems
that can be modeled with cybernetics.
7.2 Methodology
This approach consists of five steps. The first calculates optimal return on investments for competing metabolic pathways by calculating regulation that optimally fits
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the metabolic network’s genes. This is followed by generating a summary goal signal
for the metabolic network. The goal signal is compared with the total picture of cellular regulation to generate a list of genes that show statistically significant similarity
to the goal signal. The gene list is then analyzed using pathway enrichment analysis
to identify pathways that are overrepresented in the gene list. The literature is then
consulted to identify links between the overrepresented pathways and the metabolic
system of interest. This leads to a conclusion about the system’s metabolic goal. A
bird’s eye view of the method employed to learn objective functions from the data is
depicted in figure 7.1.
7.2.1 Background: Cybernetic Modeling
Before the data driven search for metabolic objective functions is fully fleshed
out, it is necessary to cover some preliminaries in the meaning of cybernetic goals.
To provide the reader with a sense of how cybernetic models are formulated, a simpler
version of a cybernetic model will be explained.
In cybernetic modeling, there is a dichotomy between so-called “regulated rates,”
ri , and “unregulated rates,” rikin . The unregulated rates are the enzyme-specific
kinetics that determine the maximal rate at which a reaction or pathway can be
expressed. The formulation of the unregulated kinetics is not fixed to one particular
function of substrate concentration, but as a point of reference, they frequently take
a Michaelis-Menten form such as
rikin =

ei ki s
,
Ki + s

(7.1)

where ei is the enzyme level, s is the concentration of substrate, and ki and Ki are
rate parameters for the ith pathway. The regulated rates are a function of the unregulated rates and determine the time dependent changes in metabolites,

dx
.
dt

From

the cybernetic viewpoint, activation of pathways is proportional to the return on
investment (ROI) that a pathway provides [11]. For instance, in diauxic growth, a
substrate’s rate of growth could be the ROI and the pathway for the substrate with
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Figure 7.1.: Overview of the use of data to analyze objective functions.
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the maximum ROI is fully activated while submaximal ROI pathways are proportionally turned down. The regulated kinetics are determined by the product of the
proportional activation cybernetic variable vi with the unregulated rate as
ri = vi rikin ,

(7.2)

with vi being a function of ROI which is represented by pi , for each competing reaction
or pathway in the metabolic network. This proportional law takes the form
vi =

pi
max (pj )

(7.3)

j

The other key feature of cybernetic models is the approximation of changes in
enzyme levels, ei :
dei
kE si
= α + ui
− (µ + β)ei .
(7.4)
dt
KE,i + si
This expression for change in enzyme level includes α for the constitutive generation
of enzymes, as well as µ and β for the depletion of enzymes due to growth dilution and
degradation respectively. The remaining term is for the induced expression of enzyme
and is a function of substrate concentration and cybernetic variable ui . This control
variable regulates induced enzyme formation according to the ROI relationship:
pi
ui = P
j

pj

(7.5)

This control law states that the fractional investment of the finite pool of cellular
resources for enzyme production among competing pathways will be proportional to
the ROI gained by investment. Prior work in chapters 4 and 5 has demonstrated a
convincing correlation between the cybernetic variable for induced enzyme synthesis
control and data representative of mRNA levels. While the ui variables themselves
cannot be directly substituted for gene expression, they are representative of control
over the same process, enzyme formation. Given this functional similarity, their scaled
versions should change in approximately the same fashion.
The ROI for the metabolic network is subject to the objective function’s formulation. The formulation of ROI is assumed to take the form
pi = wi rikin ,

(7.6)

111
where wi is some weight that states which pathways have a stronger relationship with
the metabolic goal than others. As an example, these weights in prior work have been
carbon number for the maximization of carbon uptake rate [20]. In this work, the
weight will be assumed to be derived from the following relationship to the metabolic
goal, J, that is expressed by
J˙ =

X
i

wi ẋp,i ,

(7.7)

where ẋp,i represents the time-dependent change in some product of the metabolic
network. The changing metabolic goal for the system is a function of weighted rates
of product formation from the metabolic system and the combination of weighted
˙
product formation rates makes up goal signal profile, J(t).
The purpose of the goal
signal is to compress the information generated by the metabolic network into a single
profile that changes over time. This work first seeks to establish what the best weights
are through the treatment of metabolite data and gene expression data. Subsequently,
statistical analysis of the whole set of gene transcript levels and their relationship to
weighted metabolite data works to resolve the meaning of the objective function J in
biological terms.
7.2.2 Data Requirements
The method to establish objective functions deductively first starts with dynamic
biological data. The requisite information to perform this analysis consists of two
dynamic sets of data taken for the same system under the same set of conditions:
metabolite levels and gene expression data. Expansive gene expression data sets allow for a comprehensive analysis of possible objective functions. Because of this,
microarray series are used in the following analyses. Other data sets that are representative of gene expression such as RNA-seq can also be used but were not available
for the systems analyzed.
In this work, three test cases are examined. Two focus on diauxic growth of E. coli
in two separate substrate mixtures. The first of these consists of growth on glucose
followed by growth on acetate and is developed using data from [65]. The second
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Figure 7.2.: Toy example of metabolic network. xi represent metabolites and ri
represent regulated reaction fluxes for competing pathways.

diauxic growth scenario is comprised of growth on glucose and lactose and uses data
from [66]. The final test case seeks to expand this method to a more complex system
prostaglandin formation in a macrophage cell line [87].
7.2.3 Determination of Regulated Rates from Data
To make the analysis more concrete, consider a toy metabolic network in figure
7.2 with three metabolites (x0 , x1 , x2 ) and two regulated reaction fluxes (r1 , r2 ).
Cybernetic analysis of a given dataset starts with approximation of the metabolic
fluxes through different pathways. The metabolic fluxes for a set of reactions or pathways can be estimated from the following statement where the change in metabolites
normalized by cell concentration is roughly equal to the flux through the reaction
that generates it:
1 dxi
= ri .
c dt

(7.8)
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The changes in metabolites above can be estimated through finite difference methods
by estimating the slope between the data points. If there is some downstream process
that consumes either x1 or x2 , the flux can be modeled using a linear decay process
such as
dxi
= ri − γi xi
dt

(7.9)

where the decay constant, γi , is taken from some literature value, or approximated
by means of model fitting. In the case of an irreversible reaction, this decay constant
can be estimated crudely via forcing the minimum reaction rate to be some feasible
value greater than zero such that
mint (ri,t ) > 0

(7.10)

for some time t over which the data is taken. More exhaustive approaches to estimating fluxes from metabolite data are available [109, 110]. The estimation for pathway
fluxes for more advanced pathway-based cybernetic models is detailed in the section
for this method’s generalization to hybrid cybernetic models.
7.2.4 Cybernetic Objectives
The aim of this work is to deductively ascertain the objective function for a given
metabolic network. For some metabolic network generating metabolic products, the
products can be viewed as a means that the organism uses for achieving an objective. The weights in the above representations of ROI are a channel through which
metabolic products can be connected with the goal J. In situations where the goal is
not known or easily inferred, the calculation of the most appropriate weights for the
system is possible. This method relies on the computation of ui profiles from metabolite data and then fitting weights to optimize the fit between experimental gene expression data that is representative of the control over reaction or pathway catalyst
formation. These weights determined from this fitting procedure are termed the optimal weights. The calculation of ui variables from an arbitrary set of objective weights
achieves this. To calculate these control variables from the data, the unregulated rates
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are determined from the observed regulated fluxes. These are estimated through the
manipulation of the relationship between regulated and unregulated fluxes and the
foregoing definition of ROI (pi = wi rikin ):
ri = vi rikin
ri =

(7.11)

pi
rkin
maxj (pj ) i

(7.12)

wi rikin
rkin
maxj (wj rjkin ) i
s
ri maxj (wj rj )
=
wi

ri =

(7.13)

rikin

(7.14)

The maximum weighted rate of the set of competing metabolic weights at time t is
simply the maximum regulated rate given the property that vi = 1 for this pathway.
Mathematically:
maxi (wi ri ) = maxj (wj rjkin )

(7.15)

With rikin known for each pathway, the ui control variables for each pathway are fixed
for any arbitrary set of weights wi
wi rkin
ui = P i kin
j w j rj

(7.16)

Provided that the ui variables can be calculated for any set of weights given the
metabolic data which allows for the estimation of the regulated rates, the optimal set
of weights wopt can be calculated where
wopt = arg min (
w

n X
m
X

2

(u0 i,t (wi ) − g 0 i,t ) ),

(7.17)

t=1 i=1

in which there are m competing pathways and n data points. Gene expression values
for the catalyst relevant to pathway or reaction i are denoted by gi . The prime on the
gene expression and control variable represent the scaling of both of these quantities
for their qualitative comparison. This scaling for each pathway or reaction over a
series of time is
u0 i =

ui − µ(ui )
σ(ui )

(7.18)
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The scaling of gene expression takes the same form. Both are necessary to make
for proper numerical comparison of both quantities as the magnitudes of gi vary
considerably. The scaling of both variables highlights the fact that it is difficult
to make direct comparison of the absolute magnitudes of the two quantities. For
pathways where there are multiple genes that describe theith pathway’s behavior, one
can generalize the pathway gene as a mean of the sets total changes in gene expression
as
gi ≈ µ(gk ).

(7.19)

This formulation ignores the strength of contribution of each reaction to the pathway
but is convenient to use in situations where the complete metabolic pathway is incomplete (e.g. in lumped cybernetic models). The generalization of this approach to
hybrid cybernetic models [19] is in the following section. Included is a more rigorous
way to approach to approximate pathway specific gene expression.
The vector of weights wopt for the set of reactions or pathways encapsulates the
optimal objective function to best fit both metabolite and gene expression data. Given
the ability of these weights to best estimate both sets of data, they are assumed to
capture the best objective function for the metabolic data and will provide for robust
prediction of different metabolic states.
7.2.5 Generalization to Hybrid Cybernetic Models
The determination of fluxes can be generalized to larger systems relevant to hybrid
cybernetic models. These models use elementary modes to approximate reaction
fluxes and compare the rates of uptake through these competing metabolic pathways.
The uptake fluxes, rM , have the following relationship with the reaction rate fluxes,
r, as:
r = ZrM ,

(7.20)

where the network S has the elementary flux modes (EFMs) Z, a comprehensive
representation of the pathways/macroscopic reactions through the metabolic network
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[18]. The change in measured metabolite vector x of n metabolites is modeled by the
following:
1 dx
= Sx ZVrkin
M .
c dt

(7.21)

where Sx is the stoichiometric matrix associated with only metabolites that are measurable and V is a diagonal matrix containing proportional control variables for each
pathway vi . For more detail on hybrid cybernetic models, refer to [19]. If one selects
n elementary flux modes from Z that best represent the span of the flux hypercone
defined by Z [22], then the unregulated uptake fluxes, rM , are determined in a similar
fashion to the above analysis stemming from the useful property that the product of
Sx Z is invertible. Removing the term for uptake flux regulation, we have
1
dx
rM = [Sx Z]−1 .
c
dt

(7.22)

These are the regulated uptake fluxes for each elementary mode. The relationship
between the regulated and unregulated uptake fluxes is
rM = Vrkin
M

(7.23)

In a similar fashion, the unregulated rates are approximated by assuming that the
maximum weighted wi rM,i is the same as the maximum unregulated rate wi rikin . With
the maximum rate known, the known, each individual rate is then determined as it is
in equations 7.14 and 7.15. The control variables for induced enzymes synthesis are
determined from here by the same procedure.
To calculate the optimal set of weights, genes representative of each EFM must be
selected. This is potentially difficult as EFMs can overlap in a number of the reaction
pathways that they go through. A composite gene profile that is representative of all
the genes in a given profile can be estimated as the sum of the products of an elementary mode’s value for each reaction times the gene corresponding to that reaction’s
enzyme or:
ζi =

m
X
j=1

Zi,j gj .

(7.24)
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With the composite gene expression profile for each EFM, the optimal weights for the
cybernetic objective function are calculated by minimizing the sum of squared errors
between the ui variables which are directly inferred from the data and the composite
gene expression profiles, ζi .
The optimal weights can then be used to estimate a goal signal for the metabolic
system which can then be used in the same way as above to guess at the biological
objective function. This method can also be used to extrapolate the fluxes for lumped
hybrid cybernetic models [24].
7.2.6 Further Analysis of Optimal Weights
While the weights may fit the data, they are, at this point, still a mathematical
abstraction of the goal of the process. They do not have the same intuitive meaning
as objective functions like maximization of growth rate. The proceeding analysis attempts to distill a biological meaning for the optimal weights using a comprehensive
analysis of gene expression data. While the objective is yet to be known, the optimal
weights provide some “goal signal” or time dependent profile for J. This is given by
˙ =
J(t)

X
i

wi,opt ẋp,i (t)

(7.25)

The goal signal is a means of connecting the metabolic network’s products with the
optimal returns on investment. If a metabolic network is generating a set of products,
from the cybernetic perspective, there is an underlying biological purpose for their
generation. Metabolic products that are generated from pathways with a strong ROI
contribute more to the goal signal than ones that do not. The goal signal summarizes
the dynamic behavior of the metabolic network in the context of each pathway’s
regulation resulting from the approximated ROIs.
For some arbitrary length of time, the goal signal might go up or down depending
on the network’s generation of metabolites which is influenced by substrate availability and the underlying metabolic objective. This work makes the assumption that
genes relevant to the organism’s metabolic objective will be regulated similarly to the
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network’s goal signal. In other words, genes will be regulated towards goals in the
same way that combinations of metabolites are produced to accomplish goals. Genes
that match the goal signal will have some function related to ultimate objective of
the metabolic system. This is intuitive if the genes are expressed as the product of
some signaling mechanism initiated by the generation of metabolite products with
negligible delay as
ġgoal (t) =

X
i

wi,opt ẋp,i (t)

(7.26)

The comparison of this goal signal with the entirety of gene expression data provides
a list of genes that have a strong relationship with the metabolic network’s goal.
To test the relationship between the goal signal and the overall picture of regu˙ is compared with the numerically approxlation represented in microarray data, J,
imated derivatives of each gene expression profile, ġk , in the set of genes. Pearson’s
product-moment correlation coefficient was calculated for each gene and goal signal
pair ρJ,˙ ġk . From this, a set of genes, GJ , associated with the goal was isolated using
genes that significantly correlated with J˙ at a p-value lower than 0.05. This threshold
can be adjusted to vary the length of the gene list which should be in the range of
100-2000 genes [111].
To give biological meaning to set GJ , pathway enrichment analysis is subsequently
used. Pathway enrichment analysis (PEA) compares GJ with sets of genes that
make up pathways [112]. It identifies which genes in GJ are overrepresented in any
biological pathway listed on KEGG [97,98]. For example, if a sufficiently high number
of genes in GJ are from a certain KEGG pathway, that pathway is considered to be
enriched. Given the overrepresentation of a pathway in GJ , it is considered to have
some relationship with the goal. For more detailed information on how to carry out
PEA, refer to the following references [111, 113].
The goal related pathways determined by PEA are then surveyed in the literature
to gauge their relevance to the metabolic system. For instance, if a pathway is presented as the goal for a system under a certain condition by this analysis, a literature
search using keywords for the pathway, metabolic system and condition can be made.
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If there is strong evidence of a relationship of a link between the pathways selected
by PEA and the metabolic system of focus, the objective determined by this method
is validated.
While a pathway itself may have a relationship to the metabolic objective, an
important distinction must be made. The pathways isolated by pathway enrichment analysis are feasible explanations for the biological significance of a given set
of weights. These single pathways, by themselves, do not necessarily constitute a
single objective function, but rather, the combination of enriched pathways provide a
picture of processes related to the metabolic objective function. While not as clear as
objective functions like ”maximize rate of growth,” these pathways provide a better
picture of the metabolic system’s goals.
7.3 Results
7.3.1 Diauxic Growth Objective Function Analysis
This methodology is first tested by using it to determine the metabolic objective
function for a well-known model system - E. coli cultured in mixed substrate environments. Comparing the objective functions generated by this method with those
which have been traditionally used to model E. coli such as growth rate maximization
provides a rational method to validate this objective function identification method.
For these systems which are visualized in figure 7.3a and 7.3b, lumped cybernetic
models were used to calculate hypothetical ui variables for enzymes related to the
consumption of competing substrates. These ui variables were then compared with
normalized gene expression trends. From this comparison a set of optimal weights,
wopt , was generated by minimizing the SSE between ui and the mean behavior of gene
expression profiles for genes that are related to the uptake of different substrates.
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Figure 7.3.: Metabolic networks for reaction systems analyzed by the objective function search method.
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Table 7.1.: Values of optimal weights from fitting ui variables to gene expression data.
Glucose Secondary Substrate
Glucose-Acetate 1

0.166

Glucose-Lactose

0.1215

1

PGE2

PGF2

PGD2

1

1E-3

5.59E-3

Prostaglandin

7.3.1.1 Glucose-Acetate System
The first system of focus is E. coli growing in a mixed culture of glucose and acetate
for which gene expression and growth data were available [65]. To calculate the ui
variables, substrate consumption rates were approximated using the initial substrate
levels and changes in biomass. Via comparison of the ui variables and relevant gene
expression data, optimal weights were generated for this system and are identified in
Table I. The weight for glucose consumption was higher in value compared to acetate
which indicates that an objective weight of 1 to 1 for both pathways predicts an
earlier transition in ui variables than gene expression does. The improvement in fit
of the control variables to gene expression is illustrated in figures 4a and 4b.
With these weights, a metabolic signal that is representative of the processes’
˙ is estimated. In order to determine the biological relevance of
changing goals, J,
˙ it is compared to the changes in gene expression for various genes, ġk . Pearson’s
J,
correlation was calculated for all genes. From this, genes with statistically significant
and positive values (ρ > 0 and p < 0.05) were separated into a gene list for further
analysis. These genes were determined to be the most similar in changing expression
compared to the changing goal. This gene list, found in the appendices, consists of
413 genes total and is visualized with the goal signal in figure 7.4b.
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Figure 7.4.: Return on investment optimization and goal signals with gene sets. (a)
Improvement of control prediction for glucose-acetate system where dashed lines (-) represent equal weightings to pathway ROI and solid lines (-) represent optimal
weighting for fit. In remaining subfigures, goal signal for each system is in black with
colored lines for genes in the goal signal gene set for (b) glucose-acetate system (c)
glucose-lactose system and (d) prostaglandin system.
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Pathway enrichment analysis was performed using this list to establish which
KEGG pathways were overrepresented. The top pathways that were enriched were:
ABC transporters, TCA cycle, glyoxylate and purine biosynthesis. These enriched
pathways are relevant to acetate consumption and previously used objective functions
such as growth rate maximization. Further discourse of these enriched pathways will
air in the subsequent discussion. A full list of enriched KEGG pathways and their
enrichment statistics are available in Table 7.3.
7.3.1.2 Glucose-Lactose System
Analysis of the metabolic changes in the glucose-lactose system was made in a
similar fashion to the glucose-acetate system for gene expression data [66]. In this
scenario, substrate data was provided and ui variables were directly inferred from
the changing substrate data. Note that the regulated rates for each pathway were
approximated by the negative rates of substrate uptake for each pathway. The optimized weights in this case showed the opposite behavior of the glucose acetate system
with lactose having a higher weight than glucose. This indicates that the best fit of
gene expression occurred when the objective function was weighted towards the lactose pathway for this particular data set. This is further explained in the subsequent
discussion section.
The behavior of J˙ and the genes that correlate to it are in figure 7.4c. This set
of genes that correlates with the goal signal is stated in the appendices and consists
of 46 genes. Enrichment analysis indicated that amino acid biosynthetic pathways
and pyrimidine biosynthesis were the enriched pathways. Refer to table 7.3 for more
information on the statistical nature of this relationship.
7.3.2 Prostaglandin Biosynthesis
Beyond well-characterized, bacterial systems, objective functions for more complex organisms are more difficult to hypothesize. In light of this, this method is ap-
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Table 7.2.: Enriched pathways for glucose-acetate system

KEGG Pathway

Gene Count %

P-Value

Benjamini

ABC transporters

22

5.6 1.3E-39

TCA Cycle

11

2.8 3.50E-24 2.702E-22

Purine Metabolism

13

3.3 6.80E-24 5.00E-22

Two-component System

12

3

1.30E-19 5.70E-18

Glyoxylate and Dicarboxylate Metabolism

8

2

5.1E-16

Pyruvate Metabolism

8

2

3.80E-15 1.80E-13

1.80E-36

2.20E-14

Table 7.3.: Enriched pathways for glucose-lactose system
KEGG Pathway

Gene Count %

Glycine, Serine and Threonine Metabolism

3

7.5 1.20E-3

0.27

Lysine Biosynthesis

2

5

2.3E-2

0.72

Alanine, Aspartate and Glutamine Biosynth. 2

5

4.49E-2

0.79

Pyrimidine Metabolism

5

8.4E-2

0.86

2

P-Value

Benjamini

Table 7.4.: Enriched pathways for PG system
KEGG Pathway

Gene Count %

P-Value

Benjamini

Endocytosis

7

5.7 4.10E-3

0.23

SNARE Interactions in Vesicular Transport 3

2.4 3.40E-2

0.66

Cytokine-Cytokine Receptor Interaction

6

4.9 3.80E-2

0.55

Notch Signaling Pathway

3

2.4 5.60E-2

0.6
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plied to deductively determine the objective function of prostaglandin (PG) metabolism
in RAW 246.7 macrophages, a cell line derived from Mus musculus. In this system,
one precursor, arachidonic acid (AA) is converted into downstream prostaglandins
PGD2 , PGF2a , and PGE2 in scenarios where an infectious stimulus present [83]. This
infectious stimulus is Kdo2 -lipid-A (KLA) which is similar to the molecules that cover
the surfaces of pathogenic bacteria. When KLA binds to a macrophage’s Toll-like receptor 4 (TLR4), the macrophage responds to fight the perceived infection. While
one may be able to guess at general objective functions for this situation such as
maximize the rate of inflammation generating signals, it is difficult to implement this
in a precise way.
In this system, one substrate is converted into three products which is visualized
in figure 7.3c. The optimal weights were generated directly from the metabolite data
using the product formation rate and previously fit decay parameters to designate the
regulated rate for each metabolic pathway. The gene expression for each pathway’s
enzymes were determined by identifying key genes for metabolic enzymes using the
KEGG pathway database. The optimal weights are in Table I. These weights show
that the system has a strong regulatory weighting towards the pathway that generates
PGE2 .
Using the optimal weights, the metabolic goal signal from the network was approximated and tested for correlation with all genes to generate a gene set. This is
visualized in figure 7.4d. The analysis of this gene set yielded the following explanations for metabolic goal: endocytosis, SNARE interactions in vesicular transport,
cytokine-cytokine receptor interaction, and the notch signaling pathway. The statistical significance and FDR are stated in table 7.4.
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7.4 Discussion
7.4.1 Glucose-Acetate Diauxie
The explanations provided by pathway enrichment analysis for the change in
metabolic goal signal J˙ in the glucose-acetate diauxic growth scenario interestingly
revolve around pathways that are upregulated during E. coli’s transition from growth
on glucose to growth on acetate. Flux analysis of the changes in metabolism show
that TCA cycle and glyoxylate are upregulated during this transition [70]. The fact
that the metabolic goal indicated by J˙ during this transition reflects the significant
metabolic changes that occur helps to validate the idea that pathway analysis is useful
in making sense of the weighting scheme for this system.
Furthermore, the enrichment of purine metabolism and ABC transporters pathways helps to validate the idea that well-established objectives like growth rate maximization [3, 33] and substrate uptake maximization [19, 23]. The synthesis of nucleotides enables growth via DNA and protein synthesis via mRNA, tRNA and rRNA
and is a critical component of the survival of genes. RNA and DNA make up a significant portion of cell’s macromolecular compositions and ribosomes, composed of
rRNA, are a major component of growth [30]. The uptake of substrates through ABC
transporters indicates a possible goal of promoting the scavenging of other sources of
nutrients [65] which is reflective of hypothesized goals related to resource competition.
7.4.2 Glucose-Lactose Diauxie
Pathway enrichment analysis of the glucose-lactose diauxic system yielded less
statistically significant findings. This likely stems from two factors a smaller that
desired gene list (<100) and the behavior of the gene expression data. It is possible
that these two factors are related. In reference to the behavior of the data, the
microarray data has numerous kinks in the time course going up and down and up
and down which makes the gene behavior less likely to significantly correlate with the

127
smoother profile for ui . Other time-series expression data, such as that used in the
other two test cases, does not show this kinked behavior.
Despite the lower significance in statistical data, the pathways that show similarity
to the goal signal are those for amino acid synthesis and pyrimidine biosynthesis. The
presence of pyrimidine biosynthesis in the set of enriched pathways helps to confirm
what is observed in the glucose-acetate system - an enrichment of nucleotide synthesis
which, as stated previously, is a key component of growth. This helps to confirm the
idea that more general objective functions like growth rate maximization are relevant.
The generation of amino acids is consistent with the notion of biomass maximization
as proteins constitute a majority of the macromolecules that make up cells [114].
One important item of note is the fact that the metabolic goal signal weighted different pathways inconsistently between the different scenarios tested. In the glucoseacetate system, glucose had the highest weighting while lactose had the highest
weighting in the glucose-lactose system. This difference is due to the fact that the
timing of gene expression was different with respect to the timing of glucose depletion. The ui variables were delayed in their transition times for a better fit in the
glucose-acetate case. It also means that the ui variables for the glucose-lactose best
fit the data when they described an earlier transition between gene expression for
the two pathways. To accommodate the fits of the gene expression data, the goalsignal profile shifts between the two systems. On the surface, this discrepancy should
not exist but it is conceivable that the metabolic changes during the shifts between
these two separate substrates are better explained by different objective functions.
Other work has shown that there is no single yield-based objective function that is
universally accurate for a range of systems and conditions [48].
There may be several sources of error that contribute to this difference in goal
signals. It may be due to differences in how the substrate trends were extrapolated
from the data. If the substrates showed different timing in their depletion, the goal
signal could have shifted to accommodate this timing difference. Another possible
explanation is the fact that glucose genes do not show a strongly similar relationship
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to the ui variable in this diauxic growth scenario. The metabolic overlap in pathways
for the consumption of glucose and lactose is significant with only the lac operon and
the glucose transporter ptsG being outside of this overlap. This could make it harder
for a goal signal to be generated by looking strictly at the gene expression profiles for
this system.
7.4.3 Prostaglandin Metabolism
In the context of a macrophage reacting to infection, the enrichment of the endocytosis, SNARE interactions in vesicular transport, cytokine-cytokine receptor interaction pathways have meaning. Endocytosis and SNARE interactions [115] fit into the
macrophage response to infection in that macrophages fold their cellular membranes
to envelop invasive bacteria. This is further confirmed when relaxing the filtering
criteria for the gene list from a correlational significance (p-value =0.10 from p-value
=0.05). With the new gene list, the pathway for Fc Gamma R-mediated Phagocytosis is enriched (p-value 1.9e-02, Benjamini=3.5e-01). A full list of these pathways
enriched for the enriched pathways for the gene list provided by this less stringent
filtering criterion is found in Table 7.5.
The other striking enriched pathway of the set is for the cytokine-cytokine receptor
interaction pathway. This makes sense as macrophages produce and sense a variety of
cytokines to cope with infection. This is also confirmed by relaxing the same filtering
criteria extend the gene list for the metabolic goal. When this happens, chemokine
signaling pathway is also enriched which embodies the downstream interactions of the
cytokine-cytokine receptor interaction pathway. Additionally, the toll-like receptorsignaling (TLR) pathway is enriched in the extended list which is directly related to
the condition of interest [87].
The relevance of the enriched pathways, determined by each transcript’s relationship to the goal profile, to the macrophage’s well-established response to KLA help to
validate the idea of a metabolic goal signal. Furthermore, there is a large body of liter-
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Table 7.5.: Results of pathway enrichment analysis for gene list generated using
relaxed filtering criterion p − value < 0.10.
KEGG Pathway

Gene Count %

P-Value

Benjamini

Chemokine Signaling Pathway

10

3.4 2.20E-3

0.18

Endocytosis

10

3.4 4.50E-3

0.18

Gap Junction

6

2

1.10E-2

0.290

Fc gamma R-mediated Phagocytosis

6

2

1.9E-2

3.5

Snare Interactions in Vesicular Trans. 4

1.4 2.20E-2

3.20E-3

Notch Signaling Pathway

1.4 4.40E-2

0.43

4
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ature that links prostaglandin metabolism to the pathways for phagocytosis [116–119],
chemokine signaling [120–123] and TLR 4 [87, 124].
7.5 Conclusions
The fact that goal signals have significant similarity with what is hypothesized
about the functions of various metabolic networks makes a strong case for using them
to describe the regulation of metabolic systems. Also, given that these weighting
schemes accurately reflect the changes in gene expression for the pathways of focus and
can be used to generate goal signals that can be matched to highly relevant metabolic
pathways, they should allow for a more complete cybernetic description of biological
regulation. Analysis of gene lists related to the goal signal in all three scenarios
yielded feasible biological explanations the gene lists that matched the goal signal.
Both the glucose-acetate and glucose-lactose systems showed metabolic goals related
to DNA synthesis, a key component of cellular growth. Other enriched pathways were
explained by information from the literature.
This work defines a novel method to deductively determine dynamic cybernetic
objective functions. Furthermore, it provides a rational procedure for identifying
the biological significance of the deduced objective. The ability to identify objective
functions for metabolic systems where the metabolic goal is hard to hypothesize could
facilitate the development of cybernetic models for complex metabolic systems such as
those present in mammalian cells. This approach has potential applications ranging
from bioprocessing to pharmacology.
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8. GOING BEYOND NONLINEAR OPTIMIZATION FOR PARAMETER
ESTIMATION USING LINEARIZED REACTION KINETICS
Summary
To address some of the issues related to parameterization that have arisen in
chapters 5 and 6, this chapter attempts to provide a feasible solution for the parameter
estimation problem inherent to Hybrid Cybernetic Models. Instead of relying on
cumbersome nonlinear optimization methods to minimize some error function, the
following uses an analytical approach to break down cybernetic model kinetics into
a linearized system of equations that yields a single linear least-squares solution for
parameter estimation. This contrasts with foregoing methods of parameterization for
cybernetic models (i.e. pattern searches and gradient searches) in that the solution
is computationally trivial and yields only one estimate of parameter values.
8.1 Introduction
Cybernetic models are distinguished from other methods that describe metabolism
in that they include an approximation metabolic regulation via the formulation dynamic metabolic goals that guide organisms to maximize some product of metabolism
over time. When models of this nature were first proposed to describe the diauxic
growth of bacteria on mixtures of multiple substrates, their parameterization relied
upon the characterization of growth on individual substrates [3]. As cybernetic models
have advanced in complexity to accommodate large networks of intracellular reactions
using elementary flux modes (EFMs) [18], the parameterization of these models has
become less straightforward as multiple EFMs compete for the same substrate and
no experiment can characterize the uptake of substrate into a single EFM. Given
this challenge, the specification of Hybrid Cybernetic Models (HCMs) [19, 125] and
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Lumped Hybrid Cybernetic Models (L-HCMs) [23,24] require nonlinear optimization
to estimate the kinetics of uptake into different EFMs. Identifying model parameters
in this fashion can be computationally cumbersome and minimization searches do not
guarantee that the search will conclude at a global minima of the search function.
In the identification of parameters for kinetic models of metabolism, this same
issue occurs the where the parameter search function has multiple local minima. Validation of parameters relies on predicting metabolic states on which the model was
not trained [126]. A variety of approaches to determine parameters for kinetic models have been proposed such as curated databases [127] ensemble modeling [32, 128],
Bayesian Parameter Estimation [129], and
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C labeling experiments during nonsta-

tionary states [130] among many others. Each of these methods come with their
respective pros and cons and are not readily applicable for application to HCM or
L-HCM in that the dynamic uptake of substrate into various EFMs is an abstraction
of the biophysical process. In other words, it is difficult to identify explicit facets of
a biological process that are parallel to EFMs on which one can directly characterize
parameters.
While other dynamic models of metabolism have had solutions proposed for the
identification of parameters, there still exists a need for better parameter specification
for cybernetic models. To remedy this, the present work proposes a method that
works for cases where the kinetics can be transformed into a linear function of the
analyzed and transformed. This can be readily applied to the Michaelis-Menten
kinetics that are typically used to describe the uptake of substrates into different
EFMs [19,23,24] and extended to other uptake kinetic expressions. By specifying the
following parameter identification approach, the computational burden of specifying
cybernetic models is reduced and the confidence in the resulting parameters values is
increased.
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8.2 Methods
8.2.1 Determination of Unregulated Uptake Fluxes
A cybernetic model relies on time-course data for its identification. The ultimate
aim of the method is to determine the unregulated uptake fluxes (UUFs), rkin
M , from
data for the time-profiles of the changes in substrates, products and cell concentrations. These UUFs are a kinetic expression that relates the amount of substrate, si , to
its uptake through the ith EFM through some expression such as a Michaelis-Menten
one like
kin
= ei
rM,i

ki si
,
Ki + si

(8.1)

where ei is the bulk enzyme for catalysts for the ith enzyme and ki and Ki are
parameters that we would like to establish. In establishing the UUFs from the data,
we can subsequently manipulate them to solve for the kinetic parameters in a robust
fashion.
These concentrations of substrates, products and cell concentrations are defined
in some vector x of m species as
 
s
 
 
x = p
 
c

(8.2)

where s is the vector of substrates, p is a vector of products and c is the concentration
of cells. To determine the UUFs, it is necessary to manipulate the model using data
for x.
In HCM and L-HCM, the changes in x and the regulated uptake fluxes are related
through the coupled system of differential equations
1 dx
= Sx ZrM ,
c dt

(8.3)

in which Sx is the stoichiometric matrix that describes only species in x, Z is the
matrix describing n EFMs or lumped EFMs, in the case of L-HCM, and rM is the set
of n regulated uptake fluxes through the EFMs. Given complete knowledge of x and
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an ability to extrapolate

dx
dt

from x, it is possible to characterize the regulated uptake

rates rM for each EFM given that the number of EFMs is equal to the number of
species in x or
m = n.

(8.4)

This will make the product Sx Z invertible. To enforce the above equality, one can
select a subset of EFMs that span the maximal volume of the convex hull that makes
up the yield space for the EFM set for HCM using the same approach as is specified in
yield analysis [22] or distinguish a lumping scheme that determines m lumped EFMs
for L-HCM. Given that the number of EFMs is equal to the number of species in x,
equation 8.3 can be manipulated for the regulated uptake fluxes with
dx
1
rM = (Sx Z)−1 .
c
dt

(8.5)

The regulated uptake fluxes are related to the unregulated uptake fluxes by the
following relationship:
rM = Vrkin
M ,

(8.6)

where Vis an n by n diagonal matrix for the n vi cybernetic variables that describe
enzyme activity regulation. This cybernetic variable, called the proportional law,
takes the form
vi =

pi
,
maxj pj

(8.7)

where pi represents the return on investment (ROI) for each pathway. ROI can take
a variety of forms such as maximization of growth rate
pi = Zi,G rikin ,

(8.8)

where Zi,G represents the amount of biomass or growth created by the ith elementary
model. Other forms of ROI are also feasible which is generalized to
kin
,
pi = wi rM,i

in which wi represents some weight related to the metabolic goal.

(8.9)
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For each EFM uptake, the following relationship exists:
kin
rM,i = vi rM,i

(8.10)

This can be manipulated to determine the regulated uptake fluxes through
kin
rM,i = vi rM,i

rM,i =

(8.11)

pi
kin
rM,i
maxj pj

(8.12)

2

kin
wi (rM,i
)
rM,i =
kin
maxj wj rM,j
s
kin
rM,i maxj wj rM,j
kin
rM,i =
wi

(8.13)

(8.14)

From this, each EFM’s UUF can be established in that wi is postulated by the modeler
kin
is known from the
as an assumption for a feasible objective function and maxj wj rM,j

property that the maximum ROI can is known directly from the data. This is because
kin
arg maxi (wi rM,i ) = arg maxj (wj rM,j
),

(8.15)

given that the pathway with the maximal ROI will have no downregulation of the
unregulated uptake flux rate or vi = 1. Note that because the UUFs can be determined
at each point in time, the ROIs for each EFM can also be determined at each point
in time.
8.2.2 Extracting Enzyme Profiles from Data
In HCM and L-HCM, the changes in enzyme level are established by
dei
kE,i si
= αi + ui
− (µ + βi )ei
dt
KE,i + si

(8.16)

where αi is the rate of constitutive enzyme synthesis, and the last term represents
depletion of enzyme due to growth µ and degradation βi . In this expression, the
parameters αi and βi can be taken from prior work [19]. Growth rate, µ can be
extrapolated from data for time-dependent changes in cell concentration c as
µ=

d ln c
.
dt

(8.17)
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The second term in enzyme equation 8.16 represents the controlled rate of induced
enzyme synthesis and is modulated by cybernetic variable ui which is a relationship
between the ROIs
pi
ui = P ,
j pj

(8.18)

and means that the fractional allocation of resources for the synthesis of the ith
pathway’s bulk enzyme is proportional to the fractional ROI endowed by investment
into that pathway. Given that pi is known for each pathway at each time, this
cybernetic variable is also known for each time point in the data. The MichaelisMenten expression for induced enzyme synthesis is also known given the assumption
that parameters kE,i and KE,i are the same from previous applications of HCM and
L-HCM. The substrate concentration is also known at each time. Therefore, the
entire expression for

dei
dt

is characterized at each time point given some starting guess

for each ei,0 . From this, the enzyme concentrations can be numerically approximated
using numeric integration for each pathway’s enzyme quantity.
8.2.3 Determination of Rate Parameters
Given that the unregulated uptake fluxes, substrate level and enzyme quantities
are known for each point in time, it is possible to extract the kinetic parameters by
linearizing the kinetic expression by taking its inverse or
1
kin
rM,i

=

1 1
Ki 1
+
.
ki ei si ki ei

(8.19)

The behavior of the set of observed fluxes can be generalized into a linear system
for each observed time point ts as
y = Xb

(8.20)
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(8.21)

To solve for the parameters in b, one can quickly find a least squares estimate
using the Moore-Penrose pseudoinverse for X
−1

b = (XT X) XT y

(8.22)

From b, we can establish each EFM’s uptake flux kinetic parameters ki and Ki
where
ki = b2 −1
Ki =

b1
b2

(8.23)
(8.24)

8.2.4 Linearization of Other Kinetic Expressions
This method can be used to fit parameters for other kinetic uptake expressions.
For example, if an EFM relies on the uptake of two substrates, the kinetics could take
some multiplicative form of the Michaelis-Menten kinetics such as
kin
rM,i
= ei ki

s1
s2
K1,i + s1 K2,i + s2

(8.25)

The inverse of this kinetic mechanism yields a more easily analyzed form of the kinetics
1
kin
rM,i

=

K1,i K2,i 1
K1,i 1
K2,i 1
1 1
+
+
+
ki
e i s1 s2
ki ei s1
ki ei s2 ki ei

(8.26)

which yields the same analysis as in equation 8.21 where the system of equations is
 



1
K1,i K2,i
1
1
1
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1
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  ei s1 s2 (t1 ) ei s1 (t1 ) ei s2 (t1 ) ei (t1 )  ki 
 rM,i
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(8.27)
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The pseudoinverse can then be used to determine the parameter vector in this
equation. From there, individual parameters can be identified through algebraic manipulation of the parameter vector.
Other kinetic formulations including various ways of modeling inhibition (e.g.
competitive, noncompetitive, uncompetitive) can also be treated in a similar fashion.
8.3 Results
For proof of concept, this method was used to determine the parameters for a
simplified version of the HCM model for E. coli GJT001 [19]. This simple model only
tracks the changes in concentration of a subset of all external products. The selected
subset consisted of the species glucose, biomass, acetate and ethanol. Acetate and
ethanol were chosen because they embodied the most abundant products generated
by the strain of bacteria. To allow for the inversion of the product of the external
species’ stoichiometric matrix and the EFM matrix, four elementary modes were
selected from the set of 8. This selection procedure occured in a fashion similar to
yield analysis. Towards this, the yield space of acetate on glucose and ethanol on
glucose was analyzed and a subset of 4 EFMs that maximized the area of the convex
hull was chosen. This selection procedure retained 96.82% of the 2-dimensional yield
space’s original area. This is visualized in figure 8.1.
The retained EFMs are in Table 8.1. From these 4 EFMs, the parameters for the
unregulated rates were developed using the method from the previous section. The
uptake kinetics for each EFM is composed of a simple Michaelis-Menten expression
in the form of equation 8.1. Each mode’s ki and Ki are listed in table 8.2. The Sx
matrix can be extrapolated from [19] taking the rows representative of the metabolites
glucose, acetate, ethanol and biomass.
Because the inverse of the stoiciometric-EFM product yielded negative values for
the regulated uptake rates, the routine lsqnonneg in MATLAB was employed to
extrapolate the regulated rates from the changes in metabolite concentrations which
forced the regulated rates to be positive in value. Following this, the enzyme levels
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Figure 8.1.: Visualization of yield space analyzed to reduce the original set of 8 EFMs
to 4. All EFMs are denoted with black circles and retained EFMs are represented by
a red x.

57.973 0
88.992 0

59.026 36.741 15.509 88.992 29.966 0

0

0

0

0

88.992 0

31.019 26.954 0

39.754 0

88.992 0

57.973 22.212 0

0

35.688 39.754 9.485

0

35.761 28.986 0

88.992 37.38
84.927 0

44.158 0.678

49.239 42.464 0

51.61

Table 8.1.: Elementary Flux Modes used in model developed.

1

1

1

1

140

141

Table 8.2.: Model Parameters - Simplified HCM model for E. coli GJT001.
Mode

ki

Ki

1

0.5481 99.8515

2

0.2241 42.9605

3

0.2943 0.01

4

0.1497 0.01

and parameters were determined. The parameter values are in table 8.2 and their
fit is visualized in figure 8.2. It is evident in figure 8.2 that the fit achieved by this
method describes the observed data well.
8.4 Discussion
Compared to nonlinear optimization approaches where parameters are solved by
guessing parameters to minimize some error function in a generic least-squares format
like
arg minθ

X
s

(ys − ŷs (θ))2 ,

(8.28)

in which ys represents the data at time, ts , and ŷs (θ) represents the model prediction
of the data at that same time. Gradient searches [131], genetic algorithms [132],
pattern searches [133], and other methods all require large numbers of parameter
guesses to find some minimum of the error function. Each of these parameter guesses,
in turn, necessitates the simulation of the set of differential equations which can be
often be stiff in the case of cybernetic models meaning that guessing thousands of
parameters takes a non-trivial amount of time. Moreover, once the minimization
algorithm establishes the parameters, it does not provide any insurance that a global
minimum has been found.
Prior work, in this thesis, such as for the determination of the prostaglandin parameters, needed days of computation to simulate. The presented method of param-
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Figure 8.2.: Fit of model using parameters established from this method. Data points
are marked by squares.
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eterization needs the numeric integration of only one system of differential equations
and the calculation of a pseudoinverse takes seconds to compute which contrasts with
prior work which takes significantly longer for parameter determination. Moreover,
there is only one solution in parameter space provided by this method given an input
of some set of data, a hypothesized cybernetic objective function, a guess at initial
enzyme levels and enzyme parameters used from prior work. The linear-least squares
method also provides the global minimum for the observed data and model.
Having effective ways of specifying a cybernetic model’s parameters is important
to the cybernetic framework as a whole. Nonlinear optimization approaches are cumbersome, inefficient and do not endow a modeler with confidence of the absolute
nature of parameter values. This method should be practical for any modeler seeking
to parameterize a cybernetic model and allows for flexibility in the initial modeling
assumptions. Instead of encountering the rigmarole of nonlinear optimization for
each objective function assumption, one can easily develop models and test for the
robustness of numerous objective functions.
Overall, this refined method of parameter estimation should enable modelers to
more quickly and effectively develop descriptions of metabolic phenomena using the
notion that regulation seeks dynamic optimality. It is clear from the fit achieved in
figure 8.2 that the method works. Facile model identification allows for more complete
probing of questions related to the truth of dynamic optimality in cells because less
effort is expended on parameter estimation - a significant portion of the overall effort
needed to generate cybernetic descriptions. Easier parameter identification could help
make more conclusive statements about the fundamental nature of metabolic goals
using analysis similar to what takes place in chapter 6.
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9. SUMMARY
The goal of this dissertation was to establish whether cybernetic control provides
a good description of biological regulation by probing research questions related to
three main areas: the ability of cybernetic models to compress data relative to other
models, the accuracy of the enzyme synthesis control variables in reference to data
that is representative of enzyme synthesis control, and lastly, the ability to mine data
for feasible objective functions. To phrase this as a question, when one considers the
data generated by biological systems, is there evidence that metabolic changes are
driven by goals? The analysis herein shows that there is definitive evidence that goals
are a comprehensive way of modeling and understanding metabolism.
The first test of goals was in establishing that cybernetic models provide a compact description of biological processes relative to other models. The compression
of data achieved by cybernetic models was higher relative to constraint-based and
kinetic approaches. This shows that dynamic objective functions are more effective
at capturing the regularity in data generated by metabolic systems. To reiterate, capturing the regularity in data generated by a process represents an understanding of
the generating process. Models that capture more regularity (i.e. those that provide
higher compression of the process’s data) can be understood as having a deeper understanding of the generating process. Therefore, the analysis of relative compression
of data by these different models makes the statement that metabolic goals yield a
more complete picture of metabolic systems.
In the second segment of this work, a closer look at the cybernetic variable ui
was taken to determine if relevant biological processes for enzyme synthesis showed
similar behavior. Two sets of systems were probed to establish this similarity. One
set was composed of three studies of diauxic growth systems for different types of gene
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expression data. This first study demonstrated the validity of cybernetic control of
enzyme synthesis in this model system. To see if cybernetic control of enzyme synthesis was an accurate approximation of regulation in more complex mammalian systems,
a similar study was made for prostaglandin metabolism in RAW 264.7 macrophages
from M. musculus. This analysis also showed a statistically significant relationship
between changes in the ui variables and gene expression changes. Because of the
observed likeness between cybernetic control variables for enzyme synthesis and gene
expression data across multiple systems, it can be said that metabolic goals are a
good description of metabolic control.
The last angle taken in addressing the question of cybernetic control’s veracity was
trying to deduce metabolic goals through the mining of large volumes of biological
information. This method introduced the notion of “optimal returns on investment”
and that of a generic metabolic “goal signal” which changes over time that can be
compared with volumes of dynamic gene expression data. Applying these concepts to
diauxic growth systems and prostaglandin metabolism generated feasible metabolic
objective functions that were relevant in the context of the metabolic systems that
were studied. The mining of data for objective functions is uniquely utile to the
cybernetic framework in that all prior work in developing cybernetic descriptions of
metabolism relied on a modeler’s postulation of an appropriate objective function.
Furthermore, the fact that relevant objective functions can be mined from data shows
that biological systems indicate that there is regulation towards goals.
Overall, these approaches at validating cybernetic control demonstrate that there
is reason to believe that the many iterations of biological refinement that have occured
over countless generations have yielded optimal behavior. While it is impossible to
answer the question “Are metabolic systems goal-directed?” with absolute certainty,
this dissertation has shown that this concept is indeed true through the aforementioned lines of reasoning.
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10. FUTURE WORK RECOMMENDATIONS: EXTENSIONS OF CYBERNETIC
MODELING TO TRANSLATIONAL RESEARCH
Summary
Mathematic models that capture the dynamics of metabolism offer much promise
in providing deeper insight into medical applications. While kinetic frameworks are
hindered by nontrivial complexity, cybernetic models offer a simpler approach in
describing metabolic changes by means of simplifying intricate regulatory phenomena
into the assumption of a dynamic objective function. Cybernetic models still endow
their users with an ability to make predictions of numerous metabolic phenomena
despite this simplification.
In this dissertation, cybernetic models have demonstrated an ability to simultaneously track the changes in gene expression and metabolism in mammalian cells which
demonstrates the potential for cybernetic models to forecast changes in complex,
pharmacologically relevant systems. Because of this, it is proposed that cybernetic
models be applied to the investigation of drug-metabolism interactions.
The product of this effort should yield predictions of metabolic behavior during
perturbations to metabolic systems with drugs. These projections of metabolic behavior include changes in the formation of metabolic products that are indicative
of drug side-effects. The identification of models that describe metabolic perturbations due to drugs should also generate crucial understanding of how drugs affect
cellular regulation. Classifying the nature of cellular regulation during drug-induced
metabolic dysfunction allows for a more comprehensive approach to pinpointing drug
targets, treatment timing, and dosage.
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10.1 Introduction
Metabolism is a vastly complex process that is fundamental to life. Having a
clearer picture of metabolic behavior enables a variety of societally important technologies ranging from pharmaceutical applications to biofuels. Our understanding of
the intricate machinery that drives metabolic processes is accelerating in rate due
to the advent of numerous omic technologies that allow researchers to get increasingly detailed pictures of biological processes. There is a need for models that give
new insight into the volumes of biological data that are being generated by these
technologies [134].
Cybernetic models of bacterial metabolism, armed with the assumption that
metabolic pathways are regulated towards maximizing the rate of growth or substrate uptake, have yielded numerous predictions of intriguing metabolic phenomena.
These models have provided for the predictions of complex substrate uptake patterns [3,9], the prediction of multiple steady states [14,21], metabolic fluxes [26], and,
in chapters 4 and 5, the prediction of gene expression phenomena in both bacterial
and mammalian systems.
These recommendations of future work seek to further develop cybernetic models
for medical applications. Cybernetic models are just beginning to be approximate the
behavior of mammalian systems which are germane to clinical applications. Recent
approaches have been developed to learn objective functions from omic data and can
be readily applied to these systems. The overall goal is to use cybernetic models to
robustly predict how drugs perturb metabolic behavior in mammalian systems.
10.1.1 Significance
Systems biology has a number of promising applications that could help to transform the practice of medicine. Metabolic models can empower researchers to make
sense of biological data and hypothesize connections between biomedical research and
patient outcomes [135]. Tangent to approximation of metabolic systems, a number
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of systems approaches have studied how diseases affect the behavior of regulatory
networks [136]. The combination of metabolism and regulation are highly relevant
to human health [137]. Cybernetic models offer an effective way to approximate the
dynamics of both metabolites and regulation of metabolic reactions.
Other constraint-based metabolic modeling have endowed translational researchers
the ability to predict drug targets to fight cancer [138,139]. These approaches do not
allow for researchers to gain a deeper understanding of how time-dependent changes
in metabolites affect disease progression. In light of this, cybernetic metabolic models
offer their users with the possibility of new discoveries.
10.1.2 Innovation
The proposed work will attempt to use cybernetic models to gain a more significant understanding of the way that drugs affect metabolism. Dynamic modeling of
metabolism endows researchers with the ability to make insights into biological behavior and make predictions to guide experimentation. Mathematical descriptions of
metabolic dynamics using detailed kinetic formulations have a number of significant
restrictions including difficult parameterization, and computational complexity. For
example, whole-cell models, capable of describing the time-dependent expression of
entire genomes in simple cells such as M. genitalium [140], rely on parameter sets
numbering in the thousands and still require the simplification of metabolic processes
using yield-based objective functions.
Instead of exhaustively enumerating the multitude of features that modulate
metabolism, cybernetic metabolic models strike a unique balance between model complexity and accuracy by modeling the dynamic regulation of metabolism using the
assumption that such processes are goal-directed [45]. Cybernetic models are in a
unique position to provide medically significant predictions. Recent work describing prostaglandin metabolism in a M. musculus macrophage cell line have yielded
predictions of how combinations of infection and statins affect the formation of inflammatory lipids which has been enabled by advanced technologies that characterize

150
lipids [87,89]. Beyond this, the cybernetic model for this system is capable of simultaneously predicting relative changes in gene expression. Given that cybernetic models
allow for the prediction of metabolic phenomena on multiple levels, it is conceivable
that they can also provide for the prediction of how inhibitory drugs interact with
metabolic systems.
10.2 Recommended Research Goals and Plan
Provided the preceding discussion into the merits of cybernetic modeling, attempts
to verify the following hypothesis are recommended:
10.2.1 Hypothesis:
Cybernetic models allow for the robust prediction of the interactions of drugs that
affect metabolism because they are capable of robustly forecasting the behavior of
gene expression and metabolites during perturbations to metabolism.
10.2.2 Goals:
To validate the stated hypothesis, the following research goals are recommended:
• Goal 1: Make predictions of metabolic behavior during perturbations to metabolic
systems with drugs. Predictions of metabolic behavior include changes in the
formation of metabolic products that are indicative of drug side-effects.
• Goal 2: Identify the nature of cellular regulation during drug-induced metabolic
dysfunction.
10.2.3 Recommended Research Plan
To address the first research goal, prostaglandin metabolism will be of focus.
Prostaglandins (PGs) are generated during inflammation and bind to a number of
receptors that cause a variety of responses in immune system cells through second
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messengers [81]. This system is of significant medicinal relevance in that it is targeted
by nonsteroidal anti-inflammatory drugs (NSAIDs) to inhibit cyclooxygenase (COX)
enzymes and prevent the formation of PGs. Over 30 billion OTC doses of NSAIDs
are sold in the US every year [82]. Formulation of a cybernetic model describing the
effects of different drugs that perturb PG metabolism would have clinical utility in
that it could more robustly predict the behavior of PG metabolism than other drugs.
Beyond the specific application of describing the effects of NSAIDs, this exercise would
provide proof-of-concept for the cybernetic approach for modeling drug-metabolism
interactions. The provision of a modeling framework that robustly predicts metabolic
regulation with a low degree of model complexity would empower the process of drug
development.
As covered in chapter 5, an already existing cybernetic model that describes
prostaglandin formation in RAW 264.7 macrophage cells is capable of simultaneously
predicting gene expression and metabolic behavior. This robust approximation of PG
metabolism can also be used to predict the behavior of PG metabolism in situations
where cyclooxygenase is inhibited. A sample of what the model projects is stated in
chapter 5 (figure 5.4). This finding has yet to be experimentally verified. Beyond this,
the upstream effects of blocking PG formation could be modeled using cybernetics to
complement the understanding side-effects of NSAIDs. PGs are just a facet of a larger
network of signaling lipids called eicosanoids. If there is some unique accumulation
of lipids in a larger model that tracks the formation of other eicosanoid products, a
cybernetic model would be able to predict such a phenomenon. Understanding the
accumulation of other products provides information on what side effects will occur.
A dynamic model will also enable researchers to gauge the time-dependent formation
of side effects.
Beyond providing predictions of the effects of drugs, modeling the effects of drugs
on cellular regulation and metabolic behavior will provide deeper insight into how
drugs perturb the processes that control metabolism. Cybernetic models are formulated from the perspective that cells modulate metabolism to achieve goals. These
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goals are relevant to the organism’s survival and have been finely tuned through the
eons of evolution where natural selection picks the metabolic algorithms that achieve
survival and propagation. When drugs perturb metabolic systems, they are interfering with the preprogrammed goal that drives metabolic regulation.
Regulation witnessed during drug-induced metabolic dysfunction may provide a
novel perspective on metabolic control. There a number of interesting scenarios such
as (a) the cells regulate as if there is no drug perturbation, (b) cells react to perturbation and still control metabolism towards the same goal or (c) some new metabolic
objective function becomes apparent. Cybernetic models allow for the performance
of this type of analysis in that they can be used explicitly to model these scenarios. Comparison of a cybernetic model’s prediction of optimal control during drug
treatment with data will reveal how rigid metabolic regulation mechanisms are.
Understanding, how regulation occurs during treatment with drugs supports the
development of treatment modalities that are more effective. If metabolic regulation
circumvents the full realization of a drug’s therapeutic potential, cybernetic models
are capable of forecasting this. If a drug is not fully functional due to metabolic
regulation, a cybernetic model could diagnose combinations of drug treatment that
are.
The following activities are recommended:
Goal 1:
a. Small Network Model
(a) Experimental characterization of PG dynamics during treatment with NSAIDs.
Metabolite and gene expression data for the following conditions need to
be collected: a control, inflammatory stimulus and combination of inflammatory stimulus and NSAID. Variation in doses of NSAID are needed for
model cross validation.
(b) Development of cybernetic model to describe the changes in PG formation
for the different conditions.
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(c) Validation of the model to test to see if it can predict PG changes for
different NSAID dosing.
b. Large Network Model
(a) Characterization of a larger set of eicosanoids in the same set of conditions.
(b) Formulation of cybernetic model for this system.
(c) Cross-validation study as in item above.
(d) Analysis of perturbed product formation to investigate side-effects of NSAID
treatment. This can be validated with extensive studies of NSAID use in
the literature.
Goal 2:
a. Comparison of gene expression data with model variables for enzyme control
to investigate how NSAIDs affect control of biological systems. Establish if
perturbed regulation is related to scenarios (a)-(c) stated above.
b. Use data mining approach to determine how metabolic objective function changes
in metabolic systems that are affected by drugs.
10.3 Final Thoughts
The recommended has great potential to transform medicinal development and
application using cybernetic models and bioinformatics. While much data can be
collected from biological systems, there is a dire lack of causality based theories that
can predict what is going on at the systems level of an organism. Metabolite-drug
interactions are no exception. The details of metabolic pathways are well characterized, but how these reactions are regulated as coordinated by the cell’s genes is still
unknown. Cybernetic models show great promise in providing this valuable insight
and have the potential to ultimately elucidate the complex, synchronized behavior of
intricate metabolic networks. This would constitute a significant triumph in the field
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of bioinformatics and pave the way for the more purposeful development of drugs that
interact with metabolism. When a drug is designed to affect the formation of some
metabolite, a comprehensive understanding of how the metabolic system is affected
will be known.
Each and every individual on the planet has the potential to benefit from the
fruits borne from targeted drug design and applications. Understanding how drugs
affect the metabolic process is crucial to understanding a drug’s efficacy. Knowing
the weaknesses in a cancer cell’s metabolism through the formulation of cybernetic
models can prevent the growth and evolution of the disease via the specification of
appropriate drugs. Cybernetic models have already contributed much to the field of
metabolic engineering. Their capacity to revolutionize treatment in pharmacological
applications has yet to be realized. The recommended research has the capability
of impacting a range of important activities in the application of medicine. Drug
targets, treatment timing, dosage, and prediction of side effects could all be better
informed by the cybernetic approach.
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A. DEVELOPMENT OF METABOLIC MODELS FOR MODEL SELECTION
TEST CASES
This segment features relevant details related to the development of the dynamic
models used in the dynamic model comparison in the preliminary results section.
A.1 Network
The reaction network used in this model selection exercise was taken from Kotte
et al. (2011) from which the figure is taken and placed below. On the right side
of the figure, the metabolic reactions involved are shown. In the figure within the
main body of the report, the reactions correspond to the reaction names below. The
other information related to the kinetic model is featured in table A.1 including the
influences of different signaling mechanisms.
Table A.1.: Reaction Network
Reaction Name

Balance

Biomass

3.75 AcCoA + 5.20 alKG + 1.33 G6P
+ 18.27 NADPH + 1.79 OxA + 0.52 PEP
+ 1.50 PG3 + 2.83 Pyr + 59.89 ATP
= 1 Biomass + 3.55 NADH

Uptake/Exchange
Glc PTS up

1 Gluc ext + 1 PEP = 1 G6P + 1 Pyr

Ac up

1 Ac ext = 1 Ac

Ac out

1 Ac = 1 Ac ext

continued on next page

Reversible
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Table A.1.: continued
Reaction Name

Balance

O2 up

1 O2 ext = 1 O2

CO2 ex

1 CO2 ext = 1 CO2

Reversible

Yes

Glycolysis
G6P::FBP

1 G6P + 1 ATP = 1 FBP

FBP::G6P

1 FBP = 1 G6P

FBP::PG3

1 FBP = 2 PG3 + 2 NADH + 2 ATP

Yes

PG3::PEP

1 PG3 = 1 PEP

Yes

PEP::Pyr

1 PEP = 1 Pyr + 1 ATP

Pyr::PEP

1 Pyr + 2 ATP = 1 PEP

Pyr::AcCoA

1 Pyr = 1 AcCoA + 1 NADH + 1 CO

TCA
AcCoA::ICit

1 AcCoA + 1 OxA = 1 ICit

ICit::alKG

1 ICit = 1 alKG + NADH + CO2

alKG::Mal

1 alKG = 1 Mal + 1 ATP + 1 NADH + 1 CO2

Mal::OxA

1 Mal = 1 OxA + NADH

OxA::PEP

1 OxA + 1 ATP = 1 PEP + 1 CO2

PEP::OxA

1 PEP + 1 CO2 = 1 OxA

Acetate Metabolism
AcCoA::AcP r

1 AcCoA = 1 Ac

Mal::Pyr

1 Mal = 1 Pyr + 1 NADH + 1 CO2

Ac::AcCoA

2 ATP + 1 Ac = 1 AcCoA

Glyox
ICit::Glyox

1 ICit = 1 alKG + 1 Glyox

Glyox::Mal

1 AcCoA + 1 Glyox = 1 Mal

Oxid Phos
continued on next page

Yes
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Table A.1.: continued
Reaction Name

Balance

Reversible

Oxidase

1 QH2 + 0.5 O2 = 2 Hp

NADHDehydro

1 NADH = 1 QH2 + 2 Hp

Yes

TransHydro

1 NADH + 1 Hp = 1 NADPH

Yes

ATPSynth

3 Hp = 1 ATP

Yes

Maintenance
ATPdrain

1 ATP = 1 ATP ext

A slightly more detailed network was used to develop the dFBA, HCM and L-HCM
models. These networks include both structured biomass equations and maintenance
reactions. The structured biomass equation is a simplification of the one found in
(Trinh et al. 2008).
A.2 Development of dFBA Description
The dFBA model was formed using a Monod type uptake kinetics which have the
following formulation:
dX
= X(µG + µA )
dt
dG
= −XµG /YG − rA,G
dt
dA
= rA,G − XµA /YA
dt
where
µmax
G G
KG + G
µmax A
µA = A
.
KA + A
µG =
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Table A.2.: Parameters Used for dFBA Model
Parameter Value
µmax
G

0.60898005393401899

KG

5.0099999999999999E-2

µmax
G

1.50317424025733E-2

KA

0.79990000000000006

kA

0.41966587761481799

YG

0.38668959071425302

YA

4.4608009913101997E-3

In this case, X, G, and A denote the concentrations of biomass, glucose and
acetate respectively. Glucose is taken up by the biomass and converted to acetate
which is represented by the term rA,G .
rA,G = kA GX
The model outlined has a total of 7 different parameters which take on the values
listed in table A.2.
The parameters above were solved for using Matlabs GA and fminsearch functions
in order to minimize a sum of squared errors function. Figure A.1 shows the dynamic
behavior of the 3 differential equations and their closeness to the behavior modeled.
From the Monod model, the rates of substrate uptake were inferred to use in FBA
to arrive at dynamic flux behaviors. The FBA problem used biomass maximization
as an objective function and was calculated by solving a linear programming problem.
By dividing the dynamic uptake data into discrete intervals, one can infer the
dynamic flux solution through multiple linear program solutions using the different
uptake rates.
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Figure A.1.: Visualization of Monod model for dFBA uptake rates.
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A.3 HCM and L-HCM Model Development
The same reaction network as above was used for both the L-HCM and HCM
models. For the development of both models, EFMs were calculated for the reaction
network. The total number of EFMs amounted to120 total. For the HCM model,
it was infeasible to specify 240 parameters (ki and (Ki for each mode). Instead,
yield analysis (YA) (Song et al. 2009) was used to reduce the total number of elementary modes by determining which elementary modes made up the extreme edges
of the yield space. Yield space was calculated around the glucose and acetate uptake/excretion. Elementary modes at the extreme edges were selected to preserve
99% of the n-dimensional volume. This process reduced the elementary modes from
120 to 7 modes. The modes are all yields are Yglu/bio , Yacup/bi o , and Yacout/bio . Note
that the inverse is more intuitive but undefined when the production of biomass in
the absence of one of the uptake or production of a product. The total space analyzed
is visualized in figure A.2.
These modes are listed in table A.3.
Table A.3.: Elementary Modes Isolated from Yield Analysis
Reaction Name

1

’G6P::FBP’

3

4

5

6

1.93 0

6.8

0

6.86

0.13 35.06

’PEP::Pyr’

0.45 0

3.93

0

0

0

24.4

’Pyr::PEP’

0

0

0

1.07

2

0

’Pyr::AcCoA’

2.16 0

9.89

6.26

7.16

0

54.67

’AcCoA::ICit’

0.74 1.92

2.91

9.88

5.08

2.02 22.26

’ICit::alKG’

0.74 1.75

0

0

5.08

2.02 0

’alKG::Mal’

0

1.86

0

8.58

2.21

1.9

5.69

’Mal::OxA’

0

0

2.91

11.49 0

0

27.95

continued on next page

2

2

7
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Table A.3.: continued
Reaction Name

1

2

3

4

5

6

7

’OxA::PEP’

0

0

0

1.17

0

0

0

’PEP::OxA’

1

1.94

1

0

6.07

2.06 0

’ICit::Glyox’

0

0.17

2.91

9.88

0

0

22.26

’Glyox::Mal’

0

0.17

2.91

9.88

0

0

22.26

’Oxidase’

4.65 5.43

18.16 28.96 22.21 5.75 111.51

’AcCoA::Ac’

0.88 0

1.98

0

’Ac::AcCoA’

0

2.14

0

’ATPdrain’

0

0

’mue’

0

0

0

14.44 0

2.1

1.78

0

0

0

0

0

0.14 0.01

0.56

0.25

0.55

0.02 3.19

’Glc PTS up’

2.12 0

7.55

0

7.59

0.16 39.29

’O2 up’

2.32 2.72

9.08

14.48 11.11 2.88 55.76

’Mal::Pyr’

0

2.03

0

6.97

2.21

1.9

0

’FBP::G6P’

0

0.02

0

0.33

0

0

0

’FBP::PG3’

1.93 -0.02 6.8

-0.33

6.86

0.13 35.06

’PG3::PEP’

3.64 -0.05 12.77 -1.04

12.88 0.23 65.35

’NADHDehydro’ 4.65 5.43

18.16 28.96 22.21 5.75 111.51

’TransHydro’

2.62 0.22

10.22 4.56

’ATPSynth’

5.32 7.17

20.81 37.09 26.25 7.53 129.27

10.12 0.41 58.22

For the generation of the HCM model, 10 parameters were fit to the data using
MATLABs fmincon nonlinear optimization gradient search from 8 different starting
points for robust parameter calculation. Seven kimax parameters were calculated for
each mode. 2 Michaelis-Menten constants were calculated for both glucose and acetate
substrates. 1 enzyme synthesis parameter was determined. All model constants are
stated in table A.4.
The fit of the HCM model to external substrate data is shown in figure A.3.
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Figure A.2.: Convex hull used for yield analysis.
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Table A.4.: HCM Model Parameters
Name Parameter Values
k1max

32.27

k2max

1.2

k3max

4.81

k4max

1.67

k5max

5.16

k6max

26.61

k7max

1.66

KGlu

1.77

KAc

0.43

kE

1.49
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Figure A.3.: Visualization of HCM description of extracellular species.
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The L-HCM model was generated using the same network. The metabolite data
for the yields of biomass and acetate growing on glucose and the yield of biomass on
acetate were determined by fitting logistic curves to the batch data. These yields were
used to lump the modes into two families for growth on glucose and for growth on
acetate. The yield data was used to tune the lumping parameter. This was done using
a genetic algorithm and fminsearch to minimize the difference between the lumped
modes yields and actual data for these yields. The tuning parameters nη were 11.92
and 5.57 for the glucose and acetate modes respectively. The GAR used to weight
maintenance energy was 97. The lumped modes are described in table A.5.
From these 2 lumped elementary modes, only two kimax parameters were fit to
the data. Other parameters were assumed to be robust and were taken from other
L-HCM work (Song et al. 2010/2011). The values for these parameters are in table
A.6.
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Table A.5.: L-HCM Family Modes
Reaction Name

Glucose Acetate

’G6P::FBP’

0.95

0

’PEP::Pyr’

0.58

0.21

’Pyr::PEP’

3.50E-2

1.9E-2

’Pyr::AcCoA’

1.52

0.489

’AcCoA::ICit’

0.42

0.73

’ICit::alKG’

2.50E-2

2.3E-2

’alKG::Mal’

0.11

0.65

’OxA::PEP’

0

0.26

’PEP::OxA’

0.18

0

’ICit::Glyox’

0.39

0.70

’Glyox::Mal’

0.39

0.70

’Oxidase’

3.11

2.24

’AcCoA::Ac’

0.50

0

’Ac::AcCoA’

0

1

’ATPdrain’

2.214

0.52

’mue’

0.06

1.50E-2

’Glc PTS up’

1

0

’O2 up’

1.56

1.12

’Mal::Pyr’

0.151

0.34

’FBP::G6P’

0.03

0.02

’FBP::PG3’

0.92

-0.02

’PG3::PEP’

1.75

-6.2E-2

’Mal::OxA’

0.34

1.012

’NADHDehydro’ 3.11

2.24

’TransHydro’

1.10

0.27

’ATPSynth’

3.79

2.9
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Table A.6.: L-HCM Family Parameters
Name Value
max
kglu

10.73

max
kac

19.28
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B. GENE EXPRESSION PROFILES FOR COMPLETE SET OF GENES FOR
GLUCOSE-ACETATE SYSTEM
Description
The next few figures show the behavior of different gene transcripts with their
respective cybernetic variables for different pathways as the cells shift from glucose
to acetate consumption. ui variables for comparison are selected as indicated in body
of the dissertation in chapter 4.

Figure B.1.: Glycolysis pathway gene transcripts compared to glucose ui variable.
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Figure B.2.: Gluconeogenesis pathway gene transcripts compared to acetate ui variable.
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Figure B.3.: Acetate secretion pathway gene transcripts compared to glucose ui variable.

Figure B.4.: Acetate uptake pathway gene transcripts compared to acetate ui variable.
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Figure B.5.: TCA cycle gene transcripts compared to acetate ui variable.
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Figure B.6.: Glyoxylate pathway gene transcripts compared to acetate ui variable.
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Figure B.7.: Pentose phosphate pathway gene transcripts compared to glucose ui
variable.
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C. LISTS OF GENES USED FOR PATHWAY ENRICHMENT ANALYSIS
Table C.1.: Goal Signal Gene List - Glucose-Acetate System
genes
aceB

aceE

apaH

acnA

ada

agaR

agaV

agaW

araH 2 argG

argH

aroL

arp

artJ

ascB

asd

aspA

aspS

asr

atoB

atoC

atoD

b0298

b0302

b0499

b0669

b0845

b0965

b1173

b1345

b1362

b1443

b1550

b1578

b1604

b1605

b1624

b1640

b1667

b1689

b1691

b1696

b1728

b1729

b1953

b1966

b2326

b2345

b2372

b2383

b2490

b2512

b2817

b2832

b2889

b2896

b2972

b3022

basR

bioH

bisC

btuR

cadC

ccmH

creC

cutC

cysB

cysC

cysE

dbpA

dicB

dsbB

eutG

fabG

fimF

fis

fldA

flgK

flgL

fliL

fliM

fliN

fliZ

fmt

ftsA

ftsK

fucO

fumC

glnD

glnE

glnG

glpB

gltA

gmk

grxA

gsp

hcaA1

hlpA

hofF

hofG

hsdS

htrA

hycE

hycF

hycG

hyfA

hyfE

hypC

idnR

insA 5 insA 6 insB 1

insB 3 ispB

kefC

lgt

lpdA

lpxA

lyxK

malF

mcrA

mdh

mdlA

mdlB

mdoB

menE

menF

menG

mesJ

mhpE

mhpF

mhpR

minC
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Table C.1.: continued
genes
moaA

mobB

motB

mraY

mrcB

msrA

murD

mviN

nadA

nadB

nagA

ndh

nrdB

nrdD

nrdG

nrfE

nrfF

nth

nuoB

nuoE

nuoH

nuoL

nupC

nusA

oppC

oppD

osmC

panB

pdxA

pepD

pgk

pgsA

phnE

phnK

phnO

phnP

phrB

pin

plsC

plsX

pmbA

pnp

potA

potF

pphA

ppiA

ppiB

priA

priC

prlA

proA

proV

prpB

prpE

pspD

pssR

ptsI

purD

purL

purN

purT

pyrC

recB

recR

relA

rep

rfaB

rhlB

rhlE

rho

rhsA

rpiR

rplK

rplQ

rseC

sapC

sapD

sapF

sdaA

sdaC

sdhA

sdhD

sdiA

secE

secG

sfa

sfmD

slyD

smg

smpB

sodB

soxR

sppA

sprT

sseA

sucB

tauB

tdcB

tehA

tehB

thiE

thrS

thyA

tnaB

tnaL

tra5 3

trpS

trs5 1

trs5 5

trxC

ttdA

tyrA

tyrB

tyrS

ubiX

uhpT

usg

ushA

uup

uvrA

uvrB

uvrY

uxaA

vacB

wbbK

wcaA

wcaE

wecB

wecD

xthA

xylF

xylG

yabQ

yadE

yadF

yadL

yadQ

yaeE

yafC

yafE

yafN

yafS

yafV

yagF

yagH

yagM

yagP

yagQ

yahB

yahH

yaiD

yaiT

yajG

ybaA

ybaC

ybaD

ybaE

ybaJ

ybaK

ybbS

ybbT

ybbU

ybbV

ybbW ybbY

ybcM

ybcN

ybcO

ybdE

ybdF

ybdH

ybfC

ybfD

ybfE

continued on next page

ybdS
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Table C.1.: continued
genes
ybfF

ybfG

ybfP

ybgC

ybgF

ybgJ

ybgK

ybgL

ybgO

ybgP

ybhD

ybhH

ybhJ

ybhK

ybhL

ybhM

ybhR

ybiA

ybiB

ybiC

ybiF

ybiH

ybiI

ybiM

ybiN

ybiO

ybiU

ybiW

ybiX

ybiY

ycbC

ycbE

ycbG

ycbS

ycbW

ycbY

yccA

ycdC

ycdY

yceE

ycfJ

ycfK

ycfO

ycfP

ycfQ

ycfR

ycfW

ycgE

ychE

yciC

yciI

yciO

yciV

ycjV

ycjW

ydaJ

ydaK

ydaW

ydaY

ydbA 1 ydbP

ydcN

ydeA

ydeD

ydgR

ydiR

yebF

yebU

yedE

yedF

yehD

yejK

yfhG

yfhJ

yfiB

yfiF

yfjA

yfjR

ygcP

ygdD

ygfT

ygfU

yggD

yggE

yggP

yggX

ygiL

ygiM

ygiN

ygiP

ygjO

yhaH

yhbJ

yhbQ

yhbW

yhbX

yhdA

yhdE

yhdX

yhdY

yheR

yhfM

yhfR

yhhA

yhjM

yhjU

yi22 5

yi81 2

yi91b

yiaL

yiaN

yicG

yicK

yidP

yidW

yigG

yigK

yigR

yihT

yiiE

yiiG

yjbF

yjdL

yjeT

yjfJ

yjgF

yjgR

yjhH

yjiD

yjiZ

yjjA

yjjB

yjjW

ylaC

ymbA

yneH

ynhC

yohL

ypjE

yqeJ

yqjF

yraH

yraJ

yraL

yrbC

yrbD

yrbG

yrbK

yrfF

ytfF

zwf
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Table C.2.: Glucose-Lactose System Goal Signal Gene List
murG

murF

murD

araA

leuC

hepA

carB

yadF

ilvI

aceE

ampD ileS

araB

apaH

ftsA

ftsI

leuA

ampE

hofB

yaaH

yadG

mraY

thrA

caiT

leuD

yaaI

yabO

yabP

htgA

ftsZ

yacF

speD

guaC

yi82 1 yacK

yabM

murC

yacG

yabK

talB

b0100

hofC
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Table C.3.: Prostaglandin Goal Signal Gene List (Entrez IDs / p-value < 0.05)
11542

11861

12371

12421

12686

12768

12771

13032

13132

14026

14130

14131

14313

14544

15368

15468

16181

16190

16409

16416

16438

16633

16911

17000

17112

17118

17119

17392

17480

17768

19079

19164

20293

20405

20479

20619

20907

21816

22142

22158

26941

26951

27362

28018

52004

52502

52662

52808

53599

53622

55963

56045

56177

56389

56737

58248

64382

66146

66251

66607

66898

66943

67098

67510

67588

67946

69065

69076

69608

69710

69743

69772

69959

70829

72245

72925

73710

74018

74150

74198

74603

74781

75871

76457

77125

77328

79555

80289

83602

83679

101497 105278 106200 106326 106572
107321 107934 108112 108954 109815
114601 192650 192652 208228 211496
212919 217664 226245 226409 230088
230784 232370 234199 241296 245403
258280 258940 269346 319370 327957
380686 380712 381484 382113 634881
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Table C.4.: Prostaglandin Goal Signal Gene List (Entrez
IDs / p-value < 0.10)
genes
11542

11749

11812

11861

11977

12370

12371

12421

12481

12686

12768

12771

12928

12953

12986

12988

13026

13032

13132

13390

13730

13805

13830

14026

14038

14070

14130

14131

14254

14313

14544

14977

15368

15421

15468

16181

16190

16328

16409

16416

16438

16443

16633

16859

16869

16911

16997

17000

17087

17112

17118

17119

17392

17480

17533

17768

17979

18550

18647

18704

18715

18788

19012

19079

19082

19108

19164

19219

19766

20229

20293

20353

20405

20439

20479

20555

20619

20773

20907

21816

21887

22142

22158

22324

23796

24056

26941

26951

27081

27261

27362

27381

28018

28040

28146

50523

52004

52055

52120

52502

52662

52808

53378

53599

53622

53791

54170

54713

55963

56045

56177

56380

56389

56484

56632

56722

56737

57435

57746

57781

57912

58203

58248

58998

59007

60361

64294

64380

64382

65973

66146

66251

66503

66607

66684

66816

66898

66943

66989

66994

66998

67098

67171

67198

67231

67457

67510

67588

67608

67946

67976

68038

68118

68205

68774

68952

69065

69076

69608

69710

69718

69743

69772

69834

69959

70231

70829

71782

71967

72245

72344

72925

73393

73710

73808

73827

74018

74150

74198

74568

74603

74781

74868

75018

75288

75871

76281

76457

76775

77125

77328

77573

78412

78610

78611

78830

79555

80289

80795

83397

83602

83679

83704

83984

93692

93888

94220

98878

100226 101489 101497 103806 104110 105278 106200 106326
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Table C.4.: continued
genes
106572 107321 107373 107934 108112 108954 109019 109674 109815
110920 114601 114716 170644 170744 192650 192652 207818 208228
208647 210044 210711 211329 211496 212919 213438 214855 216161
217664 219144 224432 226245 226409 227738 228775 229600 229707
230088 230784 231946 232333 232370 233571 233651 234199 236312
241296 241624 242737 244416 245403 246256 258280 258381 258727
258940 259003 263876 268752 269132 269346 270160 319355 319370
319622 319922 327957 329977 353190 380686 380712 380921 381356
381484 381724 382113 382639 433809 544905 545474 634881 654440
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